Background  ||| S:24 E:43 ||| NN
Many  ||| S:43 E:48 ||| JJ
cloned  ||| S:48 E:55 ||| JJ
animals  ||| S:55 E:63 ||| NNS
have  ||| S:63 E:68 ||| VBP
been  ||| S:68 E:73 ||| VBN
created  ||| S:73 E:81 ||| VBN
using  ||| S:81 E:87 ||| VBG
M  ||| S:87 E:89 ||| NNP
II  ||| S:89 E:92 ||| NNP
oocytes  ||| S:92 E:108 ||| NN
as  ||| S:108 E:111 ||| IN
the  ||| S:111 E:115 ||| DT
recipient  ||| S:115 E:125 ||| JJ
cytoplasm  ||| S:125 E:135 ||| NNS
( ||| S:135 E:136 ||| -LRB-
sheep  ||| S:136 E:142 ||| NN
[  ||| S:142 E:144 ||| -LRB-
1 ||| S:144 E:145 ||| CD
,  ||| S:145 E:147 ||| ,
2 ||| S:147 E:148 ||| LS
] ||| S:148 E:149 ||| -RRB-
,  ||| S:149 E:151 ||| ,
cattle  ||| S:151 E:158 ||| NNS
[  ||| S:158 E:160 ||| -LRB-
3 ||| S:160 E:161 ||| LS
,  ||| S:161 E:163 ||| ,
4 ||| S:163 E:164 ||| CD
,  ||| S:164 E:174 ||| ,
5 ||| S:174 E:175 ||| CD
] ||| S:175 E:176 ||| -RRB-
,  ||| S:176 E:178 ||| ,
mouse  ||| S:178 E:184 ||| NN
[  ||| S:184 E:186 ||| -LRB-
6 ||| S:186 E:187 ||| CD
,  ||| S:187 E:189 ||| ,
7 ||| S:189 E:190 ||| CD
] ||| S:190 E:191 ||| -RRB-
,  ||| S:191 E:193 ||| ,
goat  ||| S:193 E:198 ||| NNS
[  ||| S:198 E:200 ||| -LRB-
8 ||| S:200 E:201 ||| CD
]  ||| S:201 E:203 ||| -RRB-
and  ||| S:203 E:207 ||| CC
pig  ||| S:207 E:211 ||| NN
[  ||| S:211 E:213 ||| -LRB-
9 ||| S:213 E:214 ||| CD
,  ||| S:214 E:216 ||| ,
10 ||| S:216 E:218 ||| CD
,  ||| S:218 E:220 ||| ,
11 ||| S:220 E:222 ||| CD
] ||| S:222 E:223 ||| CD
) ||| S:223 E:224 ||| -RRB-
.  ||| S:224 E:234 ||| .
Maturation ||| S:234 E:244 ||| FW
/ ||| S:244 E:245 ||| FW
meiosis ||| S:245 E:252 ||| FW
/ ||| S:252 E:253 ||| FW
mitosis-promoting  ||| S:253 E:271 ||| FW
factor  ||| S:271 E:278 ||| FW
( ||| S:278 E:279 ||| -LRB-
MPF ||| S:279 E:282 ||| NNP
)  ||| S:282 E:284 ||| -RRB-
activity  ||| S:284 E:301 ||| NN
of  ||| S:301 E:304 ||| IN
recipient  ||| S:304 E:314 ||| JJ
M  ||| S:314 E:316 ||| NNP
II  ||| S:316 E:319 ||| NNP
oocytes  ||| S:319 E:327 ||| NN
appears  ||| S:327 E:335 ||| VBZ
to  ||| S:335 E:338 ||| TO
be  ||| S:338 E:341 ||| VB
important  ||| S:341 E:351 ||| JJ
for  ||| S:351 E:355 ||| IN
the  ||| S:355 E:367 ||| DT
reprogramming  ||| S:367 E:381 ||| NN
of  ||| S:381 E:384 ||| IN
nuclei  ||| S:384 E:391 ||| NN
of  ||| S:391 E:394 ||| IN
reconstructed  ||| S:394 E:408 ||| JJ
embryos ||| S:408 E:415 ||| NN
.  ||| S:415 E:417 ||| .
Two  ||| S:417 E:429 ||| CD
distinct  ||| S:429 E:438 ||| JJ
and  ||| S:438 E:442 ||| CC
different  ||| S:442 E:452 ||| JJ
protocols  ||| S:452 E:462 ||| NNS
emerge  ||| S:462 E:469 ||| VBP
for  ||| S:469 E:473 ||| IN
embryo  ||| S:473 E:488 ||| NN
reconstruction  ||| S:488 E:503 ||| NN
by  ||| S:503 E:506 ||| IN
nuclear  ||| S:506 E:514 ||| JJ
transfer  ||| S:514 E:523 ||| NN
when  ||| S:523 E:528 ||| WRB
using  ||| S:528 E:534 ||| VBG
M  ||| S:534 E:536 ||| NNP
II  ||| S:536 E:539 ||| NNP
oocytes  ||| S:539 E:555 ||| NN
as  ||| S:555 E:558 ||| IN
recipients ||| S:558 E:568 ||| NNS
.  ||| S:568 E:570 ||| .
The  ||| S:570 E:574 ||| DT
first  ||| S:574 E:580 ||| JJ
is  ||| S:580 E:583 ||| VBZ
the  ||| S:583 E:587 ||| DT
transfer  ||| S:587 E:596 ||| NN
of  ||| S:596 E:599 ||| IN
nuclei  ||| S:599 E:606 ||| NN
in  ||| S:606 E:609 ||| IN
G1 ||| S:609 E:611 ||| NNP
,  ||| S:611 E:613 ||| ,
S  ||| S:613 E:623 ||| NNP
or  ||| S:623 E:626 ||| CC
G2  ||| S:626 E:629 ||| CD
phase  ||| S:629 E:635 ||| NN
into  ||| S:635 E:640 ||| IN
the  ||| S:640 E:644 ||| DT
preactivated  ||| S:644 E:657 ||| JJ
recipients  ||| S:657 E:668 ||| NNS
after  ||| S:668 E:674 ||| IN
reducing  ||| S:674 E:691 ||| VBG
MPF  ||| S:691 E:695 ||| NNP
activity  ||| S:695 E:704 ||| NN
and  ||| S:704 E:708 ||| CC
the  ||| S:708 E:712 ||| DT
second  ||| S:712 E:719 ||| NN
is  ||| S:719 E:722 ||| VBZ
the  ||| S:722 E:726 ||| DT
transfer  ||| S:726 E:735 ||| NN
of  ||| S:735 E:738 ||| IN
nuclei  ||| S:738 E:745 ||| NN
in  ||| S:745 E:748 ||| IN
GO  ||| S:748 E:759 ||| NNP
or  ||| S:759 E:762 ||| CC
G1  ||| S:762 E:765 ||| CD
phase  ||| S:765 E:771 ||| NN
directly  ||| S:771 E:780 ||| RB
into  ||| S:780 E:785 ||| IN
M  ||| S:785 E:787 ||| NNP
II  ||| S:787 E:790 ||| NNP
oocytes  ||| S:790 E:798 ||| VBZ
having  ||| S:798 E:805 ||| VBG
high  ||| S:805 E:810 ||| JJ
MPF  ||| S:810 E:822 ||| NNP
activity  ||| S:822 E:831 ||| NN
[  ||| S:831 E:833 ||| -LRB-
12 ||| S:833 E:835 ||| CD
] ||| S:835 E:836 ||| -RRB-
.  ||| S:836 E:838 ||| .
Recently ||| S:838 E:846 ||| RB
,  ||| S:846 E:848 ||| ,
it  ||| S:848 E:851 ||| PRP
has  ||| S:851 E:855 ||| VBZ
been  ||| S:855 E:860 ||| VBN
shown  ||| S:860 E:866 ||| VBN
that  ||| S:866 E:871 ||| IN
when  ||| S:871 E:876 ||| WRB
mouse  ||| S:876 E:890 ||| JJ
embryonic  ||| S:890 E:900 ||| NNS
stem  ||| S:900 E:905 ||| VBP
cells  ||| S:905 E:911 ||| NNS
[  ||| S:911 E:913 ||| -LRB-
13 ||| S:913 E:915 ||| CD
]  ||| S:915 E:917 ||| -RRB-
and  ||| S:917 E:921 ||| CC
bovine  ||| S:921 E:928 ||| JJ
somatic  ||| S:928 E:936 ||| JJ
cells  ||| S:936 E:942 ||| NNS
[  ||| S:942 E:944 ||| -LRB-
14 ||| S:944 E:946 ||| CD
]  ||| S:946 E:956 ||| -RRB-
in  ||| S:956 E:959 ||| IN
the  ||| S:959 E:963 ||| DT
M  ||| S:963 E:965 ||| NNP
phase  ||| S:965 E:971 ||| NN
were  ||| S:971 E:976 ||| VBD
transferred  ||| S:976 E:988 ||| VBN
into  ||| S:988 E:993 ||| IN
non-treated  ||| S:993 E:1013 ||| JJ
recipients ||| S:1013 E:1023 ||| NNS
,  ||| S:1023 E:1025 ||| ,
the  ||| S:1025 E:1029 ||| DT
chromosome  ||| S:1029 E:1040 ||| NN
constitution  ||| S:1040 E:1053 ||| NN
of  ||| S:1053 E:1056 ||| IN
reconstructed  ||| S:1056 E:1078 ||| JJ
embryos  ||| S:1078 E:1086 ||| NN
was  ||| S:1086 E:1090 ||| VBD
normal  ||| S:1090 E:1097 ||| JJ
in  ||| S:1097 E:1100 ||| IN
that  ||| S:1100 E:1105 ||| IN
the  ||| S:1105 E:1109 ||| DT
second  ||| S:1109 E:1116 ||| JJ
polar  ||| S:1116 E:1122 ||| JJ
body  ||| S:1122 E:1127 ||| NN
was  ||| S:1127 E:1139 ||| VBD
excluded  ||| S:1139 E:1148 ||| VBN
after  ||| S:1148 E:1154 ||| IN
parthenogenetic  ||| S:1154 E:1170 ||| JJ
activation  ||| S:1170 E:1181 ||| NN
and  ||| S:1181 E:1185 ||| CC
the  ||| S:1185 E:1189 ||| DT
embryos  ||| S:1189 E:1205 ||| NN
developed  ||| S:1205 E:1215 ||| VBN
to  ||| S:1215 E:1218 ||| TO
offspring ||| S:1218 E:1227 ||| VB
.  ||| S:1227 E:1229 ||| .
The  ||| S:1229 E:1233 ||| DT
first  ||| S:1233 E:1239 ||| JJ
protocol  ||| S:1239 E:1248 ||| NN
is  ||| S:1248 E:1251 ||| VBZ
effective  ||| S:1251 E:1261 ||| JJ
for  ||| S:1261 E:1273 ||| IN
production  ||| S:1273 E:1284 ||| NN
of  ||| S:1284 E:1287 ||| IN
blastomeres  ||| S:1287 E:1299 ||| VBG
derived  ||| S:1299 E:1307 ||| VBN
cloned  ||| S:1307 E:1314 ||| JJ
embryos  ||| S:1314 E:1322 ||| NN
because  ||| S:1322 E:1338 ||| IN
cell  ||| S:1338 E:1343 ||| NN
cycle  ||| S:1343 E:1349 ||| NN
synchronization  ||| S:1349 E:1365 ||| NN
of  ||| S:1365 E:1368 ||| IN
embryonic  ||| S:1368 E:1378 ||| JJ
nuclei  ||| S:1378 E:1385 ||| NN
is  ||| S:1385 E:1388 ||| VBZ
difficult  ||| S:1388 E:1406 ||| JJ
and  ||| S:1406 E:1410 ||| CC
the  ||| S:1410 E:1414 ||| DT
majority  ||| S:1414 E:1423 ||| NN
of  ||| S:1423 E:1426 ||| IN
blastomeres  ||| S:1426 E:1438 ||| NNS
are  ||| S:1438 E:1442 ||| VBP
in  ||| S:1442 E:1445 ||| IN
the  ||| S:1445 E:1449 ||| DT
S  ||| S:1449 E:1451 ||| NNP
phase  ||| S:1451 E:1457 ||| NN
at  ||| S:1457 E:1460 ||| IN
any  ||| S:1460 E:1472 ||| DT
given  ||| S:1472 E:1478 ||| VBN
time  ||| S:1478 E:1483 ||| NN
[  ||| S:1483 E:1485 ||| -LRB-
15 ||| S:1485 E:1487 ||| CD
,  ||| S:1487 E:1489 ||| ,
16 ||| S:1489 E:1491 ||| CD
,  ||| S:1491 E:1493 ||| ,
17 ||| S:1493 E:1495 ||| CD
] ||| S:1495 E:1496 ||| -RRB-
.  ||| S:1496 E:1498 ||| .
In  ||| S:1498 E:1501 ||| IN
the  ||| S:1501 E:1505 ||| DT
preactivated  ||| S:1505 E:1518 ||| JJ
oocyte ||| S:1518 E:1524 ||| NN
,  ||| S:1524 E:1526 ||| ,
the  ||| S:1526 E:1538 ||| DT
nuclear  ||| S:1538 E:1546 ||| JJ
membrane  ||| S:1546 E:1555 ||| NN
of  ||| S:1555 E:1558 ||| IN
the  ||| S:1558 E:1562 ||| DT
donor  ||| S:1562 E:1568 ||| NN
cells  ||| S:1568 E:1574 ||| NNS
remains  ||| S:1574 E:1582 ||| VBZ
intact  ||| S:1582 E:1589 ||| JJ
due  ||| S:1589 E:1593 ||| JJ
to  ||| S:1593 E:1604 ||| TO
the  ||| S:1604 E:1608 ||| DT
low  ||| S:1608 E:1612 ||| JJ
activity  ||| S:1612 E:1621 ||| NN
of  ||| S:1621 E:1624 ||| IN
MPF  ||| S:1624 E:1628 ||| NNP
and  ||| S:1628 E:1632 ||| CC
DNA  ||| S:1632 E:1636 ||| NNP
synthesis  ||| S:1636 E:1646 ||| NN
occurs  ||| S:1646 E:1653 ||| VBZ
according  ||| S:1653 E:1671 ||| VBG
to  ||| S:1671 E:1674 ||| TO
the  ||| S:1674 E:1678 ||| DT
original  ||| S:1678 E:1687 ||| JJ
cell  ||| S:1687 E:1692 ||| NN
cycle  ||| S:1692 E:1698 ||| NN
stage  ||| S:1698 E:1704 ||| NN
at  ||| S:1704 E:1707 ||| IN
the  ||| S:1707 E:1711 ||| DT
time  ||| S:1711 E:1716 ||| NN
of  ||| S:1716 E:1719 ||| IN
nuclear  ||| S:1719 E:1735 ||| JJ
transfer  ||| S:1735 E:1744 ||| NN
[  ||| S:1744 E:1746 ||| -LRB-
12 ||| S:1746 E:1748 ||| CD
]  ||| S:1748 E:1750 ||| -RRB-
and  ||| S:1750 E:1754 ||| CC
nuclear  ||| S:1754 E:1762 ||| JJ
reprogramming  ||| S:1762 E:1776 ||| NN
occurs  ||| S:1776 E:1783 ||| VBZ
during  ||| S:1783 E:1790 ||| IN
the  ||| S:1790 E:1802 ||| DT
expansion  ||| S:1802 E:1812 ||| NN
of  ||| S:1812 E:1815 ||| IN
the  ||| S:1815 E:1819 ||| DT
donor  ||| S:1819 E:1825 ||| NN
nucleus  ||| S:1825 E:1833 ||| NNS
[  ||| S:1833 E:1835 ||| -LRB-
18 ||| S:1835 E:1837 ||| CD
,  ||| S:1837 E:1839 ||| ,
19 ||| S:1839 E:1841 ||| CD
] ||| S:1841 E:1842 ||| -RRB-
.  ||| S:1842 E:1844 ||| .
Additionally ||| S:1844 E:1856 ||| RB
,  ||| S:1856 E:1866 ||| ,
nuclei  ||| S:1866 E:1873 ||| VBG
of  ||| S:1873 E:1876 ||| IN
cells  ||| S:1876 E:1882 ||| NNS
of  ||| S:1882 E:1885 ||| IN
established  ||| S:1885 E:1897 ||| JJ
embryonic  ||| S:1897 E:1907 ||| JJ
cell  ||| S:1907 E:1912 ||| NN
lines  ||| S:1912 E:1918 ||| NNS
are  ||| S:1918 E:1930 ||| VBP
reprogrammed  ||| S:1930 E:1943 ||| VBN
in  ||| S:1943 E:1946 ||| IN
preactivated  ||| S:1946 E:1959 ||| JJ
recipient  ||| S:1959 E:1969 ||| JJ
oocytes ||| S:1969 E:1976 ||| NN
,  ||| S:1976 E:1978 ||| ,
porcine  ||| S:1978 E:1994 ||| JJ
embryos  ||| S:1994 E:2002 ||| JJ
reconstituted  ||| S:2002 E:2016 ||| NN
with  ||| S:2016 E:2021 ||| IN
blastocyst-derived  ||| S:2021 E:2040 ||| JJ
cells  ||| S:2040 E:2046 ||| NNS
and  ||| S:2046 E:2058 ||| CC
preactivated  ||| S:2058 E:2071 ||| JJ
recipients  ||| S:2071 E:2082 ||| NNS
have  ||| S:2082 E:2087 ||| VBP
the  ||| S:2087 E:2091 ||| DT
ability  ||| S:2091 E:2099 ||| NN
to  ||| S:2099 E:2102 ||| TO
develop  ||| S:2102 E:2110 ||| VB
to  ||| S:2110 E:2121 ||| TO
blastocysts  ||| S:2121 E:2133 ||| VB
[  ||| S:2133 E:2135 ||| -LRB-
20 ||| S:2135 E:2137 ||| CD
] ||| S:2137 E:2138 ||| -RRB-
.  ||| S:2138 E:2140 ||| .
However ||| S:2140 E:2147 ||| RB
,  ||| S:2147 E:2149 ||| ,
there  ||| S:2149 E:2155 ||| EX
is  ||| S:2155 E:2158 ||| VBZ
only  ||| S:2158 E:2163 ||| RB
one  ||| S:2163 E:2167 ||| CD
report  ||| S:2167 E:2174 ||| NN
in  ||| S:2174 E:2185 ||| IN
which  ||| S:2185 E:2191 ||| WDT
cloned  ||| S:2191 E:2198 ||| VBP
animals  ||| S:2198 E:2206 ||| NNS
have  ||| S:2206 E:2211 ||| VBP
been  ||| S:2211 E:2216 ||| VBN
produced  ||| S:2216 E:2225 ||| VBN
from  ||| S:2225 E:2230 ||| IN
embryos  ||| S:2230 E:2246 ||| JJ
reconstructed  ||| S:2246 E:2260 ||| NN
by  ||| S:2260 E:2263 ||| IN
transferring  ||| S:2263 E:2276 ||| VBG
differentiated  ||| S:2276 E:2291 ||| JJ
cells  ||| S:2291 E:2297 ||| NNS
into  ||| S:2297 E:2310 ||| IN
preactivated  ||| S:2310 E:2323 ||| FW
recipient  ||| S:2323 E:2333 ||| FW
oocytes  ||| S:2333 E:2341 ||| FW
[  ||| S:2341 E:2343 ||| -LRB-
8 ||| S:2343 E:2344 ||| CD
]  ||| S:2344 E:2346 ||| -RRB-
and  ||| S:2346 E:2350 ||| CC
the  ||| S:2350 E:2354 ||| DT
ability  ||| S:2354 E:2362 ||| NN
of  ||| S:2362 E:2373 ||| IN
preactivated  ||| S:2373 E:2386 ||| JJ
recipient  ||| S:2386 E:2396 ||| JJ
oocytes  ||| S:2396 E:2404 ||| NN
to  ||| S:2404 E:2407 ||| TO
reprogram  ||| S:2407 E:2417 ||| VB
differentiated  ||| S:2417 E:2440 ||| JJ
cells  ||| S:2440 E:2446 ||| NNS
is  ||| S:2446 E:2449 ||| VBZ
now  ||| S:2449 E:2453 ||| RB
in  ||| S:2453 E:2456 ||| IN
debate ||| S:2456 E:2462 ||| NN
.  ||| S:2462 E:2464 ||| .
When  ||| S:2464 E:2469 ||| WRB
bovine  ||| S:2469 E:2476 ||| JJ
somatic  ||| S:2476 E:2484 ||| JJ
cells  ||| S:2484 E:2490 ||| NNS
were  ||| S:2490 E:2503 ||| VBD
transferred  ||| S:2503 E:2515 ||| VBN
into  ||| S:2515 E:2520 ||| IN
preactivated  ||| S:2520 E:2533 ||| JJ
recipient  ||| S:2533 E:2543 ||| JJ
oocytes ||| S:2543 E:2550 ||| NN
,  ||| S:2550 E:2552 ||| ,
the  ||| S:2552 E:2564 ||| DT
resulting  ||| S:2564 E:2574 ||| VBG
reconstructed  ||| S:2574 E:2588 ||| JJ
embryo  ||| S:2588 E:2595 ||| NN
development  ||| S:2595 E:2607 ||| NN
was  ||| S:2607 E:2611 ||| VBD
limited ||| S:2611 E:2618 ||| VBN
,  ||| S:2618 E:2628 ||| ,
since  ||| S:2628 E:2634 ||| IN
all  ||| S:2634 E:2638 ||| DT
embryos  ||| S:2638 E:2646 ||| NN
arrested  ||| S:2646 E:2655 ||| VBN
at  ||| S:2655 E:2658 ||| IN
the  ||| S:2658 E:2662 ||| DT
8-cell  ||| S:2662 E:2669 ||| JJ
stage  ||| S:2669 E:2675 ||| NN
regardless  ||| S:2675 E:2694 ||| RB
of  ||| S:2694 E:2697 ||| IN
the  ||| S:2697 E:2701 ||| DT
cell  ||| S:2701 E:2706 ||| NN
cycle  ||| S:2706 E:2712 ||| NN
of  ||| S:2712 E:2715 ||| IN
the  ||| S:2715 E:2719 ||| DT
donor  ||| S:2719 E:2725 ||| NN
cells  ||| S:2725 E:2731 ||| NNS
[  ||| S:2731 E:2733 ||| -LRB-
14 ||| S:2733 E:2735 ||| CD
] ||| S:2735 E:2736 ||| -RRB-
.  ||| S:2736 E:2738 ||| .
Because  ||| S:2738 E:2754 ||| IN
embryonic  ||| S:2754 E:2764 ||| JJ
genome  ||| S:2764 E:2771 ||| JJ
activation  ||| S:2771 E:2782 ||| NN
of  ||| S:2782 E:2785 ||| IN
bovine  ||| S:2785 E:2792 ||| JJ
embryos  ||| S:2792 E:2800 ||| NN
occurs  ||| S:2800 E:2815 ||| VBZ
between  ||| S:2815 E:2823 ||| IN
the  ||| S:2823 E:2827 ||| DT
8-  ||| S:2827 E:2830 ||| NN
to  ||| S:2830 E:2833 ||| TO
16-cell  ||| S:2833 E:2841 ||| CD
stages  ||| S:2841 E:2848 ||| NNS
[  ||| S:2848 E:2850 ||| -LRB-
21 ||| S:2850 E:2852 ||| CD
] ||| S:2852 E:2853 ||| -RRB-
,  ||| S:2853 E:2855 ||| ,
preactivated  ||| S:2855 E:2876 ||| JJ
recipients  ||| S:2876 E:2887 ||| NNS
may  ||| S:2887 E:2891 ||| MD
not  ||| S:2891 E:2895 ||| RB
reprogram  ||| S:2895 E:2905 ||| JJ
somatic  ||| S:2905 E:2913 ||| JJ
nuclei ||| S:2913 E:2919 ||| NN
.  ||| S:2919 E:2921 ||| .
In  ||| S:2921 E:2924 ||| IN
contrast ||| S:2924 E:2932 ||| NN
,  ||| S:2932 E:2942 ||| ,
when  ||| S:2942 E:2947 ||| WRB
nuclei  ||| S:2947 E:2954 ||| NNS
in  ||| S:2954 E:2957 ||| IN
G0  ||| S:2957 E:2960 ||| NNP
or  ||| S:2960 E:2963 ||| CC
G1  ||| S:2963 E:2966 ||| CD
phase  ||| S:2966 E:2972 ||| NN
are  ||| S:2972 E:2976 ||| VBP
transferred  ||| S:2976 E:2988 ||| VBN
into  ||| S:2988 E:3001 ||| IN
non-treated  ||| S:3001 E:3013 ||| JJ
recipients ||| S:3013 E:3023 ||| NNS
,  ||| S:3023 E:3025 ||| ,
reconstructed  ||| S:3025 E:3039 ||| JJ
embryos  ||| S:3039 E:3047 ||| NN
can  ||| S:3047 E:3051 ||| MD
develop  ||| S:3051 E:3067 ||| VB
to  ||| S:3067 E:3070 ||| TO
offspring  ||| S:3070 E:3080 ||| VB
in  ||| S:3080 E:3083 ||| IN
many  ||| S:3083 E:3088 ||| JJ
species  ||| S:3088 E:3096 ||| NNS
[  ||| S:3096 E:3098 ||| -LRB-
1 ||| S:3098 E:3099 ||| CD
,  ||| S:3099 E:3101 ||| ,
2 ||| S:3101 E:3102 ||| CD
,  ||| S:3102 E:3104 ||| ,
3 ||| S:3104 E:3105 ||| CD
,  ||| S:3105 E:3107 ||| ,
4 ||| S:3107 E:3108 ||| CD
,  ||| S:3108 E:3110 ||| ,
5 ||| S:3110 E:3111 ||| CD
,  ||| S:3111 E:3113 ||| ,
6 ||| S:3113 E:3114 ||| CD
,  ||| S:3114 E:3116 ||| ,
8 ||| S:3116 E:3117 ||| CD
,  ||| S:3117 E:3119 ||| ,
9 ||| S:3119 E:3120 ||| CD
,  ||| S:3120 E:3122 ||| ,
10 ||| S:3122 E:3124 ||| CD
,  ||| S:3124 E:3134 ||| ,
11 ||| S:3134 E:3136 ||| CD
] ||| S:3136 E:3137 ||| -RRB-
.  ||| S:3137 E:3139 ||| .
In  ||| S:3139 E:3142 ||| IN
the  ||| S:3142 E:3146 ||| DT
M  ||| S:3146 E:3148 ||| NNP
II  ||| S:3148 E:3151 ||| NNP
oocyte ||| S:3151 E:3157 ||| NN
,  ||| S:3157 E:3159 ||| ,
the  ||| S:3159 E:3163 ||| DT
membrane  ||| S:3163 E:3172 ||| NN
of  ||| S:3172 E:3175 ||| IN
the  ||| S:3175 E:3179 ||| DT
donor  ||| S:3179 E:3185 ||| NN
nucleus  ||| S:3185 E:3201 ||| NN
is  ||| S:3201 E:3204 ||| VBZ
broken  ||| S:3204 E:3211 ||| VBN
down  ||| S:3211 E:3216 ||| RP
and  ||| S:3216 E:3220 ||| CC
the  ||| S:3220 E:3224 ||| DT
chromosomes  ||| S:3224 E:3236 ||| NNS
are  ||| S:3236 E:3240 ||| VBP
prematurely  ||| S:3240 E:3260 ||| RB
condensed  ||| S:3260 E:3270 ||| JJ
due  ||| S:3270 E:3274 ||| JJ
to  ||| S:3274 E:3277 ||| TO
the  ||| S:3277 E:3281 ||| DT
high  ||| S:3281 E:3286 ||| JJ
activity  ||| S:3286 E:3295 ||| NN
of  ||| S:3295 E:3298 ||| IN
MPF ||| S:3298 E:3301 ||| NNP
.  ||| S:3301 E:3303 ||| .
After  ||| S:3303 E:3317 ||| IN
parthenogenetic  ||| S:3317 E:3333 ||| JJ
activation ||| S:3333 E:3343 ||| NN
,  ||| S:3343 E:3345 ||| ,
the  ||| S:3345 E:3349 ||| DT
membrane  ||| S:3349 E:3358 ||| JJ
reforms  ||| S:3358 E:3366 ||| NNS
and  ||| S:3366 E:3370 ||| CC
DNA  ||| S:3370 E:3382 ||| NNP
synthesis  ||| S:3382 E:3392 ||| NN
begins  ||| S:3392 E:3399 ||| VBZ
[  ||| S:3399 E:3401 ||| -LRB-
22 ||| S:3401 E:3403 ||| CD
] ||| S:3403 E:3404 ||| -RRB-
.  ||| S:3404 E:3406 ||| .
MPF  ||| S:3406 E:3410 ||| NNP
activity  ||| S:3410 E:3419 ||| NN
during  ||| S:3419 E:3426 ||| IN
oocyte  ||| S:3426 E:3441 ||| JJ
maturation  ||| S:3441 E:3452 ||| NN
is  ||| S:3452 E:3455 ||| VBZ
maximal  ||| S:3455 E:3463 ||| VBN
at  ||| S:3463 E:3466 ||| IN
both  ||| S:3466 E:3471 ||| DT
M  ||| S:3471 E:3473 ||| NNP
I  ||| S:3473 E:3475 ||| NNP
and  ||| S:3475 E:3479 ||| CC
M  ||| S:3479 E:3481 ||| NNP
II  ||| S:3481 E:3484 ||| NNP
[  ||| S:3484 E:3486 ||| -LRB-
12 ||| S:3486 E:3488 ||| CD
] ||| S:3488 E:3489 ||| -RRB-
.  ||| S:3489 E:3491 ||| .
Because  ||| S:3491 E:3507 ||| IN
many  ||| S:3507 E:3512 ||| JJ
studies  ||| S:3512 E:3520 ||| NNS
suggest  ||| S:3520 E:3528 ||| VBP
that  ||| S:3528 E:3533 ||| DT
exposure  ||| S:3533 E:3542 ||| NN
to  ||| S:3542 E:3545 ||| TO
high  ||| S:3545 E:3550 ||| JJ
activity  ||| S:3550 E:3559 ||| NN
of  ||| S:3559 E:3562 ||| IN
MPF  ||| S:3562 E:3574 ||| NNP
is  ||| S:3574 E:3577 ||| VBZ
effective  ||| S:3577 E:3587 ||| JJ
for  ||| S:3587 E:3591 ||| IN
reprogramming  ||| S:3591 E:3605 ||| VBG
a  ||| S:3605 E:3607 ||| DT
donor  ||| S:3607 E:3613 ||| NN
nucleus  ||| S:3613 E:3621 ||| NN
from  ||| S:3621 E:3626 ||| IN
a  ||| S:3626 E:3636 ||| DT
differentiated  ||| S:3636 E:3651 ||| JJ
cell  ||| S:3651 E:3656 ||| NN
[  ||| S:3656 E:3658 ||| -LRB-
1 ||| S:3658 E:3659 ||| CD
,  ||| S:3659 E:3661 ||| ,
2 ||| S:3661 E:3662 ||| CD
,  ||| S:3662 E:3664 ||| ,
3 ||| S:3664 E:3665 ||| CD
,  ||| S:3665 E:3667 ||| ,
4 ||| S:3667 E:3668 ||| CD
,  ||| S:3668 E:3670 ||| ,
5 ||| S:3670 E:3671 ||| CD
,  ||| S:3671 E:3673 ||| ,
6 ||| S:3673 E:3674 ||| CD
,  ||| S:3674 E:3676 ||| ,
7 ||| S:3676 E:3677 ||| CD
,  ||| S:3677 E:3679 ||| ,
8 ||| S:3679 E:3680 ||| CD
,  ||| S:3680 E:3682 ||| ,
9 ||| S:3682 E:3683 ||| CD
,  ||| S:3683 E:3685 ||| ,
10 ||| S:3685 E:3687 ||| CD
,  ||| S:3687 E:3689 ||| ,
11 ||| S:3689 E:3691 ||| CD
,  ||| S:3691 E:3701 ||| ,
14 ||| S:3701 E:3703 ||| CD
] ||| S:3703 E:3704 ||| -RRB-
,  ||| S:3704 E:3706 ||| ,
M  ||| S:3706 E:3708 ||| NNP
I  ||| S:3708 E:3710 ||| NNP
oocytes  ||| S:3710 E:3718 ||| NN
may  ||| S:3718 E:3722 ||| MD
reprogram  ||| S:3722 E:3732 ||| VB
somatic  ||| S:3732 E:3740 ||| JJ
cell  ||| S:3740 E:3745 ||| NN
nuclei  ||| S:3745 E:3752 ||| NN
as  ||| S:3752 E:3755 ||| IN
well ||| S:3755 E:3759 ||| RB
.  ||| S:3759 E:3769 ||| .
In  ||| S:3769 E:3772 ||| IN
the  ||| S:3772 E:3776 ||| DT
amphibian ||| S:3776 E:3785 ||| NN
,  ||| S:3785 E:3787 ||| ,
the  ||| S:3787 E:3791 ||| DT
greatest  ||| S:3791 E:3800 ||| JJS
yield  ||| S:3800 E:3806 ||| NN
and  ||| S:3806 E:3810 ||| CC
most  ||| S:3810 E:3815 ||| RBS
advanced  ||| S:3815 E:3832 ||| JJ
tadpoles  ||| S:3832 E:3841 ||| NN
came  ||| S:3841 E:3846 ||| VBD
from  ||| S:3846 E:3851 ||| IN
differentiated  ||| S:3851 E:3866 ||| JJ
somatic  ||| S:3866 E:3874 ||| JJ
cell  ||| S:3874 E:3879 ||| NN
nuclei  ||| S:3879 E:3894 ||| VBZ
injected  ||| S:3894 E:3903 ||| VBN
into  ||| S:3903 E:3908 ||| IN
M  ||| S:3908 E:3910 ||| NNP
I  ||| S:3910 E:3912 ||| PRP
oocytes  ||| S:3912 E:3920 ||| VBP
[  ||| S:3920 E:3922 ||| -LRB-
23 ||| S:3922 E:3924 ||| CD
,  ||| S:3924 E:3926 ||| ,
24 ||| S:3926 E:3928 ||| CD
]  ||| S:3928 E:3930 ||| -RRB-
compared  ||| S:3930 E:3939 ||| VBN
to  ||| S:3939 E:3942 ||| TO
M  ||| S:3942 E:3944 ||| NNP
II  ||| S:3944 E:3955 ||| NNP
oocytes  ||| S:3955 E:3963 ||| NNS
[  ||| S:3963 E:3965 ||| -LRB-
23 ||| S:3965 E:3967 ||| CD
,  ||| S:3967 E:3969 ||| ,
25 ||| S:3969 E:3971 ||| CD
,  ||| S:3971 E:3973 ||| ,
26 ||| S:3973 E:3975 ||| CD
] ||| S:3975 E:3976 ||| -RRB-
,  ||| S:3976 E:3978 ||| ,
although  ||| S:3978 E:3987 ||| IN
adults  ||| S:3987 E:3994 ||| NNS
could  ||| S:3994 E:4000 ||| MD
not  ||| S:4000 E:4004 ||| RB
be  ||| S:4004 E:4015 ||| VB
generated  ||| S:4015 E:4025 ||| VBN
from  ||| S:4025 E:4030 ||| IN
these  ||| S:4030 E:4036 ||| DT
reconstructed  ||| S:4036 E:4050 ||| JJ
embryos ||| S:4050 E:4057 ||| NN
.  ||| S:4057 E:4059 ||| .
However ||| S:4059 E:4066 ||| RB
,  ||| S:4066 E:4068 ||| ,
there  ||| S:4068 E:4082 ||| EX
are  ||| S:4082 E:4086 ||| VBP
no  ||| S:4086 E:4089 ||| DT
reports  ||| S:4089 E:4097 ||| NNS
that  ||| S:4097 E:4102 ||| WDT
experimentally  ||| S:4102 E:4117 ||| VBZ
tested  ||| S:4117 E:4124 ||| VBN
this  ||| S:4124 E:4129 ||| DT
hypothesis  ||| S:4129 E:4148 ||| NN
in  ||| S:4148 E:4151 ||| IN
mammals ||| S:4151 E:4158 ||| NN
.  ||| S:4158 E:4160 ||| .
In  ||| S:4160 E:4163 ||| IN
the  ||| S:4163 E:4167 ||| DT
present  ||| S:4167 E:4175 ||| JJ
study ||| S:4175 E:4180 ||| NN
,  ||| S:4180 E:4182 ||| ,
we  ||| S:4182 E:4185 ||| PRP
examined  ||| S:4185 E:4194 ||| VBD
the  ||| S:4194 E:4198 ||| DT
ability  ||| S:4198 E:4214 ||| NN
of  ||| S:4214 E:4217 ||| IN
porcine  ||| S:4217 E:4225 ||| JJ
M  ||| S:4225 E:4227 ||| NNP
I  ||| S:4227 E:4229 ||| PRP
oocytes  ||| S:4229 E:4237 ||| VBP
to  ||| S:4237 E:4240 ||| TO
reprogram  ||| S:4240 E:4250 ||| VB
somatic  ||| S:4250 E:4258 ||| JJ
cell  ||| S:4258 E:4271 ||| NN
nuclei ||| S:4271 E:4277 ||| NN
.  ||| S:4277 E:4301 ||| .
Results  ||| S:4301 E:4328 ||| NNP
Cell  ||| S:4328 E:4333 ||| NNP
Cycle  ||| S:4333 E:4339 ||| NNP
Analysis  ||| S:4339 E:4348 ||| NNP
of  ||| S:4348 E:4351 ||| IN
Donor  ||| S:4351 E:4357 ||| NNP
Cells  ||| S:4357 E:4373 ||| NNP
The  ||| S:4373 E:4377 ||| DT
cell  ||| S:4377 E:4382 ||| NN
cycle  ||| S:4382 E:4388 ||| NN
stages  ||| S:4388 E:4395 ||| NNS
of  ||| S:4395 E:4398 ||| IN
ear  ||| S:4398 E:4402 ||| JJ
fibroblasts  ||| S:4402 E:4414 ||| NN
after  ||| S:4414 E:4430 ||| IN
reaching  ||| S:4430 E:4439 ||| VBG
confluence  ||| S:4439 E:4450 ||| NNS
or  ||| S:4450 E:4453 ||| CC
treatment  ||| S:4453 E:4463 ||| NN
with  ||| S:4463 E:4468 ||| IN
nocodazole  ||| S:4468 E:4479 ||| NN
were  ||| S:4479 E:4494 ||| VBD
analyzed  ||| S:4494 E:4503 ||| VBN
using  ||| S:4503 E:4509 ||| VBG
flow  ||| S:4509 E:4514 ||| NN
cytometry ||| S:4514 E:4523 ||| NN
.  ||| S:4523 E:4525 ||| .
Analysis  ||| S:4525 E:4534 ||| NN
of  ||| S:4534 E:4537 ||| IN
the  ||| S:4537 E:4541 ||| DT
cell  ||| S:4541 E:4546 ||| NN
cycle  ||| S:4546 E:4562 ||| NN
stages  ||| S:4562 E:4569 ||| NNS
in  ||| S:4569 E:4572 ||| IN
confluent  ||| S:4572 E:4582 ||| JJ
cells  ||| S:4582 E:4588 ||| NNS
revealed  ||| S:4588 E:4597 ||| VBD
that  ||| S:4597 E:4602 ||| IN
91.2  ||| S:4602 E:4607 ||| CD
±  ||| S:4607 E:4609 ||| CD
0.2 ||| S:4609 E:4612 ||| CD
%  ||| S:4612 E:4614 ||| NN
of  ||| S:4614 E:4627 ||| IN
the  ||| S:4627 E:4631 ||| DT
cells  ||| S:4631 E:4637 ||| NNS
were  ||| S:4637 E:4642 ||| VBD
at  ||| S:4642 E:4645 ||| IN
the  ||| S:4645 E:4649 ||| DT
G0 ||| S:4649 E:4651 ||| CD
/ ||| S:4651 E:4652 ||| CD
G1  ||| S:4652 E:4655 ||| CD
phase ||| S:4655 E:4660 ||| NN
,  ||| S:4660 E:4662 ||| ,
2.5  ||| S:4662 E:4666 ||| CD
±  ||| S:4666 E:4668 ||| CD
0.1 ||| S:4668 E:4671 ||| CD
%  ||| S:4671 E:4673 ||| NN
were  ||| S:4673 E:4678 ||| VBD
at  ||| S:4678 E:4681 ||| IN
the  ||| S:4681 E:4695 ||| DT
S  ||| S:4695 E:4697 ||| NNP
phase  ||| S:4697 E:4703 ||| NN
and  ||| S:4703 E:4707 ||| CC
6.4  ||| S:4707 E:4711 ||| CD
±  ||| S:4711 E:4713 ||| CD
0.1 ||| S:4713 E:4716 ||| CD
%  ||| S:4716 E:4718 ||| NN
were  ||| S:4718 E:4723 ||| VBD
at  ||| S:4723 E:4726 ||| IN
the  ||| S:4726 E:4730 ||| DT
G2 ||| S:4730 E:4732 ||| NNP
/ ||| S:4732 E:4733 ||| NNP
M  ||| S:4733 E:4735 ||| NNP
phase ||| S:4735 E:4740 ||| NN
.  ||| S:4740 E:4742 ||| .
In  ||| S:4742 E:4745 ||| IN
the  ||| S:4745 E:4759 ||| DT
population  ||| S:4759 E:4770 ||| NN
of  ||| S:4770 E:4773 ||| IN
cells  ||| S:4773 E:4779 ||| NNS
collected  ||| S:4779 E:4789 ||| VBN
after  ||| S:4789 E:4795 ||| IN
nocodazole  ||| S:4795 E:4806 ||| JJ
treatment ||| S:4806 E:4815 ||| NN
,  ||| S:4815 E:4827 ||| ,
31.0  ||| S:4827 E:4832 ||| CD
±  ||| S:4832 E:4834 ||| CD
3.6 ||| S:4834 E:4837 ||| CD
%  ||| S:4837 E:4839 ||| NN
were  ||| S:4839 E:4844 ||| VBD
at  ||| S:4844 E:4847 ||| IN
the  ||| S:4847 E:4851 ||| DT
G0 ||| S:4851 E:4853 ||| CD
/ ||| S:4853 E:4854 ||| CD
G1  ||| S:4854 E:4857 ||| CD
phase ||| S:4857 E:4862 ||| NN
,  ||| S:4862 E:4864 ||| ,
14.8  ||| S:4864 E:4869 ||| CD
±  ||| S:4869 E:4871 ||| CD
3.1 ||| S:4871 E:4874 ||| CD
%  ||| S:4874 E:4876 ||| NN
were  ||| S:4876 E:4881 ||| VBD
at  ||| S:4881 E:4894 ||| IN
the  ||| S:4894 E:4898 ||| DT
S  ||| S:4898 E:4900 ||| NNP
phase  ||| S:4900 E:4906 ||| NN
and  ||| S:4906 E:4910 ||| CC
54.1  ||| S:4910 E:4915 ||| CD
±  ||| S:4915 E:4917 ||| CD
4.4 ||| S:4917 E:4920 ||| CD
%  ||| S:4920 E:4922 ||| NN
were  ||| S:4922 E:4927 ||| VBD
at  ||| S:4927 E:4930 ||| IN
the  ||| S:4930 E:4934 ||| DT
G2 ||| S:4934 E:4936 ||| NNP
/ ||| S:4936 E:4937 ||| NNP
M  ||| S:4937 E:4939 ||| NNP
phase ||| S:4939 E:4944 ||| NN
.  ||| S:4944 E:4956 ||| .
Experiments  ||| S:4956 E:4968 ||| NNS
were  ||| S:4968 E:4973 ||| VBD
repeated  ||| S:4973 E:4982 ||| VBN
3  ||| S:4982 E:4984 ||| CD
times  ||| S:4984 E:4990 ||| NNS
and  ||| S:4990 E:4994 ||| CC
the  ||| S:4994 E:4998 ||| DT
data  ||| S:4998 E:5003 ||| NNS
are  ||| S:5003 E:5017 ||| VBP
expressed  ||| S:5017 E:5027 ||| VBN
as  ||| S:5027 E:5030 ||| RB
mean  ||| S:5030 E:5035 ||| VB
±  ||| S:5035 E:5037 ||| NNP
SEM ||| S:5037 E:5040 ||| NNP
.  ||| S:5040 E:5070 ||| .
Behaviour  ||| S:5070 E:5080 ||| NNP
before  ||| S:5080 E:5087 ||| IN
Activation  ||| S:5087 E:5098 ||| NNP
of  ||| S:5098 E:5101 ||| IN
Donor  ||| S:5101 E:5107 ||| NNP
Cell  ||| S:5107 E:5122 ||| NNP
Nuclei  ||| S:5122 E:5139 ||| NNP
When  ||| S:5139 E:5144 ||| WRB
confluent  ||| S:5144 E:5154 ||| JJ
cells  ||| S:5154 E:5160 ||| NNS
were  ||| S:5160 E:5165 ||| VBD
transferred  ||| S:5165 E:5177 ||| VBN
into  ||| S:5177 E:5182 ||| IN
M  ||| S:5182 E:5184 ||| NNP
I  ||| S:5184 E:5196 ||| PRP
oocytes ||| S:5196 E:5203 ||| VBP
,  ||| S:5203 E:5205 ||| ,
the  ||| S:5205 E:5209 ||| DT
fusion  ||| S:5209 E:5216 ||| NN
rate  ||| S:5216 E:5221 ||| NN
( ||| S:5221 E:5222 ||| -LRB-
60.2 ||| S:5222 E:5226 ||| CD
% ||| S:5226 E:5227 ||| NN
)  ||| S:5227 E:5229 ||| -RRB-
was  ||| S:5229 E:5233 ||| VBD
significantly  ||| S:5233 E:5247 ||| RB
( ||| S:5247 E:5248 ||| -LRB-
P  ||| S:5248 E:5260 ||| NNP
< ||| S:5260 E:5262 ||| SYM
0.05 ||| S:5262 E:5266 ||| CD
)  ||| S:5266 E:5268 ||| -RRB-
higher  ||| S:5268 E:5275 ||| JJR
than  ||| S:5275 E:5280 ||| IN
that  ||| S:5280 E:5285 ||| DT
( ||| S:5285 E:5286 ||| -LRB-
25.8 ||| S:5286 E:5290 ||| CD
% ||| S:5290 E:5291 ||| NN
)  ||| S:5291 E:5293 ||| -RRB-
of  ||| S:5293 E:5296 ||| IN
embryos  ||| S:5296 E:5314 ||| JJ
reconstituted  ||| S:5314 E:5328 ||| NN
with  ||| S:5328 E:5333 ||| IN
nocodazole-treated  ||| S:5333 E:5352 ||| JJ
cells  ||| S:5352 E:5358 ||| NNS
and  ||| S:5358 E:5362 ||| CC
M  ||| S:5362 E:5364 ||| NNP
I  ||| S:5364 E:5376 ||| PRP
oocytes  ||| S:5376 E:5384 ||| VBP
( ||| S:5384 E:5385 ||| -LRB-
Table  ||| S:5385 E:5391 ||| NNP
1 ||| S:5391 E:5392 ||| CD
) ||| S:5392 E:5393 ||| -RRB-
.  ||| S:5393 E:5395 ||| .
At  ||| S:5395 E:5398 ||| IN
15  ||| S:5398 E:5401 ||| CD
h  ||| S:5401 E:5403 ||| NN
after  ||| S:5403 E:5409 ||| IN
fusion ||| S:5409 E:5415 ||| NN
,  ||| S:5415 E:5417 ||| ,
spots  ||| S:5417 E:5423 ||| NNS
of  ||| S:5423 E:5436 ||| IN
condensed  ||| S:5436 E:5446 ||| JJ
chromatin  ||| S:5446 E:5456 ||| NNS
( ||| S:5456 E:5457 ||| -LRB-
Figure  ||| S:5457 E:5464 ||| NNP
1Aand  ||| S:5464 E:5470 ||| NNP
1B ||| S:5470 E:5472 ||| NNP
)  ||| S:5472 E:5474 ||| -RRB-
were  ||| S:5474 E:5479 ||| VBD
observed  ||| S:5479 E:5488 ||| VBN
in  ||| S:5488 E:5501 ||| IN
the  ||| S:5501 E:5505 ||| DT
majority  ||| S:5505 E:5514 ||| NN
( ||| S:5514 E:5515 ||| -LRB-
85.0 ||| S:5515 E:5519 ||| NNP
% ||| S:5519 E:5520 ||| NN
)  ||| S:5520 E:5522 ||| -RRB-
of  ||| S:5522 E:5525 ||| IN
embryos  ||| S:5525 E:5533 ||| JJ
reconstructed  ||| S:5533 E:5547 ||| NN
by  ||| S:5547 E:5560 ||| IN
transferring  ||| S:5560 E:5573 ||| VBG
confluent  ||| S:5573 E:5583 ||| JJ
cells  ||| S:5583 E:5589 ||| NNS
and  ||| S:5589 E:5593 ||| CC
this  ||| S:5593 E:5598 ||| DT
percentage  ||| S:5598 E:5609 ||| NN
was  ||| S:5609 E:5623 ||| VBD
significantly  ||| S:5623 E:5637 ||| RB
( ||| S:5637 E:5638 ||| -LRB-
P  ||| S:5638 E:5640 ||| NNP
< ||| S:5640 E:5642 ||| SYM
0.05 ||| S:5642 E:5646 ||| CD
)  ||| S:5646 E:5648 ||| -RRB-
higher  ||| S:5648 E:5655 ||| JJR
than  ||| S:5655 E:5660 ||| IN
that  ||| S:5660 E:5665 ||| DT
( ||| S:5665 E:5666 ||| -LRB-
63.3 ||| S:5666 E:5670 ||| NNP
% ||| S:5670 E:5671 ||| NN
)  ||| S:5671 E:5673 ||| -RRB-
of  ||| S:5673 E:5686 ||| IN
embryos  ||| S:5686 E:5694 ||| JJ
reconstituted  ||| S:5694 E:5708 ||| NN
with  ||| S:5708 E:5713 ||| IN
nocodazole-treated  ||| S:5713 E:5732 ||| JJ
cells ||| S:5732 E:5737 ||| NNS
.  ||| S:5737 E:5739 ||| .
When  ||| S:5739 E:5754 ||| WRB
nocodazole-treated  ||| S:5754 E:5773 ||| JJ
cells  ||| S:5773 E:5779 ||| NNS
were  ||| S:5779 E:5784 ||| VBD
transferred  ||| S:5784 E:5796 ||| VBN
into  ||| S:5796 E:5801 ||| IN
M  ||| S:5801 E:5803 ||| NNP
I  ||| S:5803 E:5815 ||| PRP
oocytes ||| S:5815 E:5822 ||| VBP
,  ||| S:5822 E:5824 ||| ,
one  ||| S:5824 E:5828 ||| CD
spot  ||| S:5828 E:5833 ||| NN
of  ||| S:5833 E:5836 ||| IN
condensed  ||| S:5836 E:5846 ||| JJ
chromatin  ||| S:5846 E:5856 ||| NN
and  ||| S:5856 E:5860 ||| CC
one  ||| S:5860 E:5864 ||| CD
polar  ||| S:5864 E:5880 ||| JJ
body  ||| S:5880 E:5885 ||| NN
( ||| S:5885 E:5886 ||| -LRB-
Figure  ||| S:5886 E:5893 ||| NNP
1C ||| S:5893 E:5895 ||| NNP
)  ||| S:5895 E:5897 ||| -RRB-
was  ||| S:5897 E:5901 ||| VBD
observed  ||| S:5901 E:5910 ||| VBN
in  ||| S:5910 E:5913 ||| IN
13.3 ||| S:5913 E:5917 ||| CD
%  ||| S:5917 E:5919 ||| NN
of  ||| S:5919 E:5922 ||| IN
reconstructed  ||| S:5922 E:5946 ||| JJ
embryos ||| S:5946 E:5953 ||| NN
.  ||| S:5953 E:5955 ||| .
Regardless  ||| S:5955 E:5966 ||| RB
of  ||| S:5966 E:5969 ||| IN
the  ||| S:5969 E:5973 ||| DT
cell  ||| S:5973 E:5978 ||| NN
cycle  ||| S:5978 E:5984 ||| NN
of  ||| S:5984 E:5987 ||| IN
the  ||| S:5987 E:5991 ||| DT
donor  ||| S:5991 E:5997 ||| NN
cells ||| S:5997 E:6002 ||| NNS
,  ||| S:6002 E:6014 ||| ,
the  ||| S:6014 E:6018 ||| DT
percentage  ||| S:6018 E:6029 ||| NN
( ||| S:6029 E:6030 ||| -LRB-
3.3-5.0 ||| S:6030 E:6037 ||| NNP
% ||| S:6037 E:6038 ||| NN
)  ||| S:6038 E:6040 ||| -RRB-
of  ||| S:6040 E:6043 ||| IN
embryos  ||| S:6043 E:6051 ||| NN
with  ||| S:6051 E:6056 ||| IN
swollen  ||| S:6056 E:6064 ||| JJ
nuclei  ||| S:6064 E:6081 ||| NNS
( ||| S:6081 E:6082 ||| -LRB-
Figure  ||| S:6082 E:6089 ||| NNP
1Dand  ||| S:6089 E:6095 ||| NNP
1E ||| S:6095 E:6097 ||| NNP
)  ||| S:6097 E:6099 ||| -RRB-
was  ||| S:6099 E:6103 ||| VBD
low ||| S:6103 E:6106 ||| JJ
.  ||| S:6106 E:6136 ||| .
Behaviour  ||| S:6136 E:6146 ||| NNP
after  ||| S:6146 E:6152 ||| IN
Activation  ||| S:6152 E:6163 ||| NNP
of  ||| S:6163 E:6166 ||| IN
Donor  ||| S:6166 E:6172 ||| NNP
Cell  ||| S:6172 E:6187 ||| NNP
Nuclei  ||| S:6187 E:6204 ||| NNP
As  ||| S:6204 E:6207 ||| IN
shown  ||| S:6207 E:6213 ||| VBN
in  ||| S:6213 E:6216 ||| IN
Table  ||| S:6216 E:6222 ||| NNP
2 ||| S:6222 E:6223 ||| CD
,  ||| S:6223 E:6225 ||| ,
when  ||| S:6225 E:6230 ||| WRB
confluent  ||| S:6230 E:6240 ||| JJ
cells  ||| S:6240 E:6246 ||| NNS
were  ||| S:6246 E:6251 ||| VBD
used  ||| S:6251 E:6256 ||| VBN
as  ||| S:6256 E:6269 ||| IN
donors ||| S:6269 E:6275 ||| NNS
,  ||| S:6275 E:6277 ||| ,
the  ||| S:6277 E:6281 ||| DT
fusion  ||| S:6281 E:6288 ||| NN
rate  ||| S:6288 E:6293 ||| NN
( ||| S:6293 E:6294 ||| -LRB-
60.2-62.7 ||| S:6294 E:6303 ||| NNP
% ||| S:6303 E:6304 ||| NN
)  ||| S:6304 E:6306 ||| -RRB-
was  ||| S:6306 E:6310 ||| VBD
significantly  ||| S:6310 E:6324 ||| RB
( ||| S:6324 E:6325 ||| -LRB-
P  ||| S:6325 E:6337 ||| NNP
< ||| S:6337 E:6339 ||| SYM
0.05 ||| S:6339 E:6343 ||| CD
)  ||| S:6343 E:6345 ||| -RRB-
higher  ||| S:6345 E:6352 ||| JJR
than  ||| S:6352 E:6357 ||| IN
that  ||| S:6357 E:6362 ||| DT
( ||| S:6362 E:6363 ||| -LRB-
29.0-33.6 ||| S:6363 E:6372 ||| NNP
% ||| S:6372 E:6373 ||| NN
)  ||| S:6373 E:6375 ||| -RRB-
of  ||| S:6375 E:6388 ||| IN
nocodazole-treated  ||| S:6388 E:6407 ||| JJ
cells  ||| S:6407 E:6413 ||| NNS
regardless  ||| S:6413 E:6424 ||| RB
of  ||| S:6424 E:6427 ||| IN
the  ||| S:6427 E:6431 ||| DT
maturation  ||| S:6431 E:6452 ||| JJ
stage  ||| S:6452 E:6458 ||| NN
of  ||| S:6458 E:6461 ||| IN
the  ||| S:6461 E:6465 ||| DT
recipient  ||| S:6465 E:6475 ||| JJ
oocytes ||| S:6475 E:6482 ||| NN
.  ||| S:6482 E:6484 ||| .
At  ||| S:6484 E:6487 ||| IN
6  ||| S:6487 E:6489 ||| CD
h  ||| S:6489 E:6491 ||| NN
after  ||| S:6491 E:6497 ||| IN
activation ||| S:6497 E:6507 ||| NN
,  ||| S:6507 E:6519 ||| ,
swollen  ||| S:6519 E:6527 ||| JJ
nuclei  ||| S:6527 E:6534 ||| NN
were  ||| S:6534 E:6539 ||| VBD
observed  ||| S:6539 E:6548 ||| VBN
in  ||| S:6548 E:6551 ||| IN
50.0  ||| S:6551 E:6556 ||| NNP
and  ||| S:6556 E:6560 ||| CC
88.9 ||| S:6560 E:6564 ||| CD
%  ||| S:6564 E:6566 ||| NN
of  ||| S:6566 E:6569 ||| IN
embryos  ||| S:6569 E:6587 ||| VBG
produced  ||| S:6587 E:6596 ||| VBN
by  ||| S:6596 E:6599 ||| IN
transferring  ||| S:6599 E:6612 ||| VBG
confluent  ||| S:6612 E:6622 ||| JJ
cells  ||| S:6622 E:6628 ||| NNS
into  ||| S:6628 E:6633 ||| IN
M  ||| S:6633 E:6635 ||| NNP
I  ||| S:6635 E:6637 ||| NNP
or  ||| S:6637 E:6640 ||| CC
M  ||| S:6640 E:6642 ||| NNP
II  ||| S:6642 E:6655 ||| NNP
oocytes  ||| S:6655 E:6663 ||| NN
with  ||| S:6663 E:6668 ||| IN
no  ||| S:6668 E:6671 ||| DT
significant  ||| S:6671 E:6683 ||| JJ
differences ||| S:6683 E:6694 ||| NNS
.  ||| S:6694 E:6696 ||| .
Although  ||| S:6696 E:6715 ||| IN
34.4-39.5 ||| S:6715 E:6724 ||| CD
%  ||| S:6724 E:6726 ||| NN
of  ||| S:6726 E:6729 ||| IN
embryos  ||| S:6729 E:6737 ||| JJ
reconstituted  ||| S:6737 E:6751 ||| NN
with  ||| S:6751 E:6766 ||| IN
nocodazole-treated  ||| S:6766 E:6785 ||| JJ
cells  ||| S:6785 E:6791 ||| NNS
had  ||| S:6791 E:6795 ||| VBD
swollen  ||| S:6795 E:6803 ||| JJ
nuclei ||| S:6803 E:6809 ||| NN
,  ||| S:6809 E:6811 ||| ,
the  ||| S:6811 E:6825 ||| DT
percentage  ||| S:6825 E:6836 ||| NN
of  ||| S:6836 E:6839 ||| IN
embryos  ||| S:6839 E:6847 ||| NN
with  ||| S:6847 E:6852 ||| IN
both  ||| S:6852 E:6857 ||| PDT
the  ||| S:6857 E:6861 ||| DT
swollen  ||| S:6861 E:6869 ||| JJ
nucleus  ||| S:6869 E:6877 ||| NN
and  ||| S:6877 E:6891 ||| CC
polar  ||| S:6891 E:6897 ||| JJ
body  ||| S:6897 E:6902 ||| NN
( ||| S:6902 E:6903 ||| -LRB-
Figure  ||| S:6903 E:6910 ||| NNP
1F ||| S:6910 E:6912 ||| NNP
)  ||| S:6912 E:6914 ||| -RRB-
was  ||| S:6914 E:6918 ||| VBD
only  ||| S:6918 E:6923 ||| RB
6.3-10.5 ||| S:6923 E:6931 ||| CD
% ||| S:6931 E:6932 ||| NN
.  ||| S:6932 E:6962 ||| .
Development  ||| S:6962 E:6974 ||| NN
of  ||| S:6974 E:6977 ||| IN
Reconstructed  ||| S:6977 E:6991 ||| NNP
Embryos  ||| S:6991 E:7009 ||| NNP
The  ||| S:7009 E:7013 ||| DT
cleavage  ||| S:7013 E:7022 ||| JJ
rate  ||| S:7022 E:7027 ||| NN
( ||| S:7027 E:7028 ||| -LRB-
38.2 ||| S:7028 E:7032 ||| CD
% ||| S:7032 E:7033 ||| NN
)  ||| S:7033 E:7035 ||| -RRB-
of  ||| S:7035 E:7038 ||| IN
embryos  ||| S:7038 E:7046 ||| JJ
reconstituted  ||| S:7046 E:7070 ||| NN
with  ||| S:7070 E:7075 ||| IN
confluent  ||| S:7075 E:7085 ||| JJ
cells  ||| S:7085 E:7091 ||| NNS
and  ||| S:7091 E:7095 ||| CC
M  ||| S:7095 E:7097 ||| NNP
II  ||| S:7097 E:7100 ||| NNP
oocytes  ||| S:7100 E:7108 ||| NN
was  ||| S:7108 E:7112 ||| VBD
significantly  ||| S:7112 E:7136 ||| RB
( ||| S:7136 E:7137 ||| -LRB-
P  ||| S:7137 E:7139 ||| NNP
< ||| S:7139 E:7141 ||| SYM
0.05 ||| S:7141 E:7145 ||| CD
)  ||| S:7145 E:7147 ||| -RRB-
higher  ||| S:7147 E:7154 ||| JJR
than  ||| S:7154 E:7159 ||| IN
that  ||| S:7159 E:7164 ||| DT
( ||| S:7164 E:7165 ||| -LRB-
5.3-9.7 ||| S:7165 E:7172 ||| NNP
% ||| S:7172 E:7173 ||| NN
)  ||| S:7173 E:7175 ||| -RRB-
of  ||| S:7175 E:7178 ||| IN
embryos  ||| S:7178 E:7196 ||| VBG
produced  ||| S:7196 E:7205 ||| VBN
by  ||| S:7205 E:7208 ||| IN
transferring  ||| S:7208 E:7221 ||| VBG
confluent  ||| S:7221 E:7231 ||| NNS
or  ||| S:7231 E:7234 ||| CC
nocodazole-treated  ||| S:7234 E:7263 ||| JJ
cells  ||| S:7263 E:7269 ||| NNS
into  ||| S:7269 E:7274 ||| IN
M  ||| S:7274 E:7276 ||| NNP
I  ||| S:7276 E:7278 ||| PRP
oocytes  ||| S:7278 E:7286 ||| VBP
( ||| S:7286 E:7287 ||| -LRB-
Table  ||| S:7287 E:7293 ||| NNP
3 ||| S:7293 E:7294 ||| CD
) ||| S:7294 E:7295 ||| -RRB-
.  ||| S:7295 E:7297 ||| .
However ||| S:7297 E:7304 ||| RB
,  ||| S:7304 E:7306 ||| ,
this  ||| S:7306 E:7321 ||| DT
percentage  ||| S:7321 E:7332 ||| NN
( ||| S:7332 E:7333 ||| -LRB-
38.2 ||| S:7333 E:7337 ||| CD
% ||| S:7337 E:7338 ||| NN
)  ||| S:7338 E:7340 ||| -RRB-
did  ||| S:7340 E:7344 ||| VBD
not  ||| S:7344 E:7348 ||| RB
significantly  ||| S:7348 E:7362 ||| RB
differ  ||| S:7362 E:7369 ||| VB
from  ||| S:7369 E:7374 ||| IN
that  ||| S:7374 E:7389 ||| DT
of  ||| S:7389 E:7392 ||| IN
embryos  ||| S:7392 E:7400 ||| JJ
reconstituted  ||| S:7400 E:7414 ||| NN
with  ||| S:7414 E:7419 ||| IN
nocodazole-treated  ||| S:7419 E:7438 ||| JJ
cells  ||| S:7438 E:7454 ||| NNS
and  ||| S:7454 E:7458 ||| CC
M  ||| S:7458 E:7460 ||| NNP
II  ||| S:7460 E:7463 ||| NNP
oocytes  ||| S:7463 E:7471 ||| NNS
( ||| S:7471 E:7472 ||| -LRB-
15.4 ||| S:7472 E:7476 ||| CD
% ||| S:7476 E:7477 ||| NN
) ||| S:7477 E:7478 ||| -RRB-
.  ||| S:7478 E:7480 ||| .
When  ||| S:7480 E:7485 ||| WRB
embryos  ||| S:7485 E:7493 ||| JJ
reconstituted  ||| S:7493 E:7507 ||| NN
with  ||| S:7507 E:7522 ||| IN
confluent  ||| S:7522 E:7532 ||| JJ
cells  ||| S:7532 E:7538 ||| NNS
and  ||| S:7538 E:7542 ||| CC
M  ||| S:7542 E:7544 ||| NNP
I  ||| S:7544 E:7546 ||| PRP
oocytes  ||| S:7546 E:7554 ||| RB
were  ||| S:7554 E:7559 ||| VBD
cultured ||| S:7559 E:7567 ||| CD
,  ||| S:7567 E:7569 ||| ,
2  ||| S:7569 E:7571 ||| CD
( ||| S:7571 E:7572 ||| -LRB-
1.5 ||| S:7572 E:7575 ||| CD
% ||| S:7575 E:7576 ||| NN
)  ||| S:7576 E:7588 ||| -RRB-
blastocysts  ||| S:7588 E:7600 ||| NNS
( ||| S:7600 E:7601 ||| -LRB-
Figure  ||| S:7601 E:7608 ||| NNP
2 ||| S:7608 E:7609 ||| CD
)  ||| S:7609 E:7611 ||| -RRB-
were  ||| S:7611 E:7616 ||| VBD
obtained  ||| S:7616 E:7625 ||| VBN
and  ||| S:7625 E:7629 ||| CC
this  ||| S:7629 E:7634 ||| DT
percentage  ||| S:7634 E:7655 ||| NN
was  ||| S:7655 E:7659 ||| VBD
significantly  ||| S:7659 E:7673 ||| RB
( ||| S:7673 E:7674 ||| -LRB-
P  ||| S:7674 E:7676 ||| NNP
< ||| S:7676 E:7678 ||| SYM
0.05 ||| S:7678 E:7682 ||| CD
)  ||| S:7682 E:7684 ||| -RRB-
lower  ||| S:7684 E:7690 ||| JJR
than  ||| S:7690 E:7695 ||| IN
that  ||| S:7695 E:7700 ||| DT
of  ||| S:7700 E:7713 ||| IN
embryos  ||| S:7713 E:7721 ||| VBG
produced  ||| S:7721 E:7730 ||| VBN
by  ||| S:7730 E:7733 ||| IN
transferring  ||| S:7733 E:7746 ||| VBG
confluent  ||| S:7746 E:7756 ||| JJ
cells  ||| S:7756 E:7762 ||| NNS
into  ||| S:7762 E:7767 ||| IN
M  ||| S:7767 E:7779 ||| NNP
II  ||| S:7779 E:7782 ||| NNP
oocytes  ||| S:7782 E:7790 ||| NNS
( ||| S:7790 E:7791 ||| -LRB-
7.6 ||| S:7791 E:7794 ||| CD
% ||| S:7794 E:7795 ||| NN
) ||| S:7795 E:7796 ||| -RRB-
.  ||| S:7796 E:7798 ||| .
There  ||| S:7798 E:7804 ||| EX
were  ||| S:7804 E:7809 ||| VBD
no  ||| S:7809 E:7812 ||| DT
significant  ||| S:7812 E:7824 ||| JJ
differences  ||| S:7824 E:7846 ||| NNS
in  ||| S:7846 E:7849 ||| IN
mean  ||| S:7849 E:7854 ||| JJ
numbers  ||| S:7854 E:7862 ||| NNS
of  ||| S:7862 E:7865 ||| IN
cells  ||| S:7865 E:7871 ||| NNS
in  ||| S:7871 E:7874 ||| IN
the  ||| S:7874 E:7878 ||| DT
blastocysts  ||| S:7878 E:7890 ||| NN
between  ||| S:7890 E:7908 ||| IN
different  ||| S:7908 E:7918 ||| JJ
maturation  ||| S:7918 E:7929 ||| JJ
stages  ||| S:7929 E:7936 ||| NNS
of  ||| S:7936 E:7939 ||| IN
the  ||| S:7939 E:7943 ||| DT
recipient  ||| S:7943 E:7953 ||| JJ
oocytes ||| S:7953 E:7960 ||| NN
.  ||| S:7960 E:7962 ||| .
No  ||| S:7962 E:7975 ||| DT
embryos  ||| S:7975 E:7983 ||| NN
developed  ||| S:7983 E:7993 ||| VBN
to  ||| S:7993 E:7996 ||| TO
the  ||| S:7996 E:8000 ||| DT
blastocyst  ||| S:8000 E:8011 ||| JJ
stage  ||| S:8011 E:8017 ||| NN
when  ||| S:8017 E:8032 ||| WRB
nocodazole-treated  ||| S:8032 E:8051 ||| JJ
cells  ||| S:8051 E:8057 ||| NNS
were  ||| S:8057 E:8062 ||| VBD
used  ||| S:8062 E:8067 ||| VBN
as  ||| S:8067 E:8070 ||| IN
donors  ||| S:8070 E:8077 ||| NNS
regardless  ||| S:8077 E:8098 ||| RB
of  ||| S:8098 E:8101 ||| IN
the  ||| S:8101 E:8105 ||| DT
maturation  ||| S:8105 E:8116 ||| JJ
stage  ||| S:8116 E:8122 ||| NN
of  ||| S:8122 E:8125 ||| IN
the  ||| S:8125 E:8129 ||| DT
recipient  ||| S:8129 E:8139 ||| JJ
oocytes ||| S:8139 E:8146 ||| NN
.  ||| S:8146 E:8179 ||| .
Discussion  ||| S:8179 E:8198 ||| NN
The  ||| S:8198 E:8202 ||| DT
results  ||| S:8202 E:8210 ||| NNS
of  ||| S:8210 E:8213 ||| IN
the  ||| S:8213 E:8217 ||| DT
present  ||| S:8217 E:8225 ||| JJ
study  ||| S:8225 E:8231 ||| NN
demonstrated  ||| S:8231 E:8244 ||| VBD
the  ||| S:8244 E:8248 ||| DT
in  ||| S:8248 E:8259 ||| IN
vitro  ||| S:8259 E:8265 ||| JJ
developmental  ||| S:8265 E:8279 ||| JJ
ability  ||| S:8279 E:8287 ||| NN
to  ||| S:8287 E:8290 ||| TO
blastocysts  ||| S:8290 E:8302 ||| VB
of  ||| S:8302 E:8305 ||| IN
porcine  ||| S:8305 E:8321 ||| JJ
embryos  ||| S:8321 E:8329 ||| JJ
reconstituted  ||| S:8329 E:8343 ||| NN
with  ||| S:8343 E:8348 ||| IN
somatic  ||| S:8348 E:8356 ||| JJ
cells  ||| S:8356 E:8362 ||| NNS
and  ||| S:8362 E:8366 ||| CC
enucleated  ||| S:8366 E:8377 ||| JJ
M  ||| S:8377 E:8379 ||| NNP
I  ||| S:8379 E:8389 ||| PRP
oocytes ||| S:8389 E:8396 ||| VBD
.  ||| S:8396 E:8398 ||| .
To  ||| S:8398 E:8401 ||| TO
our  ||| S:8401 E:8405 ||| PRP$
knowledge ||| S:8405 E:8414 ||| NN
,  ||| S:8414 E:8416 ||| ,
this  ||| S:8416 E:8421 ||| DT
is  ||| S:8421 E:8424 ||| VBZ
the  ||| S:8424 E:8428 ||| DT
first  ||| S:8428 E:8434 ||| JJ
report  ||| S:8434 E:8441 ||| NN
that  ||| S:8441 E:8454 ||| WDT
describes  ||| S:8454 E:8464 ||| VBZ
blastocyst  ||| S:8464 E:8475 ||| JJ
formation  ||| S:8475 E:8485 ||| NN
of  ||| S:8485 E:8488 ||| IN
embryos  ||| S:8488 E:8496 ||| JJ
reconstituted  ||| S:8496 E:8518 ||| NN
with  ||| S:8518 E:8523 ||| IN
M  ||| S:8523 E:8525 ||| NNP
I  ||| S:8525 E:8527 ||| PRP
oocytes  ||| S:8527 E:8535 ||| VBD
in  ||| S:8535 E:8538 ||| IN
mammals ||| S:8538 E:8545 ||| NN
.  ||| S:8545 E:8555 ||| .
When  ||| S:8555 E:8560 ||| WRB
donor  ||| S:8560 E:8566 ||| JJ
nuclei  ||| S:8566 E:8573 ||| NNS
are  ||| S:8573 E:8577 ||| VBP
transferred  ||| S:8577 E:8589 ||| VBN
into  ||| S:8589 E:8594 ||| IN
non-treated  ||| S:8594 E:8606 ||| NNP
M  ||| S:8606 E:8608 ||| NNP
II  ||| S:8608 E:8619 ||| NNP
recipient  ||| S:8619 E:8629 ||| JJ
oocytes  ||| S:8629 E:8637 ||| NN
that  ||| S:8637 E:8642 ||| WDT
have  ||| S:8642 E:8647 ||| VBP
high  ||| S:8647 E:8652 ||| JJ
MPF  ||| S:8652 E:8656 ||| NNP
activity ||| S:8656 E:8664 ||| NN
,  ||| S:8664 E:8666 ||| ,
various  ||| S:8666 E:8682 ||| JJ
changes  ||| S:8682 E:8690 ||| NNS
referred  ||| S:8690 E:8699 ||| VBD
to  ||| S:8699 E:8702 ||| TO
as  ||| S:8702 E:8705 ||| RB
nuclear  ||| S:8705 E:8713 ||| JJ
remodeling  ||| S:8713 E:8724 ||| NNS
occur  ||| S:8724 E:8730 ||| VBP
in  ||| S:8730 E:8733 ||| IN
the  ||| S:8733 E:8745 ||| DT
introduced  ||| S:8745 E:8756 ||| VBN
nuclei ||| S:8756 E:8762 ||| NN
.  ||| S:8762 E:8764 ||| .
This  ||| S:8764 E:8769 ||| DT
phenomenon  ||| S:8769 E:8780 ||| NN
is  ||| S:8780 E:8783 ||| VBZ
considered  ||| S:8783 E:8794 ||| VBN
to  ||| S:8794 E:8797 ||| TO
involve  ||| S:8797 E:8813 ||| VB
nuclear  ||| S:8813 E:8821 ||| JJ
structural  ||| S:8821 E:8832 ||| JJ
changes ||| S:8832 E:8839 ||| NNS
,  ||| S:8839 E:8841 ||| ,
such  ||| S:8841 E:8846 ||| JJ
as  ||| S:8846 E:8849 ||| IN
nuclear  ||| S:8849 E:8857 ||| JJ
envelope  ||| S:8857 E:8874 ||| NN
breakdown ||| S:8874 E:8883 ||| NN
,  ||| S:8883 E:8885 ||| ,
premature  ||| S:8885 E:8895 ||| JJ
chromosome  ||| S:8895 E:8906 ||| NN
condensation  ||| S:8906 E:8919 ||| NNS
and  ||| S:8919 E:8923 ||| CC
pronuclear  ||| S:8923 E:8942 ||| JJ
development  ||| S:8942 E:8954 ||| NN
and  ||| S:8954 E:8958 ||| CC
swelling  ||| S:8958 E:8967 ||| VBG
[  ||| S:8967 E:8969 ||| -LRB-
27 ||| S:8969 E:8971 ||| CD
,  ||| S:8971 E:8973 ||| ,
28 ||| S:8973 E:8975 ||| CD
,  ||| S:8975 E:8977 ||| ,
29 ||| S:8977 E:8979 ||| CD
] ||| S:8979 E:8980 ||| -RRB-
.  ||| S:8980 E:8982 ||| .
Nuclear  ||| S:8982 E:8990 ||| JJ
remodeling  ||| S:8990 E:9009 ||| NN
is  ||| S:9009 E:9012 ||| VBZ
thought  ||| S:9012 E:9020 ||| VBN
to  ||| S:9020 E:9023 ||| TO
be  ||| S:9023 E:9026 ||| VB
a  ||| S:9026 E:9028 ||| DT
result  ||| S:9028 E:9035 ||| NN
of  ||| S:9035 E:9038 ||| IN
the  ||| S:9038 E:9042 ||| DT
exchange  ||| S:9042 E:9051 ||| NN
of  ||| S:9051 E:9054 ||| IN
proteins  ||| S:9054 E:9071 ||| NNS
between  ||| S:9071 E:9079 ||| IN
the  ||| S:9079 E:9083 ||| DT
nuclear  ||| S:9083 E:9091 ||| JJ
and  ||| S:9091 E:9095 ||| CC
cytoplasmic  ||| S:9095 E:9107 ||| JJ
compartments  ||| S:9107 E:9120 ||| NNS
[  ||| S:9120 E:9122 ||| -LRB-
30 ||| S:9122 E:9124 ||| CD
]  ||| S:9124 E:9126 ||| -RRB-
and  ||| S:9126 E:9138 ||| CC
is  ||| S:9138 E:9141 ||| VBZ
pre-requisite  ||| S:9141 E:9155 ||| JJ
to  ||| S:9155 E:9158 ||| TO
or  ||| S:9158 E:9161 ||| CC
is  ||| S:9161 E:9164 ||| VBZ
part  ||| S:9164 E:9169 ||| NN
of  ||| S:9169 E:9172 ||| IN
the  ||| S:9172 E:9176 ||| DT
reprogramming  ||| S:9176 E:9190 ||| NN
of  ||| S:9190 E:9193 ||| IN
gene  ||| S:9193 E:9206 ||| NN
expression  ||| S:9206 E:9217 ||| NN
[  ||| S:9217 E:9219 ||| -LRB-
31 ||| S:9219 E:9221 ||| CD
,  ||| S:9221 E:9223 ||| ,
32 ||| S:9223 E:9225 ||| CD
,  ||| S:9225 E:9227 ||| ,
33 ||| S:9227 E:9229 ||| CD
] ||| S:9229 E:9230 ||| -RRB-
.  ||| S:9230 E:9232 ||| .
Therefore ||| S:9232 E:9241 ||| RB
,  ||| S:9241 E:9243 ||| ,
it  ||| S:9243 E:9246 ||| PRP
is  ||| S:9246 E:9249 ||| VBZ
generally  ||| S:9249 E:9267 ||| RB
considered  ||| S:9267 E:9278 ||| VBN
that  ||| S:9278 E:9283 ||| IN
the  ||| S:9283 E:9287 ||| DT
phenomenon  ||| S:9287 E:9298 ||| NN
of  ||| S:9298 E:9301 ||| IN
nuclear  ||| S:9301 E:9309 ||| JJ
swelling  ||| S:9309 E:9318 ||| NN
is  ||| S:9318 E:9321 ||| VBZ
one  ||| S:9321 E:9333 ||| CD
essential  ||| S:9333 E:9343 ||| JJ
component  ||| S:9343 E:9353 ||| NN
of  ||| S:9353 E:9356 ||| IN
the  ||| S:9356 E:9360 ||| DT
more  ||| S:9360 E:9365 ||| RBR
complex  ||| S:9365 E:9373 ||| JJ
process  ||| S:9373 E:9381 ||| NN
of  ||| S:9381 E:9384 ||| IN
genetic  ||| S:9384 E:9400 ||| JJ
reprogramming  ||| S:9400 E:9414 ||| NNS
[  ||| S:9414 E:9416 ||| -LRB-
34 ||| S:9416 E:9418 ||| CD
] ||| S:9418 E:9419 ||| -RRB-
.  ||| S:9419 E:9421 ||| .
In  ||| S:9421 E:9424 ||| IN
the  ||| S:9424 E:9428 ||| DT
present  ||| S:9428 E:9436 ||| JJ
study ||| S:9436 E:9441 ||| NN
,  ||| S:9441 E:9443 ||| ,
when  ||| S:9443 E:9448 ||| WRB
confluent  ||| S:9448 E:9466 ||| NNS
or  ||| S:9466 E:9469 ||| CC
nocodazole-treated  ||| S:9469 E:9488 ||| JJ
cells  ||| S:9488 E:9494 ||| NNS
were  ||| S:9494 E:9499 ||| VBD
transferred  ||| S:9499 E:9511 ||| VBN
into  ||| S:9511 E:9524 ||| IN
enucleated  ||| S:9524 E:9535 ||| JJ
M  ||| S:9535 E:9537 ||| NNP
I  ||| S:9537 E:9539 ||| PRP
oocytes ||| S:9539 E:9546 ||| VBP
,  ||| S:9546 E:9548 ||| ,
nuclear  ||| S:9548 E:9556 ||| JJ
swelling  ||| S:9556 E:9565 ||| NN
was  ||| S:9565 E:9569 ||| VBD
observed  ||| S:9569 E:9578 ||| VBN
in  ||| S:9578 E:9589 ||| IN
34.4-50.0 ||| S:9589 E:9598 ||| CD
%  ||| S:9598 E:9600 ||| NN
of  ||| S:9600 E:9603 ||| IN
reconstructed  ||| S:9603 E:9617 ||| JJ
embryos  ||| S:9617 E:9625 ||| NN
after  ||| S:9625 E:9631 ||| IN
activation ||| S:9631 E:9641 ||| NN
.  ||| S:9641 E:9643 ||| .
This  ||| S:9643 E:9656 ||| DT
result  ||| S:9656 E:9663 ||| NN
suggests  ||| S:9663 E:9672 ||| VBZ
that  ||| S:9672 E:9677 ||| DT
porcine  ||| S:9677 E:9685 ||| JJ
M  ||| S:9685 E:9687 ||| NNP
I  ||| S:9687 E:9689 ||| NNP
oocytes  ||| S:9689 E:9697 ||| NN
can  ||| S:9697 E:9701 ||| MD
initiate  ||| S:9701 E:9718 ||| VB
reprogramming  ||| S:9718 E:9732 ||| VBN
of  ||| S:9732 E:9735 ||| IN
both  ||| S:9735 E:9740 ||| DT
confluent  ||| S:9740 E:9750 ||| NN
and  ||| S:9750 E:9754 ||| CC
nocodazole-treated  ||| S:9754 E:9781 ||| JJ
cells ||| S:9781 E:9786 ||| NNS
.  ||| S:9786 E:9788 ||| .
Moreover ||| S:9788 E:9796 ||| RB
,  ||| S:9796 E:9798 ||| ,
some  ||| S:9798 E:9803 ||| DT
reconstructed  ||| S:9803 E:9817 ||| JJ
embryos  ||| S:9817 E:9825 ||| NNS
produced  ||| S:9825 E:9834 ||| VBN
by  ||| S:9834 E:9845 ||| IN
transferring  ||| S:9845 E:9858 ||| VBG
confluent  ||| S:9858 E:9868 ||| JJ
cells  ||| S:9868 E:9874 ||| NNS
developed  ||| S:9874 E:9884 ||| VBN
to  ||| S:9884 E:9887 ||| TO
the  ||| S:9887 E:9891 ||| DT
blastocyst  ||| S:9891 E:9910 ||| JJ
stage ||| S:9910 E:9915 ||| NN
.  ||| S:9915 E:9917 ||| .
Because  ||| S:9917 E:9925 ||| IN
activation  ||| S:9925 E:9936 ||| NN
of  ||| S:9936 E:9939 ||| IN
the  ||| S:9939 E:9943 ||| DT
embryonic  ||| S:9943 E:9953 ||| JJ
genome  ||| S:9953 E:9960 ||| NN
occurs  ||| S:9960 E:9967 ||| VBZ
by  ||| S:9967 E:9978 ||| IN
the  ||| S:9978 E:9982 ||| DT
4-cell  ||| S:9982 E:9989 ||| JJ
stage  ||| S:9989 E:9995 ||| NN
in  ||| S:9995 E:9998 ||| IN
the  ||| S:9998 E:10002 ||| DT
pig  ||| S:10002 E:10006 ||| NN
[  ||| S:10006 E:10008 ||| -LRB-
21 ||| S:10008 E:10010 ||| CD
] ||| S:10010 E:10011 ||| -RRB-
,  ||| S:10011 E:10013 ||| ,
it  ||| S:10013 E:10016 ||| PRP
is  ||| S:10016 E:10019 ||| VBZ
evident  ||| S:10019 E:10027 ||| JJ
that  ||| S:10027 E:10032 ||| IN
donor  ||| S:10032 E:10046 ||| JJ
nuclei  ||| S:10046 E:10053 ||| NN
were  ||| S:10053 E:10058 ||| VBD
at  ||| S:10058 E:10061 ||| IN
least  ||| S:10061 E:10067 ||| JJS
partially  ||| S:10067 E:10077 ||| RB
reprogrammed  ||| S:10077 E:10090 ||| VBN
in  ||| S:10090 E:10093 ||| IN
these  ||| S:10093 E:10107 ||| DT
blastocysts ||| S:10107 E:10118 ||| NN
.  ||| S:10118 E:10120 ||| .
Therefore ||| S:10120 E:10129 ||| RB
,  ||| S:10129 E:10131 ||| ,
our  ||| S:10131 E:10135 ||| PRP$
results  ||| S:10135 E:10143 ||| NNS
clearly  ||| S:10143 E:10151 ||| RB
indicate  ||| S:10151 E:10160 ||| VB
that  ||| S:10160 E:10173 ||| DT
porcine  ||| S:10173 E:10181 ||| JJ
M  ||| S:10181 E:10183 ||| NNP
I  ||| S:10183 E:10185 ||| PRP
oocytes  ||| S:10185 E:10193 ||| VBD
like  ||| S:10193 E:10198 ||| IN
M  ||| S:10198 E:10200 ||| NNP
II  ||| S:10200 E:10203 ||| NNP
oocytes  ||| S:10203 E:10211 ||| NNS
have  ||| S:10211 E:10216 ||| VBP
the  ||| S:10216 E:10220 ||| DT
ability  ||| S:10220 E:10228 ||| NN
to  ||| S:10228 E:10239 ||| TO
reprogram  ||| S:10239 E:10249 ||| VB
confluent  ||| S:10249 E:10259 ||| JJ
somatic  ||| S:10259 E:10267 ||| JJ
cell  ||| S:10267 E:10272 ||| NN
nuclei  ||| S:10272 E:10279 ||| VBZ
as  ||| S:10279 E:10282 ||| RB
determined  ||| S:10282 E:10293 ||| VBN
by  ||| S:10293 E:10304 ||| IN
nuclear  ||| S:10304 E:10312 ||| JJ
remodeling  ||| S:10312 E:10323 ||| NN
and  ||| S:10323 E:10327 ||| CC
in  ||| S:10327 E:10330 ||| IN
vitro  ||| S:10330 E:10336 ||| JJ
development ||| S:10336 E:10347 ||| NN
.  ||| S:10347 E:10357 ||| .
The  ||| S:10357 E:10361 ||| DT
blastocyst  ||| S:10361 E:10372 ||| JJ
formation  ||| S:10372 E:10382 ||| NN
rate  ||| S:10382 E:10387 ||| NN
of  ||| S:10387 E:10390 ||| IN
reconstructed  ||| S:10390 E:10404 ||| JJ
embryos  ||| S:10404 E:10420 ||| NNS
produced  ||| S:10420 E:10429 ||| VBN
by  ||| S:10429 E:10432 ||| IN
transferring  ||| S:10432 E:10445 ||| VBG
confluent  ||| S:10445 E:10455 ||| JJ
cells  ||| S:10455 E:10461 ||| NNS
into  ||| S:10461 E:10466 ||| IN
M  ||| S:10466 E:10468 ||| NNP
I  ||| S:10468 E:10470 ||| PRP
oocytes  ||| S:10470 E:10486 ||| RB
was  ||| S:10486 E:10490 ||| VBD
significantly  ||| S:10490 E:10504 ||| RB
lower  ||| S:10504 E:10510 ||| JJR
than  ||| S:10510 E:10515 ||| IN
that  ||| S:10515 E:10520 ||| DT
of  ||| S:10520 E:10523 ||| IN
embryos  ||| S:10523 E:10531 ||| JJ
reconstituted  ||| S:10531 E:10553 ||| NN
with  ||| S:10553 E:10558 ||| IN
confluent  ||| S:10558 E:10568 ||| JJ
cells  ||| S:10568 E:10574 ||| NNS
and  ||| S:10574 E:10578 ||| CC
M  ||| S:10578 E:10580 ||| NNP
II  ||| S:10580 E:10583 ||| NNP
oocytes  ||| S:10583 E:10591 ||| NN
although  ||| S:10591 E:10600 ||| IN
there  ||| S:10600 E:10606 ||| EX
were  ||| S:10606 E:10619 ||| VBD
no  ||| S:10619 E:10622 ||| DT
significant  ||| S:10622 E:10634 ||| JJ
differences  ||| S:10634 E:10646 ||| NNS
in  ||| S:10646 E:10649 ||| IN
percentages  ||| S:10649 E:10661 ||| NNS
of  ||| S:10661 E:10664 ||| IN
embryos  ||| S:10664 E:10672 ||| NN
with  ||| S:10672 E:10685 ||| IN
swollen  ||| S:10685 E:10693 ||| JJ
nuclei  ||| S:10693 E:10700 ||| NN
between  ||| S:10700 E:10708 ||| IN
different  ||| S:10708 E:10718 ||| JJ
maturation  ||| S:10718 E:10729 ||| JJ
stages  ||| S:10729 E:10736 ||| NNS
of  ||| S:10736 E:10747 ||| IN
recipient  ||| S:10747 E:10757 ||| JJ
oocytes ||| S:10757 E:10764 ||| NN
.  ||| S:10764 E:10766 ||| .
These  ||| S:10766 E:10772 ||| DT
results  ||| S:10772 E:10780 ||| NNS
suggest  ||| S:10780 E:10788 ||| VBP
that  ||| S:10788 E:10793 ||| IN
the  ||| S:10793 E:10805 ||| DT
reprogramming  ||| S:10805 E:10819 ||| NN
of  ||| S:10819 E:10822 ||| IN
donor  ||| S:10822 E:10828 ||| JJ
nuclei  ||| S:10828 E:10835 ||| NN
may  ||| S:10835 E:10839 ||| MD
be  ||| S:10839 E:10842 ||| VB
started  ||| S:10842 E:10850 ||| VBN
but  ||| S:10850 E:10854 ||| CC
is  ||| S:10854 E:10857 ||| VBZ
not  ||| S:10857 E:10869 ||| RB
completed  ||| S:10869 E:10879 ||| VBN
in  ||| S:10879 E:10882 ||| IN
some  ||| S:10882 E:10887 ||| DT
embryos  ||| S:10887 E:10895 ||| JJ
reconstituted  ||| S:10895 E:10909 ||| NN
with  ||| S:10909 E:10914 ||| IN
M  ||| S:10914 E:10916 ||| NNP
I  ||| S:10916 E:10918 ||| PRP
oocytes ||| S:10918 E:10925 ||| VBD
.  ||| S:10925 E:10935 ||| .
It  ||| S:10935 E:10938 ||| PRP
has  ||| S:10938 E:10942 ||| VBZ
been  ||| S:10942 E:10947 ||| VBN
suggested  ||| S:10947 E:10957 ||| VBN
that  ||| S:10957 E:10962 ||| IN
nuclear  ||| S:10962 E:10970 ||| JJ
swelling  ||| S:10970 E:10979 ||| NN
may  ||| S:10979 E:10983 ||| MD
not  ||| S:10983 E:10995 ||| RB
necessarily  ||| S:10995 E:11007 ||| RB
be  ||| S:11007 E:11010 ||| VB
a  ||| S:11010 E:11012 ||| DT
sufficient  ||| S:11012 E:11023 ||| JJ
indicator  ||| S:11023 E:11033 ||| NN
of  ||| S:11033 E:11036 ||| IN
developmental  ||| S:11036 E:11058 ||| JJ
potential  ||| S:11058 E:11068 ||| NN
in  ||| S:11068 E:11071 ||| IN
a  ||| S:11071 E:11073 ||| DT
reconstructed  ||| S:11073 E:11087 ||| JJ
embryo  ||| S:11087 E:11094 ||| NN
[  ||| S:11094 E:11096 ||| -LRB-
28 ||| S:11096 E:11098 ||| CD
] ||| S:11098 E:11099 ||| -RRB-
.  ||| S:11099 E:11101 ||| .
In  ||| S:11101 E:11104 ||| IN
addition  ||| S:11104 E:11113 ||| NN
to  ||| S:11113 E:11124 ||| TO
MPF ||| S:11124 E:11127 ||| NNP
,  ||| S:11127 E:11129 ||| ,
mitogen-activated  ||| S:11129 E:11147 ||| JJ
protein  ||| S:11147 E:11155 ||| NN
( ||| S:11155 E:11156 ||| -LRB-
MAP ||| S:11156 E:11159 ||| NNP
)  ||| S:11159 E:11161 ||| -RRB-
kinase  ||| S:11161 E:11168 ||| NN
is  ||| S:11168 E:11171 ||| VBZ
also  ||| S:11171 E:11176 ||| RB
known  ||| S:11176 E:11190 ||| VBN
as  ||| S:11190 E:11193 ||| IN
an  ||| S:11193 E:11196 ||| DT
important  ||| S:11196 E:11206 ||| JJ
protein  ||| S:11206 E:11214 ||| NN
kinase  ||| S:11214 E:11221 ||| NNS
that  ||| S:11221 E:11226 ||| WDT
regulates  ||| S:11226 E:11236 ||| VBZ
the  ||| S:11236 E:11240 ||| DT
meiotic  ||| S:11240 E:11256 ||| JJ
cell  ||| S:11256 E:11261 ||| NN
cycle  ||| S:11261 E:11267 ||| NN
[  ||| S:11267 E:11269 ||| -LRB-
35 ||| S:11269 E:11271 ||| CD
] ||| S:11271 E:11272 ||| -RRB-
.  ||| S:11272 E:11274 ||| .
In  ||| S:11274 E:11277 ||| IN
mouse  ||| S:11277 E:11283 ||| NN
oocytes ||| S:11283 E:11290 ||| NN
,  ||| S:11290 E:11292 ||| ,
MAP  ||| S:11292 E:11296 ||| NNP
kinase  ||| S:11296 E:11303 ||| NN
plays  ||| S:11303 E:11309 ||| VBZ
a  ||| S:11309 E:11311 ||| DT
more  ||| S:11311 E:11324 ||| RBR
important  ||| S:11324 E:11334 ||| JJ
role  ||| S:11334 E:11339 ||| NN
in  ||| S:11339 E:11342 ||| IN
controlling  ||| S:11342 E:11354 ||| VBG
chromatin  ||| S:11354 E:11364 ||| NNS
and  ||| S:11364 E:11368 ||| CC
microtubule  ||| S:11368 E:11388 ||| JJ
behavior  ||| S:11388 E:11397 ||| NN
than  ||| S:11397 E:11402 ||| IN
MPF  ||| S:11402 E:11406 ||| NNP
[  ||| S:11406 E:11408 ||| -LRB-
36 ||| S:11408 E:11410 ||| CD
] ||| S:11410 E:11411 ||| -RRB-
.  ||| S:11411 E:11413 ||| .
However ||| S:11413 E:11420 ||| RB
,  ||| S:11420 E:11422 ||| ,
MAP  ||| S:11422 E:11426 ||| NNP
kinase  ||| S:11426 E:11433 ||| NN
and  ||| S:11433 E:11437 ||| CC
MPF  ||| S:11437 E:11449 ||| NNP
activities  ||| S:11449 E:11460 ||| NNS
do  ||| S:11460 E:11463 ||| VBP
not  ||| S:11463 E:11467 ||| RB
vary  ||| S:11467 E:11472 ||| VBP
between  ||| S:11472 E:11480 ||| IN
M  ||| S:11480 E:11482 ||| NNP
I  ||| S:11482 E:11484 ||| NNP
and  ||| S:11484 E:11488 ||| CC
M  ||| S:11488 E:11490 ||| NNP
II  ||| S:11490 E:11493 ||| NNP
of  ||| S:11493 E:11496 ||| IN
porcine  ||| S:11496 E:11512 ||| JJ
oocytes  ||| S:11512 E:11520 ||| NN
because  ||| S:11520 E:11528 ||| IN
phosphorylations  ||| S:11528 E:11545 ||| NN
of  ||| S:11545 E:11548 ||| IN
MAP  ||| S:11548 E:11552 ||| NNP
kinase  ||| S:11552 E:11559 ||| NN
and  ||| S:11559 E:11563 ||| CC
histone  ||| S:11563 E:11579 ||| CD
H1  ||| S:11579 E:11582 ||| CD
kinase  ||| S:11582 E:11589 ||| NNS
which  ||| S:11589 E:11595 ||| WDT
corresponds  ||| S:11595 E:11607 ||| VBZ
to  ||| S:11607 E:11610 ||| TO
MPF  ||| S:11610 E:11614 ||| NNP
activity  ||| S:11614 E:11623 ||| NN
reach  ||| S:11623 E:11629 ||| VB
the  ||| S:11629 E:11633 ||| DT
peak  ||| S:11633 E:11646 ||| NN
level  ||| S:11646 E:11652 ||| NN
at  ||| S:11652 E:11655 ||| IN
M  ||| S:11655 E:11657 ||| NNP
I  ||| S:11657 E:11659 ||| NNP
and  ||| S:11659 E:11663 ||| CC
remain  ||| S:11663 E:11670 ||| VB
high  ||| S:11670 E:11675 ||| JJ
beyond  ||| S:11675 E:11682 ||| IN
M  ||| S:11682 E:11684 ||| NNP
II  ||| S:11684 E:11687 ||| NNP
[  ||| S:11687 E:11689 ||| -LRB-
37 ||| S:11689 E:11691 ||| CD
,  ||| S:11691 E:11693 ||| ,
38 ||| S:11693 E:11695 ||| CD
] ||| S:11695 E:11696 ||| -RRB-
.  ||| S:11696 E:11706 ||| .
Potentially ||| S:11706 E:11717 ||| RB
,  ||| S:11717 E:11719 ||| ,
an  ||| S:11719 E:11722 ||| DT
unknown  ||| S:11722 E:11730 ||| JJ
factor ||| S:11730 E:11736 ||| NN
( ||| S:11736 E:11737 ||| -LRB-
s ||| S:11737 E:11738 ||| LS
)  ||| S:11738 E:11740 ||| -RRB-
is  ||| S:11740 E:11743 ||| VBZ
required  ||| S:11743 E:11752 ||| VBN
for  ||| S:11752 E:11764 ||| IN
reprogramming  ||| S:11764 E:11778 ||| NN
of  ||| S:11778 E:11781 ||| IN
nuclei ||| S:11781 E:11787 ||| NN
,  ||| S:11787 E:11789 ||| ,
which  ||| S:11789 E:11795 ||| WDT
is  ||| S:11795 E:11798 ||| VBZ
present  ||| S:11798 E:11806 ||| JJ
in  ||| S:11806 E:11809 ||| IN
M  ||| S:11809 E:11811 ||| NNP
II  ||| S:11811 E:11814 ||| NNP
oocytes  ||| S:11814 E:11830 ||| NN
but  ||| S:11830 E:11834 ||| CC
may  ||| S:11834 E:11838 ||| MD
not  ||| S:11838 E:11842 ||| RB
be  ||| S:11842 E:11845 ||| VB
present  ||| S:11845 E:11853 ||| JJ
or  ||| S:11853 E:11856 ||| CC
active  ||| S:11856 E:11863 ||| JJ
in  ||| S:11863 E:11866 ||| IN
M  ||| S:11866 E:11868 ||| NNP
I  ||| S:11868 E:11870 ||| PRP
oocytes ||| S:11870 E:11877 ||| VBD
.  ||| S:11877 E:11879 ||| .
It  ||| S:11879 E:11882 ||| PRP
is  ||| S:11882 E:11893 ||| VBZ
known  ||| S:11893 E:11899 ||| VBN
that  ||| S:11899 E:11904 ||| IN
pronuclear  ||| S:11904 E:11915 ||| JJ
exchange  ||| S:11915 E:11924 ||| NN
between  ||| S:11924 E:11932 ||| IN
zygotes  ||| S:11932 E:11940 ||| NN
does  ||| S:11940 E:11945 ||| VBZ
not  ||| S:11945 E:11957 ||| RB
prevent  ||| S:11957 E:11965 ||| VB
development  ||| S:11965 E:11977 ||| NN
of  ||| S:11977 E:11980 ||| IN
the  ||| S:11980 E:11984 ||| DT
reconstructed  ||| S:11984 E:11998 ||| JJ
embryos  ||| S:11998 E:12006 ||| NNS
[  ||| S:12006 E:12008 ||| -LRB-
39 ||| S:12008 E:12010 ||| CD
]  ||| S:12010 E:12012 ||| -RRB-
but  ||| S:12012 E:12024 ||| CC
transfer  ||| S:12024 E:12033 ||| NN
of  ||| S:12033 E:12036 ||| IN
donor  ||| S:12036 E:12042 ||| JJ
nuclei  ||| S:12042 E:12049 ||| NN
from  ||| S:12049 E:12054 ||| IN
later  ||| S:12054 E:12060 ||| RB
developmental  ||| S:12060 E:12074 ||| JJ
stages  ||| S:12074 E:12089 ||| NNS
into  ||| S:12089 E:12094 ||| IN
enucleated  ||| S:12094 E:12105 ||| JJ
zygotes  ||| S:12105 E:12113 ||| NN
brings  ||| S:12113 E:12120 ||| VBZ
about  ||| S:12120 E:12126 ||| RB
restricted  ||| S:12126 E:12137 ||| JJ
development  ||| S:12137 E:12157 ||| NN
[  ||| S:12157 E:12159 ||| -LRB-
40 ||| S:12159 E:12161 ||| CD
,  ||| S:12161 E:12163 ||| ,
41 ||| S:12163 E:12165 ||| CD
] ||| S:12165 E:12166 ||| -RRB-
.  ||| S:12166 E:12168 ||| .
One  ||| S:12168 E:12172 ||| CD
explanation  ||| S:12172 E:12184 ||| NN
of  ||| S:12184 E:12187 ||| IN
this  ||| S:12187 E:12192 ||| DT
phenomenon  ||| S:12192 E:12203 ||| NN
is  ||| S:12203 E:12206 ||| VBZ
that  ||| S:12206 E:12211 ||| IN
a  ||| S:12211 E:12221 ||| DT
factor ||| S:12221 E:12227 ||| NN
( ||| S:12227 E:12228 ||| -LRB-
s ||| S:12228 E:12229 ||| LS
)  ||| S:12229 E:12231 ||| -RRB-
required  ||| S:12231 E:12240 ||| VBN
for  ||| S:12240 E:12244 ||| IN
reprogramming  ||| S:12244 E:12258 ||| NN
of  ||| S:12258 E:12261 ||| IN
donor  ||| S:12261 E:12267 ||| JJ
nuclei  ||| S:12267 E:12274 ||| NN
is  ||| S:12274 E:12285 ||| VBZ
removed  ||| S:12285 E:12293 ||| VBN
with  ||| S:12293 E:12298 ||| IN
the  ||| S:12298 E:12302 ||| DT
pronuclei  ||| S:12302 E:12312 ||| NN
from  ||| S:12312 E:12317 ||| IN
recipient  ||| S:12317 E:12327 ||| JJ
zygotes ||| S:12327 E:12334 ||| NN
.  ||| S:12334 E:12344 ||| .
Similarly ||| S:12344 E:12353 ||| RB
,  ||| S:12353 E:12355 ||| ,
the  ||| S:12355 E:12359 ||| DT
factor ||| S:12359 E:12365 ||| NN
( ||| S:12365 E:12366 ||| -LRB-
s ||| S:12366 E:12367 ||| LS
)  ||| S:12367 E:12369 ||| -RRB-
would  ||| S:12369 E:12375 ||| MD
be  ||| S:12375 E:12378 ||| VB
present  ||| S:12378 E:12386 ||| JJ
near  ||| S:12386 E:12391 ||| IN
the  ||| S:12391 E:12403 ||| DT
chromosomes  ||| S:12403 E:12415 ||| NN
at  ||| S:12415 E:12418 ||| IN
M  ||| S:12418 E:12420 ||| NNP
I  ||| S:12420 E:12422 ||| NNP
and  ||| S:12422 E:12426 ||| CC
removed  ||| S:12426 E:12434 ||| VBN
with  ||| S:12434 E:12439 ||| IN
the  ||| S:12439 E:12443 ||| DT
M  ||| S:12443 E:12445 ||| NNP
I  ||| S:12445 E:12447 ||| NNP
plate  ||| S:12447 E:12453 ||| NN
during  ||| S:12453 E:12468 ||| IN
enucleation  ||| S:12468 E:12480 ||| NN
in  ||| S:12480 E:12483 ||| IN
many  ||| S:12483 E:12488 ||| JJ
oocytes ||| S:12488 E:12495 ||| NN
.  ||| S:12495 E:12497 ||| .
In  ||| S:12497 E:12500 ||| IN
contrast ||| S:12500 E:12508 ||| NN
,  ||| S:12508 E:12510 ||| ,
the  ||| S:12510 E:12514 ||| DT
factor ||| S:12514 E:12520 ||| NN
( ||| S:12520 E:12521 ||| -LRB-
s ||| S:12521 E:12522 ||| LS
)  ||| S:12522 E:12524 ||| -RRB-
is  ||| S:12524 E:12535 ||| VBZ
believed  ||| S:12535 E:12544 ||| VBN
to  ||| S:12544 E:12547 ||| TO
be  ||| S:12547 E:12550 ||| VB
in  ||| S:12550 E:12553 ||| IN
cytoplasts  ||| S:12553 E:12564 ||| VBG
derived  ||| S:12564 E:12572 ||| VBN
from  ||| S:12572 E:12577 ||| IN
M  ||| S:12577 E:12579 ||| NNP
II  ||| S:12579 E:12582 ||| NNP
oocytes  ||| S:12582 E:12598 ||| NN
because  ||| S:12598 E:12606 ||| IN
embryos  ||| S:12606 E:12614 ||| JJ
reconstituted  ||| S:12614 E:12628 ||| NN
with  ||| S:12628 E:12633 ||| IN
donor  ||| S:12633 E:12639 ||| JJ
nuclei  ||| S:12639 E:12646 ||| NN
from  ||| S:12646 E:12651 ||| IN
later  ||| S:12651 E:12665 ||| RB
developmental  ||| S:12665 E:12679 ||| JJ
stages  ||| S:12679 E:12686 ||| NNS
and  ||| S:12686 E:12690 ||| CC
enucleated  ||| S:12690 E:12701 ||| JJ
M  ||| S:12701 E:12703 ||| NNP
II  ||| S:12703 E:12706 ||| NNP
oocytes  ||| S:12706 E:12714 ||| NN
can  ||| S:12714 E:12726 ||| MD
develop  ||| S:12726 E:12734 ||| VB
to  ||| S:12734 E:12737 ||| TO
adults  ||| S:12737 E:12744 ||| NNS
[  ||| S:12744 E:12746 ||| -LRB-
42 ||| S:12746 E:12748 ||| CD
] ||| S:12748 E:12749 ||| -RRB-
.  ||| S:12749 E:12751 ||| .
An  ||| S:12751 E:12754 ||| DT
alternative  ||| S:12754 E:12766 ||| JJ
cause  ||| S:12766 E:12772 ||| NN
is  ||| S:12772 E:12775 ||| VBZ
the  ||| S:12775 E:12779 ||| DT
effect  ||| S:12779 E:12794 ||| NN
of  ||| S:12794 E:12797 ||| IN
cytochalasin  ||| S:12797 E:12810 ||| JJ
B ||| S:12810 E:12811 ||| NNP
,  ||| S:12811 E:12813 ||| ,
a  ||| S:12813 E:12815 ||| DT
microfilament  ||| S:12815 E:12829 ||| JJ
polymerization  ||| S:12829 E:12852 ||| JJ
inhibitor ||| S:12852 E:12861 ||| NN
.  ||| S:12861 E:12863 ||| .
In  ||| S:12863 E:12866 ||| IN
the  ||| S:12866 E:12870 ||| DT
present  ||| S:12870 E:12878 ||| JJ
study ||| S:12878 E:12883 ||| NN
,  ||| S:12883 E:12885 ||| ,
reconstructed  ||| S:12885 E:12899 ||| VBD
embryos  ||| S:12899 E:12915 ||| VBN
produced  ||| S:12915 E:12924 ||| VBN
by  ||| S:12924 E:12927 ||| IN
transferring  ||| S:12927 E:12940 ||| VBG
confluent  ||| S:12940 E:12950 ||| JJ
cells  ||| S:12950 E:12956 ||| NNS
into  ||| S:12956 E:12961 ||| IN
M  ||| S:12961 E:12963 ||| NNP
I  ||| S:12963 E:12965 ||| PRP
oocytes  ||| S:12965 E:12981 ||| RB
were  ||| S:12981 E:12986 ||| VBD
cultured  ||| S:12986 E:12995 ||| VBN
in  ||| S:12995 E:12998 ||| IN
the  ||| S:12998 E:13002 ||| DT
maturation  ||| S:13002 E:13013 ||| JJ
medium  ||| S:13013 E:13020 ||| NN
supplemented  ||| S:13020 E:13033 ||| NN
with  ||| S:13033 E:13046 ||| IN
cytochalasin  ||| S:13046 E:13059 ||| JJ
B  ||| S:13059 E:13061 ||| NN
to  ||| S:13061 E:13064 ||| TO
prevent  ||| S:13064 E:13072 ||| VB
loss  ||| S:13072 E:13077 ||| NN
of  ||| S:13077 E:13080 ||| IN
chromosomes  ||| S:13080 E:13092 ||| NNS
by  ||| S:13092 E:13095 ||| IN
polar  ||| S:13095 E:13101 ||| JJ
body  ||| S:13101 E:13114 ||| NN
formation ||| S:13114 E:13123 ||| NN
.  ||| S:13123 E:13125 ||| .
However ||| S:13125 E:13132 ||| RB
,  ||| S:13132 E:13134 ||| ,
it  ||| S:13134 E:13137 ||| PRP
has  ||| S:13137 E:13141 ||| VBZ
been  ||| S:13141 E:13146 ||| VBN
reported  ||| S:13146 E:13155 ||| VBN
recently  ||| S:13155 E:13164 ||| RB
that  ||| S:13164 E:13177 ||| IN
morphologically  ||| S:13177 E:13193 ||| JJ
normal  ||| S:13193 E:13200 ||| JJ
M  ||| S:13200 E:13202 ||| NNP
I  ||| S:13202 E:13204 ||| NNP
spindles  ||| S:13204 E:13213 ||| NNS
are  ||| S:13213 E:13217 ||| VBP
formed  ||| S:13217 E:13224 ||| VBN
but  ||| S:13224 E:13228 ||| CC
further  ||| S:13228 E:13244 ||| RBR
meiotic  ||| S:13244 E:13252 ||| JJ
progression  ||| S:13252 E:13264 ||| NN
does  ||| S:13264 E:13269 ||| VBZ
not  ||| S:13269 E:13273 ||| RB
occur  ||| S:13273 E:13279 ||| VB
in  ||| S:13279 E:13282 ||| IN
porcine  ||| S:13282 E:13290 ||| NNS
oocytes  ||| S:13290 E:13306 ||| VBP
matured  ||| S:13306 E:13314 ||| VBN
in  ||| S:13314 E:13317 ||| IN
a  ||| S:13317 E:13319 ||| DT
cytochalasin  ||| S:13319 E:13332 ||| JJ
B-containing  ||| S:13332 E:13345 ||| JJ
medium  ||| S:13345 E:13352 ||| NN
[  ||| S:13352 E:13354 ||| -LRB-
38 ||| S:13354 E:13356 ||| CD
] ||| S:13356 E:13357 ||| -RRB-
.  ||| S:13357 E:13367 ||| .
Therefore ||| S:13367 E:13376 ||| RB
,  ||| S:13376 E:13378 ||| ,
it  ||| S:13378 E:13381 ||| PRP
is  ||| S:13381 E:13384 ||| VBZ
possible  ||| S:13384 E:13393 ||| JJ
that  ||| S:13393 E:13398 ||| IN
reprogramming  ||| S:13398 E:13412 ||| NN
of  ||| S:13412 E:13415 ||| IN
nuclei  ||| S:13415 E:13430 ||| VBG
transferred  ||| S:13430 E:13442 ||| VBN
into  ||| S:13442 E:13447 ||| IN
M  ||| S:13447 E:13449 ||| NNP
I  ||| S:13449 E:13451 ||| NNP
oocytes  ||| S:13451 E:13459 ||| NN
is  ||| S:13459 E:13462 ||| VBZ
inhibited  ||| S:13462 E:13472 ||| VBN
by  ||| S:13472 E:13475 ||| IN
cytochalasin  ||| S:13475 E:13496 ||| JJ
B.  ||| S:13496 E:13499 ||| NNP
Thirdly ||| S:13499 E:13506 ||| NNP
,  ||| S:13506 E:13508 ||| ,
M  ||| S:13508 E:13510 ||| NNP
I  ||| S:13510 E:13512 ||| NNP
and  ||| S:13512 E:13516 ||| CC
M  ||| S:13516 E:13518 ||| NNP
II  ||| S:13518 E:13521 ||| NNP
oocytes  ||| S:13521 E:13529 ||| NN
may  ||| S:13529 E:13533 ||| MD
differ  ||| S:13533 E:13540 ||| VB
in  ||| S:13540 E:13543 ||| IN
cytoplasmic  ||| S:13543 E:13563 ||| JJ
competence ||| S:13563 E:13573 ||| NN
.  ||| S:13573 E:13575 ||| .
When  ||| S:13575 E:13580 ||| WRB
porcine  ||| S:13580 E:13588 ||| JJ
M  ||| S:13588 E:13590 ||| NNP
I  ||| S:13590 E:13592 ||| NNP
oocytes  ||| S:13592 E:13600 ||| NNS
are  ||| S:13600 E:13604 ||| VBP
inseminated  ||| S:13604 E:13616 ||| VBN
with  ||| S:13616 E:13629 ||| IN
spermatozoa  ||| S:13629 E:13641 ||| NN
in  ||| S:13641 E:13644 ||| IN
vitro ||| S:13644 E:13649 ||| NN
,  ||| S:13649 E:13651 ||| ,
the  ||| S:13651 E:13655 ||| DT
formation  ||| S:13655 E:13665 ||| NN
rate  ||| S:13665 E:13670 ||| NN
of  ||| S:13670 E:13673 ||| IN
male  ||| S:13673 E:13678 ||| JJ
and  ||| S:13678 E:13682 ||| CC
female  ||| S:13682 E:13697 ||| JJ
pronuclei  ||| S:13697 E:13707 ||| NN
is  ||| S:13707 E:13710 ||| VBZ
significantly  ||| S:13710 E:13724 ||| RB
lower  ||| S:13724 E:13730 ||| JJR
than  ||| S:13730 E:13735 ||| IN
that  ||| S:13735 E:13740 ||| DT
in  ||| S:13740 E:13743 ||| IN
M  ||| S:13743 E:13745 ||| NNP
II  ||| S:13745 E:13748 ||| NNP
oocytes  ||| S:13748 E:13764 ||| NNS
[  ||| S:13764 E:13766 ||| -LRB-
43 ||| S:13766 E:13768 ||| CD
] ||| S:13768 E:13769 ||| -RRB-
.  ||| S:13769 E:13771 ||| .
Finally ||| S:13771 E:13778 ||| RB
,  ||| S:13778 E:13780 ||| ,
optimal  ||| S:13780 E:13788 ||| JJ
conditions  ||| S:13788 E:13799 ||| NNS
for  ||| S:13799 E:13803 ||| IN
activation  ||| S:13803 E:13814 ||| NNS
may  ||| S:13814 E:13818 ||| MD
vary  ||| S:13818 E:13831 ||| VB
between  ||| S:13831 E:13839 ||| IN
M  ||| S:13839 E:13841 ||| NNP
I  ||| S:13841 E:13843 ||| NNP
and  ||| S:13843 E:13847 ||| CC
M  ||| S:13847 E:13849 ||| NNP
II  ||| S:13849 E:13852 ||| NNP
oocytes ||| S:13852 E:13859 ||| NN
.  ||| S:13859 E:13861 ||| .
To  ||| S:13861 E:13864 ||| TO
our  ||| S:13864 E:13868 ||| PRP$
knowledge ||| S:13868 E:13877 ||| NN
,  ||| S:13877 E:13879 ||| ,
there  ||| S:13879 E:13885 ||| EX
are  ||| S:13885 E:13897 ||| VBP
no  ||| S:13897 E:13900 ||| DT
reports  ||| S:13900 E:13908 ||| NNS
that  ||| S:13908 E:13913 ||| WDT
describe  ||| S:13913 E:13922 ||| VBP
activation  ||| S:13922 E:13933 ||| VBN
of  ||| S:13933 E:13936 ||| IN
MI  ||| S:13936 E:13939 ||| NNP
oocytes  ||| S:13939 E:13947 ||| NN
in  ||| S:13947 E:13958 ||| IN
mammals ||| S:13958 E:13965 ||| NN
.  ||| S:13965 E:13967 ||| .
Parameters  ||| S:13967 E:13978 ||| NNS
of  ||| S:13978 E:13981 ||| IN
the  ||| S:13981 E:13985 ||| DT
activation  ||| S:13985 E:13996 ||| JJ
pulse  ||| S:13996 E:14002 ||| NN
used  ||| S:14002 E:14007 ||| VBN
in  ||| S:14007 E:14010 ||| IN
the  ||| S:14010 E:14022 ||| DT
present  ||| S:14022 E:14030 ||| JJ
study  ||| S:14030 E:14036 ||| NN
were  ||| S:14036 E:14041 ||| VBD
also  ||| S:14041 E:14046 ||| RB
optimized  ||| S:14046 E:14056 ||| VBN
in  ||| S:14056 E:14059 ||| IN
a  ||| S:14059 E:14061 ||| DT
preliminary  ||| S:14061 E:14081 ||| JJ
experiment  ||| S:14081 E:14092 ||| NN
using  ||| S:14092 E:14098 ||| VBG
M  ||| S:14098 E:14100 ||| NNP
II  ||| S:14100 E:14103 ||| NNP
oocytes ||| S:14103 E:14110 ||| NN
.  ||| S:14110 E:14112 ||| .
It  ||| S:14112 E:14115 ||| PRP
is  ||| S:14115 E:14118 ||| VBZ
possible  ||| S:14118 E:14127 ||| JJ
that  ||| S:14127 E:14140 ||| IN
optimization  ||| S:14140 E:14153 ||| NN
of  ||| S:14153 E:14156 ||| IN
methods  ||| S:14156 E:14164 ||| NNS
for  ||| S:14164 E:14168 ||| IN
activation  ||| S:14168 E:14179 ||| NN
improves  ||| S:14179 E:14188 ||| VBZ
the  ||| S:14188 E:14200 ||| DT
development  ||| S:14200 E:14212 ||| NN
of  ||| S:14212 E:14215 ||| IN
embryos  ||| S:14215 E:14223 ||| JJ
reconstituted  ||| S:14223 E:14237 ||| NN
with  ||| S:14237 E:14242 ||| IN
M  ||| S:14242 E:14244 ||| NNP
I  ||| S:14244 E:14246 ||| PRP
oocytes ||| S:14246 E:14253 ||| VBD
.  ||| S:14253 E:14263 ||| .
In  ||| S:14263 E:14266 ||| IN
contrast ||| S:14266 E:14274 ||| NN
,  ||| S:14274 E:14276 ||| ,
no  ||| S:14276 E:14279 ||| DT
reconstructed  ||| S:14279 E:14293 ||| JJ
embryos  ||| S:14293 E:14301 ||| NNS
developed  ||| S:14301 E:14311 ||| VBN
to  ||| S:14311 E:14314 ||| TO
the  ||| S:14314 E:14326 ||| DT
blastocyst  ||| S:14326 E:14337 ||| JJ
stage  ||| S:14337 E:14343 ||| NN
regardless  ||| S:14343 E:14354 ||| RB
of  ||| S:14354 E:14357 ||| IN
the  ||| S:14357 E:14361 ||| DT
maturation  ||| S:14361 E:14372 ||| JJ
stage  ||| S:14372 E:14378 ||| NN
of  ||| S:14378 E:14381 ||| IN
the  ||| S:14381 E:14393 ||| DT
recipient  ||| S:14393 E:14403 ||| JJ
oocytes  ||| S:14403 E:14411 ||| NN
when  ||| S:14411 E:14416 ||| WRB
nocodazole-treated  ||| S:14416 E:14435 ||| JJ
cells  ||| S:14435 E:14441 ||| NNS
were  ||| S:14441 E:14454 ||| VBD
transferred ||| S:14454 E:14465 ||| VBN
,  ||| S:14465 E:14467 ||| ,
although  ||| S:14467 E:14476 ||| IN
nuclear  ||| S:14476 E:14484 ||| JJ
swelling  ||| S:14484 E:14493 ||| NN
was  ||| S:14493 E:14497 ||| VBD
observed  ||| S:14497 E:14506 ||| VBN
in  ||| S:14506 E:14517 ||| IN
34.4-39.5 ||| S:14517 E:14526 ||| CD
%  ||| S:14526 E:14528 ||| NN
of  ||| S:14528 E:14531 ||| IN
the  ||| S:14531 E:14535 ||| DT
embryos ||| S:14535 E:14542 ||| NN
.  ||| S:14542 E:14544 ||| .
When  ||| S:14544 E:14549 ||| WRB
cells  ||| S:14549 E:14555 ||| NNS
in  ||| S:14555 E:14558 ||| IN
M  ||| S:14558 E:14560 ||| NNP
phase  ||| S:14560 E:14566 ||| NN
are  ||| S:14566 E:14570 ||| VBP
used  ||| S:14570 E:14583 ||| VBN
as  ||| S:14583 E:14586 ||| IN
donors ||| S:14586 E:14592 ||| NNS
,  ||| S:14592 E:14594 ||| ,
reconstructed  ||| S:14594 E:14608 ||| VBD
embryos  ||| S:14608 E:14616 ||| VBN
with  ||| S:14616 E:14621 ||| IN
a  ||| S:14621 E:14623 ||| DT
polar  ||| S:14623 E:14629 ||| JJ
body  ||| S:14629 E:14634 ||| NN
are  ||| S:14634 E:14646 ||| VBP
diploid  ||| S:14646 E:14654 ||| VBN
but  ||| S:14654 E:14658 ||| CC
embryos  ||| S:14658 E:14666 ||| NN
without  ||| S:14666 E:14674 ||| IN
a  ||| S:14674 E:14676 ||| DT
polar  ||| S:14676 E:14682 ||| JJ
body  ||| S:14682 E:14687 ||| NN
are  ||| S:14687 E:14691 ||| VBP
tetraploid  ||| S:14691 E:14702 ||| NNS
[  ||| S:14702 E:14712 ||| -LRB-
14 ||| S:14712 E:14714 ||| CD
] ||| S:14714 E:14715 ||| -RRB-
.  ||| S:14715 E:14717 ||| .
In  ||| S:14717 E:14720 ||| IN
the  ||| S:14720 E:14724 ||| DT
present  ||| S:14724 E:14732 ||| JJ
study ||| S:14732 E:14737 ||| NN
,  ||| S:14737 E:14739 ||| ,
the  ||| S:14739 E:14743 ||| DT
percentage  ||| S:14743 E:14754 ||| NN
of  ||| S:14754 E:14757 ||| IN
embryos  ||| S:14757 E:14765 ||| NN
with  ||| S:14765 E:14778 ||| IN
both  ||| S:14778 E:14783 ||| PDT
a  ||| S:14783 E:14785 ||| DT
swollen  ||| S:14785 E:14793 ||| JJ
nucleus  ||| S:14793 E:14801 ||| NN
and  ||| S:14801 E:14805 ||| CC
a  ||| S:14805 E:14807 ||| DT
polar  ||| S:14807 E:14813 ||| JJ
body  ||| S:14813 E:14818 ||| NN
was  ||| S:14818 E:14822 ||| VBD
low  ||| S:14822 E:14826 ||| JJ
after  ||| S:14826 E:14840 ||| IN
transfer  ||| S:14840 E:14849 ||| NN
of  ||| S:14849 E:14852 ||| IN
nocodazole-treated  ||| S:14852 E:14871 ||| JJ
cells ||| S:14871 E:14876 ||| NNS
.  ||| S:14876 E:14878 ||| .
In  ||| S:14878 E:14881 ||| IN
the  ||| S:14881 E:14885 ||| DT
bovine ||| S:14885 E:14891 ||| NN
,  ||| S:14891 E:14893 ||| ,
the  ||| S:14893 E:14905 ||| DT
potential  ||| S:14905 E:14915 ||| NN
of  ||| S:14915 E:14918 ||| IN
reconstructed  ||| S:14918 E:14932 ||| JJ
embryos  ||| S:14932 E:14940 ||| NN
with  ||| S:14940 E:14945 ||| IN
or  ||| S:14945 E:14948 ||| CC
without  ||| S:14948 E:14956 ||| IN
the  ||| S:14956 E:14968 ||| DT
polar  ||| S:14968 E:14974 ||| JJ
body  ||| S:14974 E:14979 ||| NN
to  ||| S:14979 E:14982 ||| TO
develop  ||| S:14982 E:14990 ||| VB
to  ||| S:14990 E:14993 ||| TO
the  ||| S:14993 E:14997 ||| DT
blastocyst  ||| S:14997 E:15008 ||| JJ
stage  ||| S:15008 E:15014 ||| NN
is  ||| S:15014 E:15017 ||| VBZ
not  ||| S:15017 E:15029 ||| RB
different  ||| S:15029 E:15039 ||| JJ
[  ||| S:15039 E:15041 ||| -LRB-
14 ||| S:15041 E:15043 ||| CD
] ||| S:15043 E:15044 ||| -RRB-
.  ||| S:15044 E:15046 ||| .
However ||| S:15046 E:15053 ||| RB
,  ||| S:15053 E:15055 ||| ,
this  ||| S:15055 E:15060 ||| DT
study  ||| S:15060 E:15066 ||| NN
suggests  ||| S:15066 E:15075 ||| VBZ
that  ||| S:15075 E:15080 ||| DT
porcine  ||| S:15080 E:15096 ||| JJ
tetraploid  ||| S:15096 E:15107 ||| JJ
embryos  ||| S:15107 E:15115 ||| NN
may  ||| S:15115 E:15119 ||| MD
not  ||| S:15119 E:15123 ||| RB
develop  ||| S:15123 E:15131 ||| VB
to  ||| S:15131 E:15134 ||| TO
blastocysts ||| S:15134 E:15145 ||| VB
.  ||| S:15145 E:15155 ||| .
In  ||| S:15155 E:15158 ||| IN
the  ||| S:15158 E:15162 ||| DT
present  ||| S:15162 E:15170 ||| JJ
study ||| S:15170 E:15175 ||| NN
,  ||| S:15175 E:15177 ||| ,
there  ||| S:15177 E:15183 ||| EX
was  ||| S:15183 E:15187 ||| VBD
a  ||| S:15187 E:15189 ||| DT
significant  ||| S:15189 E:15201 ||| JJ
difference  ||| S:15201 E:15220 ||| NN
in  ||| S:15220 E:15223 ||| IN
fusion  ||| S:15223 E:15230 ||| NN
rates  ||| S:15230 E:15236 ||| NNS
between  ||| S:15236 E:15244 ||| IN
the  ||| S:15244 E:15248 ||| DT
cell  ||| S:15248 E:15253 ||| NN
cycles  ||| S:15253 E:15260 ||| NNS
of  ||| S:15260 E:15263 ||| IN
donor  ||| S:15263 E:15269 ||| JJ
cells ||| S:15269 E:15274 ||| NNS
.  ||| S:15274 E:15276 ||| .
The  ||| S:15276 E:15288 ||| DT
plasma  ||| S:15288 E:15295 ||| JJ
membrane  ||| S:15295 E:15304 ||| NN
of  ||| S:15304 E:15307 ||| IN
nocodazole-treated  ||| S:15307 E:15326 ||| JJ
cells  ||| S:15326 E:15332 ||| NNS
was  ||| S:15332 E:15336 ||| VBD
weak  ||| S:15336 E:15349 ||| JJ
compared  ||| S:15349 E:15358 ||| VBN
to  ||| S:15358 E:15361 ||| TO
that  ||| S:15361 E:15366 ||| DT
of  ||| S:15366 E:15369 ||| IN
confluent  ||| S:15369 E:15379 ||| JJ
cells  ||| S:15379 E:15385 ||| NNS
and  ||| S:15385 E:15389 ||| CC
many  ||| S:15389 E:15394 ||| JJ
cells  ||| S:15394 E:15400 ||| NNS
were  ||| S:15400 E:15413 ||| VBD
broken  ||| S:15413 E:15420 ||| VBN
before  ||| S:15420 E:15427 ||| IN
and  ||| S:15427 E:15431 ||| CC
after  ||| S:15431 E:15437 ||| IN
applying  ||| S:15437 E:15446 ||| VBG
a  ||| S:15446 E:15448 ||| DT
fusion  ||| S:15448 E:15455 ||| NN
pulse ||| S:15455 E:15460 ||| NN
.  ||| S:15460 E:15462 ||| .
Parameters  ||| S:15462 E:15481 ||| NNS
of  ||| S:15481 E:15484 ||| IN
the  ||| S:15484 E:15488 ||| DT
fusion  ||| S:15488 E:15495 ||| NN
pulse  ||| S:15495 E:15501 ||| NN
were  ||| S:15501 E:15506 ||| VBD
optimized  ||| S:15506 E:15516 ||| VBN
in  ||| S:15516 E:15519 ||| IN
a  ||| S:15519 E:15521 ||| DT
preliminary  ||| S:15521 E:15541 ||| JJ
experiment  ||| S:15541 E:15552 ||| NN
using  ||| S:15552 E:15558 ||| VBG
confluent  ||| S:15558 E:15568 ||| JJ
cells ||| S:15568 E:15573 ||| NNS
.  ||| S:15573 E:15575 ||| .
Therefore ||| S:15575 E:15584 ||| RB
,  ||| S:15584 E:15586 ||| ,
it  ||| S:15586 E:15589 ||| PRP
is  ||| S:15589 E:15592 ||| VBZ
expected  ||| S:15592 E:15609 ||| VBN
that  ||| S:15609 E:15614 ||| IN
optimal  ||| S:15614 E:15622 ||| JJ
conditions  ||| S:15622 E:15633 ||| NNS
for  ||| S:15633 E:15637 ||| IN
fusion  ||| S:15637 E:15644 ||| NN
vary  ||| S:15644 E:15649 ||| VBP
among  ||| S:15649 E:15655 ||| IN
cell  ||| S:15655 E:15660 ||| NN
cycles  ||| S:15660 E:15675 ||| NNS
of  ||| S:15675 E:15678 ||| IN
donor  ||| S:15678 E:15684 ||| JJ
cells  ||| S:15684 E:15690 ||| NNS
in  ||| S:15690 E:15693 ||| IN
the  ||| S:15693 E:15697 ||| DT
pig ||| S:15697 E:15700 ||| NN
.  ||| S:15700 E:15710 ||| .
In  ||| S:15710 E:15713 ||| IN
general ||| S:15713 E:15720 ||| JJ
,  ||| S:15720 E:15722 ||| ,
in  ||| S:15722 E:15725 ||| IN
vitro  ||| S:15725 E:15731 ||| JJ
maturation  ||| S:15731 E:15742 ||| NNS
( ||| S:15742 E:15743 ||| -LRB-
IVM ||| S:15743 E:15746 ||| NNP
)  ||| S:15746 E:15748 ||| -RRB-
media  ||| S:15748 E:15754 ||| NNS
used  ||| S:15754 E:15759 ||| VBN
to  ||| S:15759 E:15770 ||| TO
prepare  ||| S:15770 E:15778 ||| VB
recipient  ||| S:15778 E:15788 ||| JJ
oocytes  ||| S:15788 E:15796 ||| NN
for  ||| S:15796 E:15800 ||| IN
production  ||| S:15800 E:15811 ||| NN
of  ||| S:15811 E:15814 ||| IN
cloned  ||| S:15814 E:15821 ||| JJ
embryos  ||| S:15821 E:15837 ||| NNS
are  ||| S:15837 E:15841 ||| VBP
usually  ||| S:15841 E:15849 ||| RB
supplemented  ||| S:15849 E:15862 ||| VBN
with  ||| S:15862 E:15867 ||| IN
fetal  ||| S:15867 E:15873 ||| JJ
calf  ||| S:15873 E:15878 ||| JJ
serum  ||| S:15878 E:15884 ||| NNS
( ||| S:15884 E:15885 ||| -LRB-
FCS ||| S:15885 E:15888 ||| NNP
)  ||| S:15888 E:15890 ||| -RRB-
[  ||| S:15890 E:15892 ||| -LRB-
3 ||| S:15892 E:15893 ||| LS
,  ||| S:15893 E:15903 ||| ,
4 ||| S:15903 E:15904 ||| CD
,  ||| S:15904 E:15906 ||| ,
5 ||| S:15906 E:15907 ||| CD
,  ||| S:15907 E:15909 ||| ,
14 ||| S:15909 E:15911 ||| CD
]  ||| S:15911 E:15913 ||| -RRB-
or  ||| S:15913 E:15916 ||| CC
porcine  ||| S:15916 E:15924 ||| FW
follicular  ||| S:15924 E:15935 ||| FW
fluid  ||| S:15935 E:15941 ||| FW
( ||| S:15941 E:15942 ||| -LRB-
pFF ||| S:15942 E:15945 ||| NNP
)  ||| S:15945 E:15947 ||| -RRB-
[  ||| S:15947 E:15949 ||| -LRB-
11 ||| S:15949 E:15951 ||| CD
,  ||| S:15951 E:15953 ||| ,
20 ||| S:15953 E:15955 ||| CD
,  ||| S:15955 E:15957 ||| ,
44 ||| S:15957 E:15959 ||| CD
] ||| S:15959 E:15960 ||| -RRB-
.  ||| S:15960 E:15970 ||| .
It  ||| S:15970 E:15973 ||| PRP
is  ||| S:15973 E:15976 ||| VBZ
a  ||| S:15976 E:15978 ||| DT
well  ||| S:15978 E:15983 ||| RB
known  ||| S:15983 E:15989 ||| VBN
fact  ||| S:15989 E:15994 ||| NN
that  ||| S:15994 E:15999 ||| IN
growth  ||| S:15999 E:16006 ||| NN
factors  ||| S:16006 E:16014 ||| NNS
and  ||| S:16014 E:16018 ||| CC
hormones ||| S:16018 E:16026 ||| NNS
,  ||| S:16026 E:16036 ||| ,
in  ||| S:16036 E:16039 ||| IN
addition  ||| S:16039 E:16048 ||| NN
to  ||| S:16048 E:16051 ||| TO
many  ||| S:16051 E:16056 ||| JJ
other  ||| S:16056 E:16062 ||| JJ
factors ||| S:16062 E:16069 ||| NNS
,  ||| S:16069 E:16071 ||| ,
are  ||| S:16071 E:16075 ||| VBP
abundant  ||| S:16075 E:16084 ||| VBN
in  ||| S:16084 E:16087 ||| IN
serum  ||| S:16087 E:16093 ||| NNS
[  ||| S:16093 E:16103 ||| -LRB-
45 ||| S:16103 E:16105 ||| CD
,  ||| S:16105 E:16107 ||| ,
46 ||| S:16107 E:16109 ||| CD
]  ||| S:16109 E:16111 ||| -RRB-
and  ||| S:16111 E:16115 ||| CC
follicular  ||| S:16115 E:16126 ||| JJ
fluid  ||| S:16126 E:16132 ||| NN
[  ||| S:16132 E:16134 ||| -LRB-
45 ||| S:16134 E:16136 ||| CD
,  ||| S:16136 E:16138 ||| ,
47 ||| S:16138 E:16140 ||| CD
,  ||| S:16140 E:16142 ||| ,
48 ||| S:16142 E:16144 ||| CD
] ||| S:16144 E:16145 ||| -RRB-
.  ||| S:16145 E:16147 ||| .
Therefore ||| S:16147 E:16156 ||| RB
,  ||| S:16156 E:16166 ||| ,
supplementation  ||| S:16166 E:16182 ||| VBG
of  ||| S:16182 E:16185 ||| IN
IVM  ||| S:16185 E:16189 ||| NNP
media  ||| S:16189 E:16195 ||| NNS
with  ||| S:16195 E:16200 ||| IN
FCS  ||| S:16200 E:16204 ||| NNP
or  ||| S:16204 E:16207 ||| CC
pFF  ||| S:16207 E:16211 ||| NNP
presents  ||| S:16211 E:16220 ||| VBZ
the  ||| S:16220 E:16232 ||| DT
potential  ||| S:16232 E:16242 ||| JJ
problems  ||| S:16242 E:16251 ||| NNS
in  ||| S:16251 E:16254 ||| IN
proper  ||| S:16254 E:16261 ||| JJ
quality  ||| S:16261 E:16269 ||| NN
control  ||| S:16269 E:16277 ||| NN
and  ||| S:16277 E:16289 ||| CC
repeatability  ||| S:16289 E:16303 ||| NN
among  ||| S:16303 E:16309 ||| IN
laboratories  ||| S:16309 E:16322 ||| NNS
or  ||| S:16322 E:16325 ||| CC
replicates ||| S:16325 E:16335 ||| NN
.  ||| S:16335 E:16337 ||| .
Recently ||| S:16337 E:16345 ||| RB
,  ||| S:16345 E:16347 ||| ,
a  ||| S:16347 E:16357 ||| DT
defined  ||| S:16357 E:16365 ||| VBN
IVM  ||| S:16365 E:16369 ||| NNP
system  ||| S:16369 E:16376 ||| NN
for  ||| S:16376 E:16380 ||| IN
porcine  ||| S:16380 E:16388 ||| JJ
oocytes  ||| S:16388 E:16396 ||| NN
was  ||| S:16396 E:16400 ||| VBD
developed  ||| S:16400 E:16410 ||| VBN
in  ||| S:16410 E:16421 ||| IN
order  ||| S:16421 E:16427 ||| NN
to  ||| S:16427 E:16430 ||| TO
eliminate  ||| S:16430 E:16440 ||| VB
such  ||| S:16440 E:16445 ||| JJ
variability  ||| S:16445 E:16457 ||| NNS
[  ||| S:16457 E:16459 ||| -LRB-
49 ||| S:16459 E:16461 ||| CD
,  ||| S:16461 E:16463 ||| ,
50 ||| S:16463 E:16465 ||| CD
] ||| S:16465 E:16466 ||| -RRB-
.  ||| S:16466 E:16468 ||| .
In  ||| S:16468 E:16471 ||| IN
the  ||| S:16471 E:16483 ||| DT
present  ||| S:16483 E:16491 ||| JJ
study ||| S:16491 E:16496 ||| NN
,  ||| S:16496 E:16498 ||| ,
7.6 ||| S:16498 E:16501 ||| CD
%  ||| S:16501 E:16503 ||| NN
of  ||| S:16503 E:16506 ||| IN
reconstructed  ||| S:16506 E:16520 ||| JJ
embryos  ||| S:16520 E:16528 ||| NNS
produced  ||| S:16528 E:16537 ||| VBN
by  ||| S:16537 E:16548 ||| IN
transferring  ||| S:16548 E:16561 ||| VBG
confluent  ||| S:16561 E:16571 ||| JJ
adult  ||| S:16571 E:16577 ||| NN
somatic  ||| S:16577 E:16585 ||| NN
cells  ||| S:16585 E:16591 ||| NNS
into  ||| S:16591 E:16596 ||| IN
enucleated  ||| S:16596 E:16615 ||| JJ
M  ||| S:16615 E:16617 ||| NNP
II  ||| S:16617 E:16620 ||| NNP
oocytes  ||| S:16620 E:16628 ||| VBD
matured  ||| S:16628 E:16636 ||| VBN
in  ||| S:16636 E:16639 ||| IN
the  ||| S:16639 E:16643 ||| DT
protein-free  ||| S:16643 E:16656 ||| JJ
medium  ||| S:16656 E:16663 ||| NN
developed  ||| S:16663 E:16681 ||| VBN
to  ||| S:16681 E:16684 ||| TO
the  ||| S:16684 E:16688 ||| DT
blastocyst  ||| S:16688 E:16699 ||| JJ
stage ||| S:16699 E:16704 ||| NN
.  ||| S:16704 E:16706 ||| .
The  ||| S:16706 E:16710 ||| DT
blastocyst  ||| S:16710 E:16721 ||| JJ
formation  ||| S:16721 E:16731 ||| NN
rate  ||| S:16731 E:16736 ||| NN
in  ||| S:16736 E:16747 ||| IN
our  ||| S:16747 E:16751 ||| PRP$
study  ||| S:16751 E:16757 ||| NN
is  ||| S:16757 E:16760 ||| VBZ
similar  ||| S:16760 E:16768 ||| JJ
to  ||| S:16768 E:16771 ||| TO
results  ||| S:16771 E:16779 ||| NNS
from  ||| S:16779 E:16784 ||| IN
the  ||| S:16784 E:16788 ||| DT
recent  ||| S:16788 E:16795 ||| JJ
reports  ||| S:16795 E:16803 ||| NNS
in  ||| S:16803 E:16814 ||| IN
which  ||| S:16814 E:16820 ||| WDT
porcine  ||| S:16820 E:16828 ||| VBZ
adult  ||| S:16828 E:16834 ||| JJ
somatic  ||| S:16834 E:16842 ||| NNS
( ||| S:16842 E:16843 ||| -LRB-
cumulus ||| S:16843 E:16850 ||| LS
)  ||| S:16850 E:16852 ||| -RRB-
cells  ||| S:16852 E:16858 ||| NNS
( ||| S:16858 E:16859 ||| -LRB-
5-10 ||| S:16859 E:16863 ||| JJ
% ||| S:16863 E:16864 ||| NN
)  ||| S:16864 E:16866 ||| -RRB-
[  ||| S:16866 E:16868 ||| -LRB-
29 ||| S:16868 E:16870 ||| CD
,  ||| S:16870 E:16880 ||| ,
51 ||| S:16880 E:16882 ||| CD
]  ||| S:16882 E:16884 ||| -RRB-
or  ||| S:16884 E:16887 ||| CC
fetal  ||| S:16887 E:16893 ||| JJ
fibroblasts  ||| S:16893 E:16905 ||| NNS
( ||| S:16905 E:16906 ||| -LRB-
1-16 ||| S:16906 E:16910 ||| NNP
% ||| S:16910 E:16911 ||| NN
)  ||| S:16911 E:16913 ||| -RRB-
[  ||| S:16913 E:16915 ||| -LRB-
11 ||| S:16915 E:16917 ||| CD
,  ||| S:16917 E:16919 ||| ,
29 ||| S:16919 E:16921 ||| CD
,  ||| S:16921 E:16923 ||| ,
51 ||| S:16923 E:16925 ||| CD
,  ||| S:16925 E:16927 ||| ,
52 ||| S:16927 E:16929 ||| CD
,  ||| S:16929 E:16931 ||| ,
53 ||| S:16931 E:16933 ||| CD
,  ||| S:16933 E:16935 ||| ,
54 ||| S:16935 E:16937 ||| CD
,  ||| S:16937 E:16947 ||| ,
55 ||| S:16947 E:16949 ||| CD
,  ||| S:16949 E:16951 ||| ,
56 ||| S:16951 E:16953 ||| CD
,  ||| S:16953 E:16955 ||| ,
57 ||| S:16955 E:16957 ||| CD
]  ||| S:16957 E:16959 ||| -RRB-
were  ||| S:16959 E:16964 ||| VBD
transferred  ||| S:16964 E:16976 ||| VBN
into  ||| S:16976 E:16981 ||| IN
enucleated  ||| S:16981 E:16992 ||| JJ
M  ||| S:16992 E:16994 ||| NNP
II  ||| S:16994 E:16997 ||| NNP
oocytes  ||| S:16997 E:17013 ||| VBD
matured  ||| S:17013 E:17021 ||| VBN
in  ||| S:17021 E:17024 ||| IN
media  ||| S:17024 E:17030 ||| NNS
supplemented  ||| S:17030 E:17043 ||| VBN
with  ||| S:17043 E:17048 ||| IN
pFF ||| S:17048 E:17051 ||| JJ
.  ||| S:17051 E:17053 ||| .
In  ||| S:17053 E:17056 ||| IN
addition ||| S:17056 E:17064 ||| NN
,  ||| S:17064 E:17074 ||| ,
quality  ||| S:17074 E:17082 ||| NN
of  ||| S:17082 E:17085 ||| IN
the  ||| S:17085 E:17089 ||| DT
blastocysts  ||| S:17089 E:17101 ||| NN
based  ||| S:17101 E:17107 ||| VBN
on  ||| S:17107 E:17110 ||| IN
the  ||| S:17110 E:17114 ||| DT
mean  ||| S:17114 E:17119 ||| JJ
number  ||| S:17119 E:17126 ||| NN
of  ||| S:17126 E:17137 ||| IN
cells  ||| S:17137 E:17143 ||| NNS
( ||| S:17143 E:17144 ||| -LRB-
45.1  ||| S:17144 E:17149 ||| CD
cells ||| S:17149 E:17154 ||| NNS
)  ||| S:17154 E:17156 ||| -RRB-
equals  ||| S:17156 E:17163 ||| VBZ
if  ||| S:17163 E:17166 ||| IN
not  ||| S:17166 E:17170 ||| RB
exceeds  ||| S:17170 E:17178 ||| VBZ
results  ||| S:17178 E:17186 ||| NNS
from  ||| S:17186 E:17199 ||| IN
previous  ||| S:17199 E:17208 ||| JJ
studies  ||| S:17208 E:17216 ||| NNS
( ||| S:17216 E:17217 ||| -LRB-
cumulus  ||| S:17217 E:17225 ||| JJ
cells ||| S:17225 E:17230 ||| NNS
:  ||| S:17230 E:17232 ||| :
28.9  ||| S:17232 E:17237 ||| CD
cells  ||| S:17237 E:17243 ||| NNS
[  ||| S:17243 E:17245 ||| -LRB-
51 ||| S:17245 E:17247 ||| CD
] ||| S:17247 E:17248 ||| -RRB-
;  ||| S:17248 E:17250 ||| :
fetal  ||| S:17250 E:17264 ||| JJ
fibroblasts ||| S:17264 E:17275 ||| NN
:  ||| S:17275 E:17277 ||| :
12.5-66.0  ||| S:17277 E:17287 ||| CD
cells  ||| S:17287 E:17293 ||| NNS
[  ||| S:17293 E:17295 ||| -LRB-
11 ||| S:17295 E:17297 ||| CD
,  ||| S:17297 E:17299 ||| ,
51 ||| S:17299 E:17301 ||| CD
,  ||| S:17301 E:17303 ||| ,
52 ||| S:17303 E:17305 ||| CD
,  ||| S:17305 E:17307 ||| ,
53 ||| S:17307 E:17309 ||| CD
,  ||| S:17309 E:17311 ||| ,
54 ||| S:17311 E:17313 ||| CD
,  ||| S:17313 E:17315 ||| ,
55 ||| S:17315 E:17317 ||| CD
,  ||| S:17317 E:17327 ||| ,
56 ||| S:17327 E:17329 ||| CD
] ||| S:17329 E:17330 ||| CD
) ||| S:17330 E:17331 ||| -RRB-
.  ||| S:17331 E:17333 ||| .
Although  ||| S:17333 E:17342 ||| IN
this  ||| S:17342 E:17347 ||| DT
study  ||| S:17347 E:17353 ||| NN
did  ||| S:17353 E:17357 ||| VBD
not  ||| S:17357 E:17361 ||| RB
compare  ||| S:17361 E:17369 ||| VB
defined  ||| S:17369 E:17377 ||| VBN
IVM  ||| S:17377 E:17389 ||| NNP
medium  ||| S:17389 E:17396 ||| NN
with  ||| S:17396 E:17401 ||| IN
complex  ||| S:17401 E:17409 ||| JJ
medium  ||| S:17409 E:17416 ||| NN
the  ||| S:17416 E:17420 ||| DT
results  ||| S:17420 E:17428 ||| NNS
indicate  ||| S:17428 E:17437 ||| VBP
that  ||| S:17437 E:17450 ||| IN
protein-free  ||| S:17450 E:17463 ||| NNP
IVM  ||| S:17463 E:17467 ||| NNP
medium  ||| S:17467 E:17474 ||| NN
is  ||| S:17474 E:17477 ||| VBZ
suitable  ||| S:17477 E:17486 ||| VBN
for  ||| S:17486 E:17490 ||| IN
maturing  ||| S:17490 E:17499 ||| VBG
recipient  ||| S:17499 E:17517 ||| JJ
oocytes  ||| S:17517 E:17525 ||| NN
for  ||| S:17525 E:17529 ||| IN
the  ||| S:17529 E:17533 ||| DT
production  ||| S:17533 E:17544 ||| NN
of  ||| S:17544 E:17547 ||| IN
cloned  ||| S:17547 E:17554 ||| JJ
embryos ||| S:17554 E:17561 ||| NN
.  ||| S:17561 E:17563 ||| .
The  ||| S:17563 E:17567 ||| DT
defined  ||| S:17567 E:17583 ||| JJ
conditions  ||| S:17583 E:17594 ||| NNS
will  ||| S:17594 E:17599 ||| MD
allow  ||| S:17599 E:17605 ||| VB
us  ||| S:17605 E:17608 ||| PRP
to  ||| S:17608 E:17611 ||| TO
examine  ||| S:17611 E:17619 ||| VB
factors  ||| S:17619 E:17627 ||| NNS
affecting  ||| S:17627 E:17645 ||| VBG
nuclear  ||| S:17645 E:17653 ||| JJ
reprogramming  ||| S:17653 E:17667 ||| NN
of  ||| S:17667 E:17670 ||| IN
reconstructed  ||| S:17670 E:17684 ||| JJ
embryos  ||| S:17684 E:17692 ||| NN
more  ||| S:17692 E:17705 ||| RBR
precisely  ||| S:17705 E:17715 ||| RB
and  ||| S:17715 E:17719 ||| CC
better  ||| S:17719 E:17726 ||| RB
understand  ||| S:17726 E:17737 ||| VB
the  ||| S:17737 E:17741 ||| DT
basic  ||| S:17741 E:17747 ||| JJ
molecular  ||| S:17747 E:17765 ||| JJ
mechanisms  ||| S:17765 E:17776 ||| NNS
of  ||| S:17776 E:17779 ||| IN
the  ||| S:17779 E:17783 ||| DT
process ||| S:17783 E:17790 ||| NN
.  ||| S:17790 E:17814 ||| .
Conclusions  ||| S:17814 E:17834 ||| NNS
We  ||| S:17834 E:17837 ||| PRP
have  ||| S:17837 E:17842 ||| VBP
shown  ||| S:17842 E:17848 ||| VBN
that  ||| S:17848 E:17853 ||| IN
porcine  ||| S:17853 E:17861 ||| JJ
M  ||| S:17861 E:17863 ||| NNP
I  ||| S:17863 E:17865 ||| PRP
oocytes  ||| S:17865 E:17873 ||| RB
have  ||| S:17873 E:17878 ||| VB
a  ||| S:17878 E:17880 ||| DT
potential  ||| S:17880 E:17898 ||| JJ
to  ||| S:17898 E:17901 ||| TO
develop  ||| S:17901 E:17909 ||| VB
into  ||| S:17909 E:17914 ||| IN
blastocysts  ||| S:17914 E:17926 ||| NN
after  ||| S:17926 E:17932 ||| IN
nuclear  ||| S:17932 E:17940 ||| JJ
transfer  ||| S:17940 E:17949 ||| NN
of  ||| S:17949 E:17960 ||| IN
somatic  ||| S:17960 E:17968 ||| JJ
cells ||| S:17968 E:17973 ||| NNS
.  ||| S:17973 E:17975 ||| .
However ||| S:17975 E:17982 ||| RB
,  ||| S:17982 E:17984 ||| ,
the  ||| S:17984 E:17988 ||| DT
process  ||| S:17988 E:17996 ||| NN
of  ||| S:17996 E:17999 ||| IN
nuclear  ||| S:17999 E:18015 ||| JJ
reprogramming  ||| S:18015 E:18029 ||| NN
may  ||| S:18029 E:18033 ||| MD
be  ||| S:18033 E:18036 ||| VB
different  ||| S:18036 E:18046 ||| JJ
between  ||| S:18046 E:18054 ||| IN
M  ||| S:18054 E:18056 ||| NNP
I  ||| S:18056 E:18058 ||| NNP
and  ||| S:18058 E:18062 ||| CC
M  ||| S:18062 E:18064 ||| NNP
II  ||| S:18064 E:18067 ||| NNP
oocytes  ||| S:18067 E:18083 ||| NN
because  ||| S:18083 E:18091 ||| IN
developmental  ||| S:18091 E:18105 ||| JJ
abilities  ||| S:18105 E:18115 ||| NNS
of  ||| S:18115 E:18118 ||| IN
reconstructed  ||| S:18118 E:18132 ||| JJ
embryos  ||| S:18132 E:18148 ||| NNS
vary  ||| S:18148 E:18153 ||| VBP
between  ||| S:18153 E:18161 ||| IN
the  ||| S:18161 E:18165 ||| DT
maturation  ||| S:18165 E:18176 ||| JJ
stages  ||| S:18176 E:18183 ||| NNS
of  ||| S:18183 E:18186 ||| IN
recipient  ||| S:18186 E:18196 ||| JJ
oocytes ||| S:18196 E:18203 ||| NN
.  ||| S:18203 E:18213 ||| .
Comparison  ||| S:18213 E:18224 ||| NN
of  ||| S:18224 E:18227 ||| IN
reprogramming  ||| S:18227 E:18241 ||| JJ
events  ||| S:18241 E:18248 ||| NNS
between  ||| S:18248 E:18256 ||| IN
M  ||| S:18256 E:18258 ||| NNP
I  ||| S:18258 E:18260 ||| NNP
and  ||| S:18260 E:18264 ||| CC
M  ||| S:18264 E:18266 ||| NNP
II  ||| S:18266 E:18277 ||| NNP
oocytes  ||| S:18277 E:18285 ||| NN
would  ||| S:18285 E:18291 ||| MD
bring  ||| S:18291 E:18297 ||| VB
about  ||| S:18297 E:18303 ||| IN
important  ||| S:18303 E:18313 ||| JJ
information  ||| S:18313 E:18325 ||| NN
to  ||| S:18325 E:18336 ||| TO
understand  ||| S:18336 E:18347 ||| VB
the  ||| S:18347 E:18351 ||| DT
mechanisms  ||| S:18351 E:18362 ||| NNS
of  ||| S:18362 E:18365 ||| IN
nuclear  ||| S:18365 E:18373 ||| JJ
reprogramming  ||| S:18373 E:18387 ||| NN
in  ||| S:18387 E:18398 ||| IN
reconstructed  ||| S:18398 E:18412 ||| JJ
embryos ||| S:18412 E:18419 ||| NN
.  ||| S:18419 E:18421 ||| .
The  ||| S:18421 E:18425 ||| DT
use  ||| S:18425 E:18429 ||| NN
of  ||| S:18429 E:18432 ||| IN
defined  ||| S:18432 E:18440 ||| VBN
IVM  ||| S:18440 E:18444 ||| NNP
medium  ||| S:18444 E:18451 ||| NN
will  ||| S:18451 E:18464 ||| MD
be  ||| S:18464 E:18467 ||| VB
useful  ||| S:18467 E:18474 ||| JJ
for  ||| S:18474 E:18478 ||| IN
these  ||| S:18478 E:18484 ||| DT
studies ||| S:18484 E:18491 ||| NNS
.  ||| S:18491 E:18493 ||| .
Taken  ||| S:18493 E:18499 ||| VBN
together ||| S:18499 E:18507 ||| RB
,  ||| S:18507 E:18509 ||| ,
the  ||| S:18509 E:18513 ||| DT
use  ||| S:18513 E:18517 ||| NN
of  ||| S:18517 E:18520 ||| IN
a  ||| S:18520 E:18530 ||| DT
defined  ||| S:18530 E:18538 ||| JJ
medium  ||| S:18538 E:18545 ||| NN
and  ||| S:18545 E:18549 ||| CC
optimal  ||| S:18549 E:18557 ||| JJ
reprogramming  ||| S:18557 E:18571 ||| JJ
conditions  ||| S:18571 E:18582 ||| NNS
such  ||| S:18582 E:18587 ||| JJ
as  ||| S:18587 E:18598 ||| IN
the  ||| S:18598 E:18602 ||| DT
type  ||| S:18602 E:18607 ||| NN
of  ||| S:18607 E:18610 ||| IN
donor  ||| S:18610 E:18616 ||| JJ
nuclei  ||| S:18616 E:18623 ||| NN
and  ||| S:18623 E:18627 ||| CC
recipient  ||| S:18627 E:18637 ||| JJ
oocyte  ||| S:18637 E:18644 ||| NN
will  ||| S:18644 E:18649 ||| MD
lead  ||| S:18649 E:18654 ||| VB
to  ||| S:18654 E:18665 ||| TO
improvements  ||| S:18665 E:18678 ||| NNS
in  ||| S:18678 E:18681 ||| IN
porcine  ||| S:18681 E:18689 ||| JJ
cloning  ||| S:18689 E:18697 ||| JJ
outcomes ||| S:18697 E:18705 ||| NNS
.  ||| S:18705 E:18729 ||| .
Materials  ||| S:18729 E:18739 ||| NNS
and  ||| S:18739 E:18743 ||| CC
Methods  ||| S:18743 E:18770 ||| NNP
Donor  ||| S:18770 E:18776 ||| NNP
Cells  ||| S:18776 E:18792 ||| NNP
Porcine  ||| S:18792 E:18800 ||| NNP
fibroblasts  ||| S:18800 E:18812 ||| NN
were  ||| S:18812 E:18817 ||| VBD
harvested  ||| S:18817 E:18827 ||| VBN
from  ||| S:18827 E:18832 ||| IN
an  ||| S:18832 E:18835 ||| DT
ear  ||| S:18835 E:18839 ||| NN
skin  ||| S:18839 E:18854 ||| NN
biopsy  ||| S:18854 E:18861 ||| VBZ
obtained  ||| S:18861 E:18870 ||| VBN
from  ||| S:18870 E:18875 ||| IN
an  ||| S:18875 E:18878 ||| DT
adult  ||| S:18878 E:18884 ||| NN
pig ||| S:18884 E:18887 ||| NN
.  ||| S:18887 E:18889 ||| .
The  ||| S:18889 E:18893 ||| DT
tissue  ||| S:18893 E:18900 ||| NN
was  ||| S:18900 E:18904 ||| VBD
finely  ||| S:18904 E:18921 ||| RB
minced  ||| S:18921 E:18928 ||| JJ
and  ||| S:18928 E:18932 ||| CC
digested  ||| S:18932 E:18941 ||| VBN
in  ||| S:18941 E:18944 ||| IN
0.125 ||| S:18944 E:18949 ||| CD
%  ||| S:18949 E:18951 ||| NN
( ||| S:18951 E:18952 ||| -LRB-
w ||| S:18952 E:18953 ||| FW
/ ||| S:18953 E:18954 ||| FW
v ||| S:18954 E:18955 ||| FW
)  ||| S:18955 E:18957 ||| -RRB-
trypsin ||| S:18957 E:18964 ||| VBD
/ ||| S:18964 E:18965 ||| CD
0.02 ||| S:18965 E:18969 ||| CD
%  ||| S:18969 E:18971 ||| NN
( ||| S:18971 E:18972 ||| -LRB-
w ||| S:18972 E:18973 ||| FW
/ ||| S:18973 E:18974 ||| FW
v ||| S:18974 E:18975 ||| FW
)  ||| S:18975 E:18987 ||| -RRB-
EDTA  ||| S:18987 E:18992 ||| NNP
solution  ||| S:18992 E:19001 ||| NN
( ||| S:19001 E:19002 ||| -LRB-
Sigma  ||| S:19002 E:19008 ||| NNP
Chemical  ||| S:19008 E:19017 ||| NNP
Co. ||| S:19017 E:19020 ||| NNP
,  ||| S:19020 E:19022 ||| ,
St.  ||| S:19022 E:19026 ||| NNP
Louis ||| S:19026 E:19031 ||| NNP
,  ||| S:19031 E:19033 ||| ,
MO ||| S:19033 E:19035 ||| NNP
)  ||| S:19035 E:19047 ||| -RRB-
containing  ||| S:19047 E:19058 ||| VBG
1  ||| S:19058 E:19060 ||| CD
mg ||| S:19060 E:19062 ||| FW
/ ||| S:19062 E:19063 ||| FW
ml  ||| S:19063 E:19066 ||| FW
collagenase  ||| S:19066 E:19078 ||| FW
( ||| S:19078 E:19079 ||| -LRB-
Sigma ||| S:19079 E:19084 ||| NNP
)  ||| S:19084 E:19086 ||| -RRB-
and  ||| S:19086 E:19090 ||| CC
0.3  ||| S:19090 E:19094 ||| CD
mg ||| S:19094 E:19096 ||| FW
/ ||| S:19096 E:19097 ||| FW
ml  ||| S:19097 E:19110 ||| FW
hyaluronidase  ||| S:19110 E:19124 ||| FW
( ||| S:19124 E:19125 ||| -LRB-
Sigma ||| S:19125 E:19130 ||| NNP
)  ||| S:19130 E:19132 ||| -RRB-
for  ||| S:19132 E:19136 ||| IN
2  ||| S:19136 E:19138 ||| CD
h  ||| S:19138 E:19140 ||| NN
at  ||| S:19140 E:19143 ||| IN
37°C ||| S:19143 E:19147 ||| CD
.  ||| S:19147 E:19149 ||| .
After  ||| S:19149 E:19155 ||| IN
digestion ||| S:19155 E:19164 ||| NN
,  ||| S:19164 E:19176 ||| ,
the  ||| S:19176 E:19180 ||| DT
mixture  ||| S:19180 E:19188 ||| NN
was  ||| S:19188 E:19192 ||| VBD
filtered  ||| S:19192 E:19201 ||| VBN
through  ||| S:19201 E:19209 ||| IN
four  ||| S:19209 E:19214 ||| CD
layers  ||| S:19214 E:19221 ||| NNS
of  ||| S:19221 E:19224 ||| IN
sterile  ||| S:19224 E:19242 ||| JJ
gauze  ||| S:19242 E:19248 ||| NN
and  ||| S:19248 E:19252 ||| CC
cells  ||| S:19252 E:19258 ||| NNS
were  ||| S:19258 E:19263 ||| VBD
pelleted  ||| S:19263 E:19272 ||| VBN
by  ||| S:19272 E:19275 ||| IN
centrifugation ||| S:19275 E:19289 ||| NN
.  ||| S:19289 E:19291 ||| .
Cells  ||| S:19291 E:19307 ||| NNS
were  ||| S:19307 E:19312 ||| VBD
cultured  ||| S:19312 E:19321 ||| VBN
in  ||| S:19321 E:19324 ||| IN
DMEM ||| S:19324 E:19328 ||| NNP
/ ||| S:19328 E:19329 ||| NNP
F-12  ||| S:19329 E:19334 ||| NNP
medium  ||| S:19334 E:19341 ||| NN
( ||| S:19341 E:19342 ||| -LRB-
Sigma ||| S:19342 E:19347 ||| NNP
)  ||| S:19347 E:19349 ||| -RRB-
supplemented  ||| S:19349 E:19372 ||| NN
with  ||| S:19372 E:19377 ||| IN
20 ||| S:19377 E:19379 ||| CD
%  ||| S:19379 E:19381 ||| NN
( ||| S:19381 E:19382 ||| -LRB-
v ||| S:19382 E:19383 ||| FW
/ ||| S:19383 E:19384 ||| FW
v ||| S:19384 E:19385 ||| FW
)  ||| S:19385 E:19387 ||| -RRB-
FCS  ||| S:19387 E:19391 ||| NNP
( ||| S:19391 E:19392 ||| -LRB-
Biowhittaker  ||| S:19392 E:19405 ||| NNP
Inc. ||| S:19405 E:19409 ||| NNP
,  ||| S:19409 E:19411 ||| ,
Walkersville ||| S:19411 E:19423 ||| NNP
,  ||| S:19423 E:19425 ||| ,
MD ||| S:19425 E:19427 ||| NNP
)  ||| S:19427 E:19439 ||| -RRB-
under  ||| S:19439 E:19445 ||| IN
5 ||| S:19445 E:19446 ||| CD
%  ||| S:19446 E:19448 ||| NN
CO  ||| S:19448 E:19462 ||| NNP
2  ||| S:19462 E:19464 ||| CD
in  ||| S:19464 E:19467 ||| IN
air  ||| S:19467 E:19471 ||| NN
at  ||| S:19471 E:19474 ||| IN
37°C ||| S:19474 E:19478 ||| CD
.  ||| S:19478 E:19480 ||| .
After  ||| S:19480 E:19486 ||| IN
reaching  ||| S:19486 E:19505 ||| VBG
confluence ||| S:19505 E:19515 ||| NN
,  ||| S:19515 E:19517 ||| ,
cells  ||| S:19517 E:19523 ||| NNS
were  ||| S:19523 E:19528 ||| VBD
passaged ||| S:19528 E:19536 ||| VBN
.  ||| S:19536 E:19538 ||| .
Passage  ||| S:19538 E:19546 ||| NNP
2  ||| S:19546 E:19548 ||| CD
fibroblasts  ||| S:19548 E:19570 ||| NNS
were  ||| S:19570 E:19575 ||| VBD
trypsinized ||| S:19575 E:19586 ||| CD
,  ||| S:19586 E:19588 ||| ,
suspended  ||| S:19588 E:19598 ||| VBN
in  ||| S:19598 E:19601 ||| IN
the  ||| S:19601 E:19605 ||| DT
culture  ||| S:19605 E:19613 ||| NN
medium  ||| S:19613 E:19620 ||| NN
with  ||| S:19620 E:19635 ||| IN
10 ||| S:19635 E:19637 ||| CD
%  ||| S:19637 E:19639 ||| NN
( ||| S:19639 E:19640 ||| -LRB-
v ||| S:19640 E:19641 ||| FW
/ ||| S:19641 E:19642 ||| FW
v ||| S:19642 E:19643 ||| FW
)  ||| S:19643 E:19645 ||| -RRB-
dimethyl  ||| S:19645 E:19654 ||| FW
sulfoxide  ||| S:19654 E:19664 ||| FW
( ||| S:19664 E:19665 ||| -LRB-
Sigma ||| S:19665 E:19670 ||| NNP
)  ||| S:19670 E:19672 ||| -RRB-
and  ||| S:19672 E:19676 ||| CC
stored  ||| S:19676 E:19683 ||| VBD
as  ||| S:19683 E:19686 ||| IN
frozen  ||| S:19686 E:19703 ||| JJ
aliquots ||| S:19703 E:19711 ||| NN
.  ||| S:19711 E:19713 ||| .
Donor  ||| S:19713 E:19719 ||| JJ
cells  ||| S:19719 E:19725 ||| NNS
were  ||| S:19725 E:19730 ||| VBD
used  ||| S:19730 E:19735 ||| VBN
for  ||| S:19735 E:19739 ||| IN
nuclear  ||| S:19739 E:19747 ||| JJ
transfer  ||| S:19747 E:19766 ||| NN
between  ||| S:19766 E:19774 ||| IN
passages  ||| S:19774 E:19783 ||| CD
3  ||| S:19783 E:19785 ||| CD
and  ||| S:19785 E:19789 ||| CC
9  ||| S:19789 E:19791 ||| CD
of  ||| S:19791 E:19794 ||| IN
culture ||| S:19794 E:19801 ||| NN
.  ||| S:19801 E:19803 ||| .
For  ||| S:19803 E:19807 ||| IN
preparation  ||| S:19807 E:19819 ||| NN
of  ||| S:19819 E:19832 ||| IN
donors  ||| S:19832 E:19839 ||| NNS
in  ||| S:19839 E:19842 ||| IN
G0 ||| S:19842 E:19844 ||| CD
/ ||| S:19844 E:19845 ||| CD
G1  ||| S:19845 E:19848 ||| CD
phase ||| S:19848 E:19853 ||| NN
,  ||| S:19853 E:19855 ||| ,
the  ||| S:19855 E:19859 ||| DT
cells  ||| S:19859 E:19865 ||| NNS
were  ||| S:19865 E:19870 ||| VBD
allowed  ||| S:19870 E:19878 ||| VBN
to  ||| S:19878 E:19881 ||| TO
grow  ||| S:19881 E:19886 ||| VB
to  ||| S:19886 E:19899 ||| TO
confluency  ||| S:19899 E:19910 ||| VB
by  ||| S:19910 E:19913 ||| IN
culturing  ||| S:19913 E:19923 ||| NN
for  ||| S:19923 E:19927 ||| IN
6  ||| S:19927 E:19929 ||| CD
days  ||| S:19929 E:19934 ||| NNS
and  ||| S:19934 E:19938 ||| CC
a  ||| S:19938 E:19940 ||| DT
single  ||| S:19940 E:19947 ||| JJ
cell  ||| S:19947 E:19962 ||| NN
suspension  ||| S:19962 E:19973 ||| NN
was  ||| S:19973 E:19977 ||| VBD
prepared  ||| S:19977 E:19986 ||| VBN
by  ||| S:19986 E:19989 ||| IN
standard  ||| S:19989 E:19998 ||| JJ
trypsinization ||| S:19998 E:20012 ||| NN
.  ||| S:20012 E:20014 ||| .
The  ||| S:20014 E:20028 ||| DT
cells  ||| S:20028 E:20034 ||| NNS
were  ||| S:20034 E:20039 ||| VBD
used  ||| S:20039 E:20044 ||| VBN
for  ||| S:20044 E:20048 ||| IN
nuclear  ||| S:20048 E:20056 ||| JJ
transfer  ||| S:20056 E:20065 ||| NN
within  ||| S:20065 E:20072 ||| IN
5  ||| S:20072 E:20074 ||| CD
days  ||| S:20074 E:20079 ||| NNS
after  ||| S:20079 E:20095 ||| IN
reaching  ||| S:20095 E:20104 ||| VBG
confluence ||| S:20104 E:20114 ||| NN
.  ||| S:20114 E:20116 ||| .
After  ||| S:20116 E:20122 ||| IN
2-4  ||| S:20122 E:20126 ||| CD
days  ||| S:20126 E:20131 ||| NNS
of  ||| S:20131 E:20134 ||| IN
subculturing ||| S:20134 E:20146 ||| NN
,  ||| S:20146 E:20148 ||| ,
the  ||| S:20148 E:20162 ||| DT
cells  ||| S:20162 E:20168 ||| NNS
( ||| S:20168 E:20169 ||| -LRB-
approximately  ||| S:20169 E:20183 ||| RB
50 ||| S:20183 E:20185 ||| CD
%  ||| S:20185 E:20187 ||| NN
of  ||| S:20187 E:20190 ||| IN
confluency ||| S:20190 E:20200 ||| CD
)  ||| S:20200 E:20202 ||| -RRB-
were  ||| S:20202 E:20207 ||| VBD
cultured  ||| S:20207 E:20216 ||| VBN
in  ||| S:20216 E:20229 ||| IN
the  ||| S:20229 E:20233 ||| DT
medium  ||| S:20233 E:20240 ||| NN
supplemented  ||| S:20240 E:20253 ||| NN
with  ||| S:20253 E:20258 ||| IN
0.3  ||| S:20258 E:20262 ||| CD
μg ||| S:20262 E:20264 ||| FW
/ ||| S:20264 E:20265 ||| FW
ml  ||| S:20265 E:20268 ||| FW
nocodazole  ||| S:20268 E:20289 ||| FW
( ||| S:20289 E:20290 ||| -LRB-
Sigma ||| S:20290 E:20295 ||| NNP
) ||| S:20295 E:20296 ||| -RRB-
,  ||| S:20296 E:20298 ||| ,
a  ||| S:20298 E:20300 ||| DT
microtubule  ||| S:20300 E:20312 ||| JJ
polymerization  ||| S:20312 E:20327 ||| JJ
inhibitor ||| S:20327 E:20336 ||| NN
,  ||| S:20336 E:20338 ||| ,
for  ||| S:20338 E:20342 ||| IN
10  ||| S:20342 E:20345 ||| CD
h  ||| S:20345 E:20357 ||| NN
to  ||| S:20357 E:20360 ||| TO
induce  ||| S:20360 E:20367 ||| VB
G2 ||| S:20367 E:20369 ||| NNP
/ ||| S:20369 E:20370 ||| NNP
M  ||| S:20370 E:20372 ||| NNP
phase  ||| S:20372 E:20378 ||| NN
arrest ||| S:20378 E:20384 ||| NN
.  ||| S:20384 E:20386 ||| .
After  ||| S:20386 E:20392 ||| IN
gentle  ||| S:20392 E:20399 ||| JJ
pipetting ||| S:20399 E:20408 ||| NN
,  ||| S:20408 E:20420 ||| ,
cells  ||| S:20420 E:20426 ||| NNS
floating  ||| S:20426 E:20435 ||| VBG
in  ||| S:20435 E:20438 ||| IN
the  ||| S:20438 E:20442 ||| DT
medium  ||| S:20442 E:20449 ||| NN
were  ||| S:20449 E:20454 ||| VBD
collected ||| S:20454 E:20463 ||| VBN
.  ||| S:20463 E:20465 ||| .
Both  ||| S:20465 E:20470 ||| DT
donor  ||| S:20470 E:20486 ||| NN
cells  ||| S:20486 E:20492 ||| NNS
were  ||| S:20492 E:20497 ||| VBD
prepared  ||| S:20497 E:20506 ||| VBN
immediately  ||| S:20506 E:20518 ||| RB
prior  ||| S:20518 E:20524 ||| RB
to  ||| S:20524 E:20527 ||| TO
nuclear  ||| S:20527 E:20545 ||| JJ
transfer ||| S:20545 E:20553 ||| NN
.  ||| S:20553 E:20583 ||| .
Recipient  ||| S:20583 E:20593 ||| NNP
Oocytes  ||| S:20593 E:20611 ||| NNP
Ovaries  ||| S:20611 E:20619 ||| NNP
were  ||| S:20619 E:20624 ||| VBD
collected  ||| S:20624 E:20634 ||| VBN
from  ||| S:20634 E:20639 ||| IN
a  ||| S:20639 E:20641 ||| DT
local  ||| S:20641 E:20647 ||| JJ
slaughterhouse  ||| S:20647 E:20662 ||| NN
and  ||| S:20662 E:20676 ||| CC
transported  ||| S:20676 E:20688 ||| VBN
in  ||| S:20688 E:20691 ||| IN
0.9 ||| S:20691 E:20694 ||| CD
%  ||| S:20694 E:20696 ||| NN
saline  ||| S:20696 E:20703 ||| NN
at  ||| S:20703 E:20706 ||| IN
approximately  ||| S:20706 E:20720 ||| RB
32°C ||| S:20720 E:20724 ||| CD
.  ||| S:20724 E:20736 ||| .
Follicles  ||| S:20736 E:20746 ||| RB
greater  ||| S:20746 E:20754 ||| JJR
than  ||| S:20754 E:20759 ||| IN
3  ||| S:20759 E:20761 ||| CD
mm  ||| S:20761 E:20764 ||| NN
in  ||| S:20764 E:20767 ||| IN
diameter  ||| S:20767 E:20776 ||| NN
were  ||| S:20776 E:20781 ||| VBD
aspirated  ||| S:20781 E:20801 ||| VBN
with  ||| S:20801 E:20806 ||| IN
an  ||| S:20806 E:20809 ||| DT
18-gauge  ||| S:20809 E:20818 ||| FW
needle  ||| S:20818 E:20825 ||| FW
using  ||| S:20825 E:20831 ||| FW
vacuum  ||| S:20831 E:20838 ||| FW
suction  ||| S:20838 E:20846 ||| FW
( ||| S:20846 E:20847 ||| -LRB-
100  ||| S:20847 E:20851 ||| CD
mmHg ||| S:20851 E:20855 ||| NN
;  ||| S:20855 E:20867 ||| :
28  ||| S:20867 E:20870 ||| CD
ml ||| S:20870 E:20872 ||| CD
/ ||| S:20872 E:20873 ||| CD
min ||| S:20873 E:20876 ||| CD
) ||| S:20876 E:20877 ||| -RRB-
.  ||| S:20877 E:20879 ||| .
Aspirated  ||| S:20879 E:20889 ||| JJ
oocytes  ||| S:20889 E:20897 ||| NN
that  ||| S:20897 E:20902 ||| WDT
had  ||| S:20902 E:20906 ||| VBD
an  ||| S:20906 E:20909 ||| DT
evenly  ||| S:20909 E:20926 ||| RB
granulated  ||| S:20926 E:20937 ||| JJ
cytoplasm  ||| S:20937 E:20947 ||| NN
and  ||| S:20947 E:20951 ||| CC
were  ||| S:20951 E:20956 ||| VBD
surrounded  ||| S:20956 E:20967 ||| VBN
by  ||| S:20967 E:20970 ||| IN
at  ||| S:20970 E:20973 ||| IN
least  ||| S:20973 E:20979 ||| JJS
two  ||| S:20979 E:20993 ||| CD
uniform  ||| S:20993 E:21001 ||| JJ
layers  ||| S:21001 E:21008 ||| NNS
of  ||| S:21008 E:21011 ||| IN
compact  ||| S:21011 E:21019 ||| JJ
cumulus  ||| S:21019 E:21027 ||| JJ
cells  ||| S:21027 E:21033 ||| NNS
were  ||| S:21033 E:21038 ||| VBD
selected  ||| S:21038 E:21047 ||| VBN
and  ||| S:21047 E:21061 ||| CC
washed  ||| S:21061 E:21068 ||| VBD
three  ||| S:21068 E:21074 ||| CD
times  ||| S:21074 E:21080 ||| NNS
in  ||| S:21080 E:21083 ||| IN
Hepes-buffered  ||| S:21083 E:21098 ||| JJ
synthetic  ||| S:21098 E:21108 ||| JJ
oviductal  ||| S:21108 E:21128 ||| JJ
fluid  ||| S:21128 E:21134 ||| JJ
medium  ||| S:21134 E:21141 ||| NN
[  ||| S:21141 E:21143 ||| -LRB-
58 ||| S:21143 E:21145 ||| CD
] ||| S:21145 E:21146 ||| -RRB-
.  ||| S:21146 E:21148 ||| .
Oocytes  ||| S:21148 E:21156 ||| NNP
were  ||| S:21156 E:21161 ||| VBD
transferred  ||| S:21161 E:21173 ||| VBN
into  ||| S:21173 E:21178 ||| IN
tubes  ||| S:21178 E:21194 ||| NNS
containing  ||| S:21194 E:21205 ||| VBG
Hepes-buffered  ||| S:21205 E:21220 ||| JJ
TCM-199  ||| S:21220 E:21228 ||| NNP
( ||| S:21228 E:21229 ||| -LRB-
Gibco  ||| S:21229 E:21235 ||| NNP
BRL ||| S:21235 E:21238 ||| NNP
,  ||| S:21238 E:21240 ||| ,
Grand  ||| S:21240 E:21256 ||| NNP
Island ||| S:21256 E:21262 ||| NNP
,  ||| S:21262 E:21264 ||| ,
NY ||| S:21264 E:21266 ||| NNP
)  ||| S:21266 E:21268 ||| -RRB-
supplemented  ||| S:21268 E:21281 ||| NN
with  ||| S:21281 E:21286 ||| IN
0.57  ||| S:21286 E:21291 ||| CD
mM  ||| S:21291 E:21294 ||| JJ
cysteine ||| S:21294 E:21302 ||| NN
,  ||| S:21302 E:21304 ||| ,
10  ||| S:21304 E:21307 ||| CD
ng ||| S:21307 E:21309 ||| CD
/ ||| S:21309 E:21310 ||| CD
ml  ||| S:21310 E:21323 ||| CD
epidermal  ||| S:21323 E:21333 ||| JJ
growth  ||| S:21333 E:21340 ||| NN
factor  ||| S:21340 E:21347 ||| NN
( ||| S:21347 E:21348 ||| -LRB-
Sigma ||| S:21348 E:21353 ||| NNP
) ||| S:21353 E:21354 ||| -RRB-
,  ||| S:21354 E:21356 ||| ,
100  ||| S:21356 E:21360 ||| CD
IU ||| S:21360 E:21362 ||| FW
/ ||| S:21362 E:21363 ||| FW
ml  ||| S:21363 E:21366 ||| FW
penicillin ||| S:21366 E:21376 ||| FW
,  ||| S:21376 E:21388 ||| ,
100  ||| S:21388 E:21392 ||| CD
μg ||| S:21392 E:21394 ||| CD
/ ||| S:21394 E:21395 ||| CD
ml  ||| S:21395 E:21398 ||| JJ
streptomycin ||| S:21398 E:21410 ||| NN
,  ||| S:21410 E:21412 ||| ,
0.25  ||| S:21412 E:21417 ||| CD
ng ||| S:21417 E:21419 ||| CD
/ ||| S:21419 E:21420 ||| CD
ml  ||| S:21420 E:21423 ||| JJ
amphotericin ||| S:21423 E:21435 ||| NN
,  ||| S:21435 E:21437 ||| ,
0.01  ||| S:21437 E:21452 ||| FW
IU ||| S:21452 E:21454 ||| FW
/ ||| S:21454 E:21455 ||| FW
ml  ||| S:21455 E:21458 ||| FW
porcine  ||| S:21458 E:21466 ||| FW
FSH  ||| S:21466 E:21470 ||| FW
( ||| S:21470 E:21471 ||| -LRB-
Sioux  ||| S:21471 E:21477 ||| NNP
Biochemicals ||| S:21477 E:21489 ||| NNP
,  ||| S:21489 E:21491 ||| ,
Sioux  ||| S:21491 E:21497 ||| NNP
Center ||| S:21497 E:21503 ||| NNP
,  ||| S:21503 E:21505 ||| ,
IA ||| S:21505 E:21507 ||| NNP
) ||| S:21507 E:21508 ||| -RRB-
,  ||| S:21508 E:21520 ||| ,
0.01  ||| S:21520 E:21525 ||| FW
IU ||| S:21525 E:21527 ||| FW
/ ||| S:21527 E:21528 ||| FW
ml  ||| S:21528 E:21531 ||| FW
porcine  ||| S:21531 E:21539 ||| FW
LH  ||| S:21539 E:21542 ||| FW
( ||| S:21542 E:21543 ||| -LRB-
Sioux  ||| S:21543 E:21549 ||| NNP
Biochemicals ||| S:21549 E:21561 ||| NNP
)  ||| S:21561 E:21563 ||| -RRB-
and  ||| S:21563 E:21567 ||| CC
0.1 ||| S:21567 E:21570 ||| CD
%  ||| S:21570 E:21572 ||| NN
( ||| S:21572 E:21573 ||| -LRB-
w ||| S:21573 E:21574 ||| NN
: ||| S:21574 E:21575 ||| :
v ||| S:21575 E:21576 ||| LS
)  ||| S:21576 E:21588 ||| -RRB-
polyvinyl  ||| S:21588 E:21598 ||| JJ
alcohol  ||| S:21598 E:21606 ||| NN
( ||| S:21606 E:21607 ||| -LRB-
maturation  ||| S:21607 E:21618 ||| JJ
medium ||| S:21618 E:21624 ||| NN
)  ||| S:21624 E:21626 ||| -RRB-
[  ||| S:21626 E:21628 ||| -LRB-
50 ||| S:21628 E:21630 ||| CD
] ||| S:21630 E:21631 ||| -RRB-
,  ||| S:21631 E:21633 ||| ,
and  ||| S:21633 E:21637 ||| CC
shipped  ||| S:21637 E:21655 ||| VBN
to  ||| S:21655 E:21658 ||| TO
the  ||| S:21658 E:21662 ||| DT
laboratory  ||| S:21662 E:21673 ||| NN
overnight  ||| S:21673 E:21683 ||| JJ
( ||| S:21683 E:21684 ||| -LRB-
20-24  ||| S:21684 E:21690 ||| FW
h ||| S:21690 E:21691 ||| FW
)  ||| S:21691 E:21693 ||| -RRB-
at  ||| S:21693 E:21696 ||| IN
38.5°C ||| S:21696 E:21702 ||| CD
.  ||| S:21702 E:21704 ||| .
Oocytes  ||| S:21704 E:21722 ||| NNP
continued  ||| S:21722 E:21732 ||| VBD
to  ||| S:21732 E:21735 ||| TO
be  ||| S:21735 E:21738 ||| VB
cultured  ||| S:21738 E:21747 ||| VBN
in  ||| S:21747 E:21750 ||| IN
the  ||| S:21750 E:21754 ||| DT
tubes  ||| S:21754 E:21760 ||| NN
under  ||| S:21760 E:21766 ||| IN
38.5°C  ||| S:21766 E:21773 ||| CD
until  ||| S:21773 E:21789 ||| IN
enucleation ||| S:21789 E:21800 ||| NN
.  ||| S:21800 E:21830 ||| .
Nuclear  ||| S:21830 E:21838 ||| NNP
Transfer  ||| S:21838 E:21857 ||| NNP
Reconstructed  ||| S:21857 E:21871 ||| NNP
embryos  ||| S:21871 E:21879 ||| NN
were  ||| S:21879 E:21884 ||| VBD
produced  ||| S:21884 E:21893 ||| VBN
using  ||| S:21893 E:21899 ||| VBG
a  ||| S:21899 E:21911 ||| DT
modification  ||| S:21911 E:21924 ||| NN
of  ||| S:21924 E:21927 ||| IN
the  ||| S:21927 E:21931 ||| DT
method  ||| S:21931 E:21938 ||| NN
described  ||| S:21938 E:21948 ||| VBD
by  ||| S:21948 E:21951 ||| IN
Miyoshi  ||| S:21951 E:21959 ||| NNP
et  ||| S:21959 E:21962 ||| FW
al.  ||| S:21962 E:21966 ||| FW
[  ||| S:21966 E:21978 ||| -LRB-
44 ||| S:21978 E:21980 ||| CD
] ||| S:21980 E:21981 ||| -RRB-
.  ||| S:21981 E:21983 ||| .
Cumulus  ||| S:21983 E:21991 ||| JJ
cells  ||| S:21991 E:21997 ||| NNS
were  ||| S:21997 E:22002 ||| VBD
removed  ||| S:22002 E:22010 ||| VBN
by  ||| S:22010 E:22013 ||| IN
vortexing  ||| S:22013 E:22023 ||| NN
with  ||| S:22023 E:22028 ||| IN
0.1 ||| S:22028 E:22031 ||| CD
%  ||| S:22031 E:22043 ||| NN
( ||| S:22043 E:22044 ||| -LRB-
w ||| S:22044 E:22045 ||| NN
: ||| S:22045 E:22046 ||| :
v ||| S:22046 E:22047 ||| LS
)  ||| S:22047 E:22049 ||| -RRB-
hyaluronidase  ||| S:22049 E:22063 ||| NN
and  ||| S:22063 E:22067 ||| CC
denuded  ||| S:22067 E:22075 ||| JJ
oocytes  ||| S:22075 E:22083 ||| NN
were  ||| S:22083 E:22088 ||| VBD
transferred  ||| S:22088 E:22110 ||| VBN
into  ||| S:22110 E:22115 ||| IN
100  ||| S:22115 E:22119 ||| CD
μl  ||| S:22119 E:22122 ||| NN
of  ||| S:22122 E:22125 ||| IN
Hepes-buffered  ||| S:22125 E:22140 ||| JJ
TCM-199  ||| S:22140 E:22148 ||| CD
supplemented  ||| S:22148 E:22161 ||| NN
with  ||| S:22161 E:22176 ||| IN
7.5  ||| S:22176 E:22180 ||| CD
μg ||| S:22180 E:22182 ||| FW
/ ||| S:22182 E:22183 ||| FW
ml  ||| S:22183 E:22186 ||| FW
cytochalasin  ||| S:22186 E:22199 ||| FW
B  ||| S:22199 E:22201 ||| NNP
( ||| S:22201 E:22202 ||| -LRB-
Sigma ||| S:22202 E:22207 ||| NNP
)  ||| S:22207 E:22209 ||| -RRB-
and  ||| S:22209 E:22213 ||| CC
10 ||| S:22213 E:22215 ||| CD
%  ||| S:22215 E:22217 ||| NN
FCS  ||| S:22217 E:22221 ||| NN
with  ||| S:22221 E:22226 ||| IN
the  ||| S:22226 E:22240 ||| DT
osmolarity  ||| S:22240 E:22251 ||| NN
adjusted  ||| S:22251 E:22260 ||| VBN
to  ||| S:22260 E:22263 ||| TO
300  ||| S:22263 E:22267 ||| CD
mOsm  ||| S:22267 E:22272 ||| NN
by  ||| S:22272 E:22275 ||| IN
adding  ||| S:22275 E:22282 ||| VBG
sorbitol  ||| S:22282 E:22301 ||| NNS
( ||| S:22301 E:22302 ||| -LRB-
manipulation  ||| S:22302 E:22315 ||| NN
medium ||| S:22315 E:22321 ||| NN
)  ||| S:22321 E:22323 ||| -RRB-
at  ||| S:22323 E:22326 ||| IN
29  ||| S:22326 E:22329 ||| CD
or  ||| S:22329 E:22332 ||| CC
42  ||| S:22332 E:22335 ||| CD
h  ||| S:22335 E:22337 ||| NN
after  ||| S:22337 E:22343 ||| IN
IVM ||| S:22343 E:22346 ||| NNP
.  ||| S:22346 E:22348 ||| .
The  ||| S:22348 E:22352 ||| DT
M  ||| S:22352 E:22354 ||| NNP
I  ||| S:22354 E:22366 ||| NNP
plate  ||| S:22366 E:22372 ||| NN
or  ||| S:22372 E:22375 ||| CC
the  ||| S:22375 E:22379 ||| DT
first  ||| S:22379 E:22385 ||| JJ
polar  ||| S:22385 E:22391 ||| JJ
body  ||| S:22391 E:22396 ||| NN
and  ||| S:22396 E:22400 ||| CC
M  ||| S:22400 E:22402 ||| NNP
II  ||| S:22402 E:22405 ||| NNP
plate  ||| S:22405 E:22411 ||| NN
were  ||| S:22411 E:22416 ||| VBD
removed  ||| S:22416 E:22434 ||| VBN
by  ||| S:22434 E:22437 ||| IN
aspiration  ||| S:22437 E:22448 ||| NN
with  ||| S:22448 E:22453 ||| IN
a  ||| S:22453 E:22455 ||| DT
15-μm  ||| S:22455 E:22461 ||| FW
inner  ||| S:22461 E:22467 ||| FW
diameter  ||| S:22467 E:22476 ||| FW
glass  ||| S:22476 E:22482 ||| FW
pipette ||| S:22482 E:22489 ||| FW
.  ||| S:22489 E:22501 ||| .
The  ||| S:22501 E:22505 ||| DT
oocytes  ||| S:22505 E:22513 ||| NN
had  ||| S:22513 E:22517 ||| VBD
been  ||| S:22517 E:22522 ||| VBN
previously  ||| S:22522 E:22533 ||| RB
stained  ||| S:22533 E:22541 ||| VBN
in  ||| S:22541 E:22544 ||| IN
the  ||| S:22544 E:22558 ||| DT
manipulation  ||| S:22558 E:22571 ||| NN
medium  ||| S:22571 E:22578 ||| NN
supplemented  ||| S:22578 E:22591 ||| NN
with  ||| S:22591 E:22596 ||| IN
5  ||| S:22596 E:22598 ||| CD
μg ||| S:22598 E:22600 ||| CD
/ ||| S:22600 E:22601 ||| CD
ml  ||| S:22601 E:22604 ||| JJ
Hoechst  ||| S:22604 E:22622 ||| NNP
33342  ||| S:22622 E:22628 ||| CD
( ||| S:22628 E:22629 ||| -LRB-
Sigma ||| S:22629 E:22634 ||| NNP
)  ||| S:22634 E:22636 ||| -RRB-
for  ||| S:22636 E:22640 ||| IN
20  ||| S:22640 E:22643 ||| CD
min  ||| S:22643 E:22647 ||| NNS
and  ||| S:22647 E:22651 ||| CC
confirmation  ||| S:22651 E:22664 ||| NN
of  ||| S:22664 E:22667 ||| IN
successful  ||| S:22667 E:22688 ||| JJ
enucleation  ||| S:22688 E:22700 ||| NN
was  ||| S:22700 E:22704 ||| VBD
achieved  ||| S:22704 E:22713 ||| VBN
by  ||| S:22713 E:22716 ||| IN
visualizing  ||| S:22716 E:22728 ||| VBG
the  ||| S:22728 E:22732 ||| DT
cytoplast  ||| S:22732 E:22742 ||| NN
and  ||| S:22742 E:22756 ||| CC
removed  ||| S:22756 E:22764 ||| VBD
cytoplasm  ||| S:22764 E:22774 ||| VBN
under  ||| S:22774 E:22780 ||| IN
ultraviolet  ||| S:22780 E:22792 ||| JJ
light ||| S:22792 E:22797 ||| NN
.  ||| S:22797 E:22799 ||| .
After  ||| S:22799 E:22815 ||| IN
enucleation ||| S:22815 E:22826 ||| NN
,  ||| S:22826 E:22828 ||| ,
a  ||| S:22828 E:22830 ||| DT
donor  ||| S:22830 E:22836 ||| NN
cell  ||| S:22836 E:22841 ||| NN
was  ||| S:22841 E:22845 ||| VBD
inserted  ||| S:22845 E:22854 ||| VBN
into  ||| S:22854 E:22859 ||| IN
the  ||| S:22859 E:22873 ||| DT
perivitelline  ||| S:22873 E:22887 ||| JJ
space  ||| S:22887 E:22893 ||| NN
of  ||| S:22893 E:22896 ||| IN
each  ||| S:22896 E:22901 ||| DT
enucleated  ||| S:22901 E:22912 ||| JJ
oocyte  ||| S:22912 E:22919 ||| NNS
using  ||| S:22919 E:22925 ||| VBG
the  ||| S:22925 E:22939 ||| DT
same  ||| S:22939 E:22944 ||| JJ
glass  ||| S:22944 E:22950 ||| NN
pipette ||| S:22950 E:22957 ||| NN
.  ||| S:22957 E:22959 ||| .
When  ||| S:22959 E:22964 ||| WRB
nocodazole-treated  ||| S:22964 E:22983 ||| JJ
cells  ||| S:22983 E:22989 ||| NNS
were  ||| S:22989 E:23004 ||| VBD
used  ||| S:23004 E:23009 ||| VBN
as  ||| S:23009 E:23012 ||| IN
donors ||| S:23012 E:23018 ||| NNS
,  ||| S:23018 E:23020 ||| ,
large  ||| S:23020 E:23026 ||| JJ
cells  ||| S:23026 E:23032 ||| NNS
( ||| S:23032 E:23033 ||| -LRB-
cell  ||| S:23033 E:23038 ||| NN
diameter  ||| S:23038 E:23047 ||| NN
was  ||| S:23047 E:23051 ||| VBD
> ||| S:23051 E:23052 ||| CD
15  ||| S:23052 E:23055 ||| CD
μm ||| S:23055 E:23057 ||| CD
)  ||| S:23057 E:23069 ||| -RRB-
were  ||| S:23069 E:23074 ||| VBD
selected ||| S:23074 E:23082 ||| VBN
.  ||| S:23082 E:23084 ||| .
In  ||| S:23084 E:23087 ||| IN
our  ||| S:23087 E:23091 ||| PRP$
preliminary  ||| S:23091 E:23103 ||| JJ
experiment ||| S:23103 E:23113 ||| NN
,  ||| S:23113 E:23115 ||| ,
such  ||| S:23115 E:23120 ||| PDT
a  ||| S:23120 E:23132 ||| DT
relatively  ||| S:23132 E:23143 ||| RB
large  ||| S:23143 E:23149 ||| JJ
cytoplasmic  ||| S:23149 E:23161 ||| JJ
volume  ||| S:23161 E:23168 ||| NN
was  ||| S:23168 E:23172 ||| VBD
typical  ||| S:23172 E:23180 ||| JJ
of  ||| S:23180 E:23183 ||| IN
cells  ||| S:23183 E:23199 ||| NNS
at  ||| S:23199 E:23202 ||| IN
the  ||| S:23202 E:23206 ||| DT
G2 ||| S:23206 E:23208 ||| NNP
/ ||| S:23208 E:23209 ||| NNP
M  ||| S:23209 E:23211 ||| NNP
phase  ||| S:23211 E:23217 ||| NN
as  ||| S:23217 E:23220 ||| IN
described  ||| S:23220 E:23230 ||| VBN
by  ||| S:23230 E:23233 ||| IN
Wakayama  ||| S:23233 E:23242 ||| NNP
et  ||| S:23242 E:23245 ||| FW
al.  ||| S:23245 E:23249 ||| FW
[  ||| S:23249 E:23251 ||| -LRB-
13 ||| S:23251 E:23253 ||| CD
] ||| S:23253 E:23254 ||| -RRB-
.  ||| S:23254 E:23266 ||| .
Cell-oocyte  ||| S:23266 E:23278 ||| JJ
complexes  ||| S:23278 E:23288 ||| NNS
were  ||| S:23288 E:23293 ||| VBD
washed  ||| S:23293 E:23300 ||| VBN
in  ||| S:23300 E:23303 ||| IN
TCM-199  ||| S:23303 E:23311 ||| CD
supplemented  ||| S:23311 E:23334 ||| NN
with  ||| S:23334 E:23339 ||| IN
10 ||| S:23339 E:23341 ||| CD
%  ||| S:23341 E:23343 ||| NN
FCS ||| S:23343 E:23346 ||| NNP
,  ||| S:23346 E:23348 ||| ,
transferred  ||| S:23348 E:23360 ||| VBN
to  ||| S:23360 E:23363 ||| TO
the  ||| S:23363 E:23367 ||| DT
same  ||| S:23367 E:23372 ||| JJ
medium  ||| S:23372 E:23379 ||| NN
and  ||| S:23379 E:23383 ||| CC
kept  ||| S:23383 E:23398 ||| VBD
under  ||| S:23398 E:23404 ||| IN
5 ||| S:23404 E:23405 ||| CD
%  ||| S:23405 E:23407 ||| NN
CO  ||| S:23407 E:23421 ||| NNP
2  ||| S:23421 E:23423 ||| CD
in  ||| S:23423 E:23426 ||| IN
air  ||| S:23426 E:23430 ||| NN
at  ||| S:23430 E:23433 ||| IN
38.5°C  ||| S:23433 E:23440 ||| CD
until  ||| S:23440 E:23446 ||| IN
fusion ||| S:23446 E:23452 ||| NN
.  ||| S:23452 E:23464 ||| .
Fusion  ||| S:23464 E:23471 ||| NN
was  ||| S:23471 E:23475 ||| VBD
performed  ||| S:23475 E:23485 ||| VBN
in  ||| S:23485 E:23488 ||| IN
a  ||| S:23488 E:23490 ||| DT
100  ||| S:23490 E:23494 ||| CD
mm  ||| S:23494 E:23497 ||| NNS
dish  ||| S:23497 E:23502 ||| VBP
filled  ||| S:23502 E:23509 ||| VBN
with  ||| S:23509 E:23514 ||| IN
15  ||| S:23514 E:23527 ||| CD
ml  ||| S:23527 E:23530 ||| NN
of  ||| S:23530 E:23533 ||| IN
Zimmermann  ||| S:23533 E:23544 ||| NNP
fusion  ||| S:23544 E:23551 ||| NN
medium  ||| S:23551 E:23558 ||| NN
[  ||| S:23558 E:23560 ||| -LRB-
59 ||| S:23560 E:23562 ||| CD
] ||| S:23562 E:23563 ||| -RRB-
.  ||| S:23563 E:23565 ||| .
Two  ||| S:23565 E:23569 ||| CD
stainless  ||| S:23569 E:23579 ||| JJ
steel  ||| S:23579 E:23595 ||| NN
wires  ||| S:23595 E:23601 ||| NNS
( ||| S:23601 E:23602 ||| -LRB-
100  ||| S:23602 E:23606 ||| CD
μm  ||| S:23606 E:23609 ||| CD
diameter ||| S:23609 E:23617 ||| CD
)  ||| S:23617 E:23619 ||| -RRB-
attached  ||| S:23619 E:23628 ||| VBN
to  ||| S:23628 E:23631 ||| TO
micromanipulators  ||| S:23631 E:23659 ||| NNS
were  ||| S:23659 E:23664 ||| VBD
used  ||| S:23664 E:23669 ||| VBN
as  ||| S:23669 E:23672 ||| IN
electrodes ||| S:23672 E:23682 ||| NNS
.  ||| S:23682 E:23684 ||| .
The  ||| S:23684 E:23688 ||| DT
single  ||| S:23688 E:23695 ||| JJ
cell-oocyte  ||| S:23695 E:23707 ||| JJ
complex  ||| S:23707 E:23725 ||| NN
was  ||| S:23725 E:23729 ||| VBD
sandwiched  ||| S:23729 E:23740 ||| VBN
between  ||| S:23740 E:23748 ||| IN
the  ||| S:23748 E:23752 ||| DT
electrodes  ||| S:23752 E:23763 ||| NNS
and  ||| S:23763 E:23767 ||| CC
oriented  ||| S:23767 E:23776 ||| VBN
with  ||| S:23776 E:23791 ||| IN
the  ||| S:23791 E:23795 ||| DT
contact  ||| S:23795 E:23803 ||| NN
surface  ||| S:23803 E:23811 ||| NN
between  ||| S:23811 E:23819 ||| IN
the  ||| S:23819 E:23823 ||| DT
cytoplast  ||| S:23823 E:23833 ||| NN
and  ||| S:23833 E:23837 ||| CC
the  ||| S:23837 E:23841 ||| DT
donor  ||| S:23841 E:23857 ||| NN
cell  ||| S:23857 E:23862 ||| NN
perpendicular  ||| S:23862 E:23876 ||| NN
to  ||| S:23876 E:23879 ||| TO
the  ||| S:23879 E:23883 ||| DT
electrodes ||| S:23883 E:23893 ||| NNS
.  ||| S:23893 E:23895 ||| .
The  ||| S:23895 E:23899 ||| DT
distance  ||| S:23899 E:23918 ||| NN
between  ||| S:23918 E:23926 ||| IN
the  ||| S:23926 E:23930 ||| DT
electrodes  ||| S:23930 E:23941 ||| NNS
was  ||| S:23941 E:23945 ||| VBD
about  ||| S:23945 E:23951 ||| IN
100  ||| S:23951 E:23955 ||| CD
μm ||| S:23955 E:23957 ||| NNS
.  ||| S:23957 E:23959 ||| .
Membrane  ||| S:23959 E:23968 ||| JJ
fusion  ||| S:23968 E:23985 ||| NN
was  ||| S:23985 E:23989 ||| VBD
induced  ||| S:23989 E:23997 ||| VBN
by  ||| S:23997 E:24000 ||| IN
applying  ||| S:24000 E:24009 ||| VBG
a  ||| S:24009 E:24011 ||| DT
single  ||| S:24011 E:24018 ||| JJ
direct  ||| S:24018 E:24025 ||| JJ
current  ||| S:24025 E:24033 ||| JJ
pulse  ||| S:24033 E:24039 ||| NN
of  ||| S:24039 E:24052 ||| IN
250  ||| S:24052 E:24056 ||| CD
V ||| S:24056 E:24057 ||| NNP
/ ||| S:24057 E:24058 ||| NNP
mm  ||| S:24058 E:24061 ||| NN
for  ||| S:24061 E:24065 ||| IN
a  ||| S:24065 E:24067 ||| DT
duration  ||| S:24067 E:24076 ||| NN
of  ||| S:24076 E:24079 ||| IN
20  ||| S:24079 E:24082 ||| CD
μsec  ||| S:24082 E:24087 ||| NN
with  ||| S:24087 E:24092 ||| IN
a  ||| S:24092 E:24094 ||| DT
prepulse  ||| S:24094 E:24103 ||| NN
of  ||| S:24103 E:24116 ||| IN
alternating  ||| S:24116 E:24128 ||| VBG
current  ||| S:24128 E:24136 ||| JJ
field  ||| S:24136 E:24142 ||| NN
of  ||| S:24142 E:24145 ||| IN
5  ||| S:24145 E:24147 ||| CD
V ||| S:24147 E:24148 ||| NNP
,  ||| S:24148 E:24150 ||| ,
1  ||| S:24150 E:24152 ||| CD
MHz  ||| S:24152 E:24156 ||| NN
for  ||| S:24156 E:24160 ||| IN
2  ||| S:24160 E:24162 ||| CD
sec  ||| S:24162 E:24166 ||| NNS
using  ||| S:24166 E:24182 ||| VBG
an  ||| S:24182 E:24185 ||| DT
LF  ||| S:24185 E:24188 ||| NNP
101  ||| S:24188 E:24192 ||| CD
Fusion  ||| S:24192 E:24199 ||| NNP
Machine  ||| S:24199 E:24207 ||| NNP
( ||| S:24207 E:24208 ||| -LRB-
TR  ||| S:24208 E:24211 ||| NNP
Tech  ||| S:24211 E:24216 ||| NNP
Co. ||| S:24216 E:24219 ||| NNP
,  ||| S:24219 E:24221 ||| ,
Tokyo ||| S:24221 E:24226 ||| NNP
,  ||| S:24226 E:24228 ||| ,
Japan ||| S:24228 E:24233 ||| NNP
) ||| S:24233 E:24234 ||| -RRB-
.  ||| S:24234 E:24246 ||| .
Following  ||| S:24246 E:24256 ||| VBG
fusion ||| S:24256 E:24262 ||| NN
,  ||| S:24262 E:24264 ||| ,
the  ||| S:24264 E:24268 ||| DT
complexes  ||| S:24268 E:24278 ||| NNS
were  ||| S:24278 E:24283 ||| VBD
washed  ||| S:24283 E:24290 ||| VBN
in  ||| S:24290 E:24293 ||| IN
G  ||| S:24293 E:24295 ||| NNP
1.2  ||| S:24295 E:24309 ||| CD
medium  ||| S:24309 E:24316 ||| NN
[  ||| S:24316 E:24318 ||| -LRB-
60 ||| S:24318 E:24320 ||| CD
]  ||| S:24320 E:24322 ||| -RRB-
and  ||| S:24322 E:24326 ||| CC
cultured  ||| S:24326 E:24335 ||| NN
for  ||| S:24335 E:24339 ||| IN
a  ||| S:24339 E:24341 ||| DT
period  ||| S:24341 E:24348 ||| NN
of  ||| S:24348 E:24351 ||| IN
1  ||| S:24351 E:24353 ||| CD
h  ||| S:24353 E:24355 ||| NN
in  ||| S:24355 E:24358 ||| IN
100  ||| S:24358 E:24362 ||| CD
μl  ||| S:24362 E:24375 ||| NN
of  ||| S:24375 E:24378 ||| IN
the  ||| S:24378 E:24382 ||| DT
same  ||| S:24382 E:24387 ||| JJ
medium ||| S:24387 E:24393 ||| NN
.  ||| S:24393 E:24395 ||| .
Fusion  ||| S:24395 E:24402 ||| NN
rate  ||| S:24402 E:24407 ||| NN
was  ||| S:24407 E:24411 ||| VBD
then  ||| S:24411 E:24416 ||| RB
determined  ||| S:24416 E:24427 ||| VBN
by  ||| S:24427 E:24440 ||| IN
microscopic  ||| S:24440 E:24452 ||| JJ
examination ||| S:24452 E:24463 ||| NN
.  ||| S:24463 E:24493 ||| .
Activation  ||| S:24493 E:24504 ||| NNP
of  ||| S:24504 E:24507 ||| IN
Reconstructed  ||| S:24507 E:24521 ||| NNP
Embryos  ||| S:24521 E:24539 ||| NNP
Fused  ||| S:24539 E:24545 ||| NNP
embryos  ||| S:24545 E:24553 ||| NN
were  ||| S:24553 E:24558 ||| VBD
washed  ||| S:24558 E:24565 ||| VBN
once  ||| S:24565 E:24570 ||| RB
in  ||| S:24570 E:24573 ||| IN
Zimmermann  ||| S:24573 E:24584 ||| NNP
fusion  ||| S:24584 E:24601 ||| NN
medium  ||| S:24601 E:24608 ||| NN
and  ||| S:24608 E:24612 ||| CC
then  ||| S:24612 E:24617 ||| RB
placed  ||| S:24617 E:24624 ||| VBN
between  ||| S:24624 E:24632 ||| IN
2  ||| S:24632 E:24634 ||| CD
wire  ||| S:24634 E:24639 ||| NN
electrodes  ||| S:24639 E:24650 ||| NNS
( ||| S:24650 E:24651 ||| -LRB-
1  ||| S:24651 E:24653 ||| CD
mm  ||| S:24653 E:24666 ||| NNS
apart ||| S:24666 E:24671 ||| RB
)  ||| S:24671 E:24673 ||| -RRB-
of  ||| S:24673 E:24676 ||| IN
the  ||| S:24676 E:24680 ||| DT
fusion  ||| S:24680 E:24687 ||| NN
chamber  ||| S:24687 E:24695 ||| NN
slide  ||| S:24695 E:24701 ||| NN
with  ||| S:24701 E:24706 ||| IN
15  ||| S:24706 E:24709 ||| CD
ml  ||| S:24709 E:24712 ||| NN
of  ||| S:24712 E:24715 ||| IN
the  ||| S:24715 E:24729 ||| DT
fusion  ||| S:24729 E:24736 ||| NN
medium ||| S:24736 E:24742 ||| NN
.  ||| S:24742 E:24744 ||| .
Direct  ||| S:24744 E:24751 ||| JJ
current  ||| S:24751 E:24759 ||| JJ
pulses  ||| S:24759 E:24766 ||| NN
of  ||| S:24766 E:24769 ||| IN
75  ||| S:24769 E:24772 ||| CD
V ||| S:24772 E:24773 ||| NNP
/ ||| S:24773 E:24774 ||| NNP
mm  ||| S:24774 E:24777 ||| NN
were  ||| S:24777 E:24792 ||| VBD
applied  ||| S:24792 E:24800 ||| VBN
twice  ||| S:24800 E:24806 ||| RB
to  ||| S:24806 E:24809 ||| TO
the  ||| S:24809 E:24813 ||| DT
embryos  ||| S:24813 E:24821 ||| NN
for  ||| S:24821 E:24825 ||| IN
a  ||| S:24825 E:24827 ||| DT
duration  ||| S:24827 E:24836 ||| NN
of  ||| S:24836 E:24839 ||| IN
60  ||| S:24839 E:24842 ||| CD
μsec  ||| S:24842 E:24847 ||| NN
at  ||| S:24847 E:24860 ||| IN
intervals  ||| S:24860 E:24870 ||| NNS
of  ||| S:24870 E:24873 ||| IN
5  ||| S:24873 E:24875 ||| CD
sec ||| S:24875 E:24878 ||| NNS
.  ||| S:24878 E:24908 ||| .
Examination  ||| S:24908 E:24920 ||| NN
of  ||| S:24920 E:24923 ||| IN
Reconstructed  ||| S:24923 E:24937 ||| NNP
Embryos  ||| S:24937 E:24955 ||| NNP
Before  ||| S:24955 E:24962 ||| NNP
and  ||| S:24962 E:24966 ||| CC
after  ||| S:24966 E:24972 ||| IN
activation ||| S:24972 E:24982 ||| NN
,  ||| S:24982 E:24984 ||| ,
fused  ||| S:24984 E:24990 ||| JJ
embryos  ||| S:24990 E:24998 ||| NN
were  ||| S:24998 E:25013 ||| VBD
stained  ||| S:25013 E:25021 ||| VBN
with  ||| S:25021 E:25026 ||| IN
5  ||| S:25026 E:25028 ||| CD
μg ||| S:25028 E:25030 ||| CD
/ ||| S:25030 E:25031 ||| CD
ml  ||| S:25031 E:25034 ||| JJ
Hoechst  ||| S:25034 E:25042 ||| NNP
33342  ||| S:25042 E:25048 ||| CD
for  ||| S:25048 E:25052 ||| IN
20  ||| S:25052 E:25055 ||| CD
min  ||| S:25055 E:25059 ||| NNS
and  ||| S:25059 E:25063 ||| CC
then  ||| S:25063 E:25078 ||| RB
examined  ||| S:25078 E:25087 ||| VBN
for  ||| S:25087 E:25091 ||| IN
nuclear  ||| S:25091 E:25099 ||| JJ
swelling  ||| S:25099 E:25108 ||| NN
and  ||| S:25108 E:25112 ||| CC
polar  ||| S:25112 E:25118 ||| JJ
body  ||| S:25118 E:25123 ||| NN
formation  ||| S:25123 E:25143 ||| NN
under  ||| S:25143 E:25149 ||| IN
ultraviolet  ||| S:25149 E:25161 ||| JJ
light ||| S:25161 E:25166 ||| NN
.  ||| S:25166 E:25168 ||| .
The  ||| S:25168 E:25172 ||| DT
nucleus  ||| S:25172 E:25180 ||| NN
with  ||| S:25180 E:25185 ||| IN
a  ||| S:25185 E:25187 ||| DT
diameter  ||| S:25187 E:25196 ||| NN
that  ||| S:25196 E:25211 ||| WDT
was  ||| S:25211 E:25215 ||| VBD
at  ||| S:25215 E:25218 ||| IN
least  ||| S:25218 E:25224 ||| JJS
twice  ||| S:25224 E:25230 ||| RB
bigger  ||| S:25230 E:25237 ||| JJR
than  ||| S:25237 E:25242 ||| IN
the  ||| S:25242 E:25246 ||| DT
original  ||| S:25246 E:25255 ||| JJ
size  ||| S:25255 E:25260 ||| NN
of  ||| S:25260 E:25263 ||| IN
donor  ||| S:25263 E:25279 ||| JJ
cell  ||| S:25279 E:25284 ||| NN
nuclei  ||| S:25284 E:25291 ||| NNS
was  ||| S:25291 E:25295 ||| VBD
considered  ||| S:25295 E:25306 ||| VBN
to  ||| S:25306 E:25309 ||| TO
be  ||| S:25309 E:25312 ||| VB
a  ||| S:25312 E:25314 ||| DT
swollen  ||| S:25314 E:25322 ||| JJ
nucleus ||| S:25322 E:25329 ||| NN
.  ||| S:25329 E:25359 ||| .
Experimental  ||| S:25359 E:25372 ||| NNP
Studies  ||| S:25372 E:25403 ||| NNPS
Cell  ||| S:25403 E:25408 ||| NNP
Cycle  ||| S:25408 E:25414 ||| NNP
Analysis  ||| S:25414 E:25423 ||| NNP
of  ||| S:25423 E:25426 ||| IN
Donor  ||| S:25426 E:25432 ||| NNP
Cells  ||| S:25432 E:25450 ||| NNP
In  ||| S:25450 E:25453 ||| IN
Experiment  ||| S:25453 E:25464 ||| NNP
1 ||| S:25464 E:25465 ||| CD
,  ||| S:25465 E:25467 ||| ,
the  ||| S:25467 E:25471 ||| DT
cell  ||| S:25471 E:25476 ||| NN
cycle  ||| S:25476 E:25482 ||| NN
stages  ||| S:25482 E:25489 ||| NNS
of  ||| S:25489 E:25492 ||| IN
confluent  ||| S:25492 E:25514 ||| NN
and  ||| S:25514 E:25518 ||| CC
nocodazole-treated  ||| S:25518 E:25537 ||| JJ
donor  ||| S:25537 E:25543 ||| NN
cells  ||| S:25543 E:25549 ||| NNS
were  ||| S:25549 E:25554 ||| VBD
analyzed  ||| S:25554 E:25563 ||| VBN
using  ||| S:25563 E:25581 ||| VBG
flow  ||| S:25581 E:25586 ||| NN
cytometry ||| S:25586 E:25595 ||| NN
.  ||| S:25595 E:25597 ||| .
Collected  ||| S:25597 E:25607 ||| JJ
cells  ||| S:25607 E:25613 ||| NNS
( ||| S:25613 E:25614 ||| -LRB-
approx.  ||| S:25614 E:25622 ||| CD
2  ||| S:25622 E:25624 ||| CD
×  ||| S:25624 E:25626 ||| CD
10  ||| S:25626 E:25629 ||| CD
6cells ||| S:25629 E:25635 ||| CD
)  ||| S:25635 E:25649 ||| -RRB-
were  ||| S:25649 E:25654 ||| VBD
centrifuged  ||| S:25654 E:25666 ||| JJ
and  ||| S:25666 E:25670 ||| CC
the  ||| S:25670 E:25674 ||| DT
pellet  ||| S:25674 E:25681 ||| NN
was  ||| S:25681 E:25685 ||| VBD
re-suspended  ||| S:25685 E:25698 ||| JJ
in  ||| S:25698 E:25701 ||| IN
1  ||| S:25701 E:25715 ||| CD
ml  ||| S:25715 E:25718 ||| NN
of  ||| S:25718 E:25721 ||| IN
cold  ||| S:25721 E:25726 ||| JJ
PBS ||| S:25726 E:25729 ||| NNP
.  ||| S:25729 E:25731 ||| .
Then ||| S:25731 E:25735 ||| RB
,  ||| S:25735 E:25737 ||| ,
cells  ||| S:25737 E:25743 ||| NNS
were  ||| S:25743 E:25748 ||| VBD
fixed  ||| S:25748 E:25754 ||| VBN
by  ||| S:25754 E:25757 ||| IN
adding  ||| S:25757 E:25764 ||| VBG
4  ||| S:25764 E:25766 ||| CD
ml  ||| S:25766 E:25781 ||| NN
of  ||| S:25781 E:25784 ||| IN
-20°C  ||| S:25784 E:25790 ||| CD
absolute  ||| S:25790 E:25799 ||| JJ
ethanol  ||| S:25799 E:25807 ||| NN
and  ||| S:25807 E:25811 ||| CC
stored  ||| S:25811 E:25818 ||| VBD
in  ||| S:25818 E:25821 ||| IN
-20°C ||| S:25821 E:25826 ||| CD
.  ||| S:25826 E:25828 ||| .
Before  ||| S:25828 E:25847 ||| IN
analysis ||| S:25847 E:25855 ||| NN
,  ||| S:25855 E:25857 ||| ,
cells  ||| S:25857 E:25863 ||| NNS
were  ||| S:25863 E:25868 ||| VBD
centrifuged  ||| S:25868 E:25880 ||| JJ
and  ||| S:25880 E:25884 ||| CC
the  ||| S:25884 E:25888 ||| DT
pellet  ||| S:25888 E:25895 ||| NN
was  ||| S:25895 E:25911 ||| VBD
re-suspended  ||| S:25911 E:25924 ||| JJ
in  ||| S:25924 E:25927 ||| IN
1  ||| S:25927 E:25929 ||| CD
ml  ||| S:25929 E:25932 ||| NN
of  ||| S:25932 E:25935 ||| IN
PBS ||| S:25935 E:25938 ||| NNP
.  ||| S:25938 E:25940 ||| .
Then ||| S:25940 E:25944 ||| RB
,  ||| S:25944 E:25946 ||| ,
100  ||| S:25946 E:25950 ||| CD
μl  ||| S:25950 E:25953 ||| NN
of  ||| S:25953 E:25956 ||| IN
DNase-free  ||| S:25956 E:25979 ||| NNP
RNase  ||| S:25979 E:25985 ||| NNP
A  ||| S:25985 E:25987 ||| NNP
( ||| S:25987 E:25988 ||| -LRB-
200  ||| S:25988 E:25992 ||| CD
μg ||| S:25992 E:25994 ||| CD
/ ||| S:25994 E:25995 ||| CD
ml ||| S:25995 E:25997 ||| NNS
;  ||| S:25997 E:25999 ||| :
Sigma ||| S:25999 E:26004 ||| NNP
)  ||| S:26004 E:26006 ||| -RRB-
was  ||| S:26006 E:26010 ||| VBD
added  ||| S:26010 E:26016 ||| VBN
and  ||| S:26016 E:26020 ||| CC
samples  ||| S:26020 E:26028 ||| NNS
were  ||| S:26028 E:26045 ||| VBD
incubated  ||| S:26045 E:26055 ||| VBN
for  ||| S:26055 E:26059 ||| IN
30  ||| S:26059 E:26062 ||| CD
min  ||| S:26062 E:26066 ||| NN
at  ||| S:26066 E:26069 ||| IN
37°C ||| S:26069 E:26073 ||| CD
.  ||| S:26073 E:26075 ||| .
After  ||| S:26075 E:26081 ||| IN
incubation ||| S:26081 E:26091 ||| NN
,  ||| S:26091 E:26093 ||| ,
100  ||| S:26093 E:26097 ||| CD
μl  ||| S:26097 E:26112 ||| NN
of  ||| S:26112 E:26115 ||| IN
propidium  ||| S:26115 E:26125 ||| JJ
iodide  ||| S:26125 E:26132 ||| NNS
( ||| S:26132 E:26133 ||| -LRB-
1  ||| S:26133 E:26135 ||| CD
mg ||| S:26135 E:26137 ||| CD
/ ||| S:26137 E:26138 ||| CD
ml ||| S:26138 E:26140 ||| NNS
;  ||| S:26140 E:26142 ||| :
Sigma ||| S:26142 E:26147 ||| NNP
)  ||| S:26147 E:26149 ||| -RRB-
was  ||| S:26149 E:26153 ||| VBD
added  ||| S:26153 E:26159 ||| VBN
into  ||| S:26159 E:26176 ||| IN
each  ||| S:26176 E:26181 ||| DT
sample  ||| S:26181 E:26188 ||| NN
and  ||| S:26188 E:26192 ||| CC
cells  ||| S:26192 E:26198 ||| NNS
were  ||| S:26198 E:26203 ||| VBD
analyzed  ||| S:26203 E:26212 ||| VBN
using  ||| S:26212 E:26218 ||| VBG
FACStartPLUS  ||| S:26218 E:26243 ||| JJ
analyzer  ||| S:26243 E:26252 ||| NNS
( ||| S:26252 E:26253 ||| -LRB-
Becton  ||| S:26253 E:26260 ||| NNP
Dickinson ||| S:26260 E:26269 ||| NNP
,  ||| S:26269 E:26271 ||| ,
San  ||| S:26271 E:26275 ||| NNP
Jose ||| S:26275 E:26279 ||| NNP
,  ||| S:26279 E:26281 ||| ,
CA ||| S:26281 E:26283 ||| NNP
) ||| S:26283 E:26284 ||| -RRB-
.  ||| S:26284 E:26320 ||| .
Behavior  ||| S:26320 E:26329 ||| NN
before  ||| S:26329 E:26336 ||| IN
Activation  ||| S:26336 E:26347 ||| NNP
of  ||| S:26347 E:26350 ||| IN
Donor  ||| S:26350 E:26356 ||| NNP
Cell  ||| S:26356 E:26373 ||| NNP
Nuclei  ||| S:26373 E:26392 ||| NNP
In  ||| S:26392 E:26395 ||| IN
Experiment  ||| S:26395 E:26406 ||| NNP
2 ||| S:26406 E:26407 ||| CD
,  ||| S:26407 E:26409 ||| ,
we  ||| S:26409 E:26412 ||| PRP
examined  ||| S:26412 E:26421 ||| VBD
the  ||| S:26421 E:26425 ||| DT
behavior  ||| S:26425 E:26434 ||| NN
before  ||| S:26434 E:26453 ||| IN
activation  ||| S:26453 E:26464 ||| NN
of  ||| S:26464 E:26467 ||| IN
donor  ||| S:26467 E:26473 ||| JJ
cell  ||| S:26473 E:26478 ||| NN
nuclei  ||| S:26478 E:26485 ||| VBZ
transferred  ||| S:26485 E:26497 ||| VBN
into  ||| S:26497 E:26514 ||| IN
enucleated  ||| S:26514 E:26525 ||| JJ
M  ||| S:26525 E:26527 ||| NNP
I  ||| S:26527 E:26529 ||| PRP
oocytes ||| S:26529 E:26536 ||| VBD
.  ||| S:26536 E:26538 ||| .
M  ||| S:26538 E:26540 ||| NNP
I  ||| S:26540 E:26542 ||| PRP
oocytes  ||| S:26542 E:26550 ||| RB
were  ||| S:26550 E:26555 ||| VBD
enucleated  ||| S:26555 E:26566 ||| VBN
at  ||| S:26566 E:26581 ||| IN
29  ||| S:26581 E:26584 ||| CD
h  ||| S:26584 E:26586 ||| NN
after  ||| S:26586 E:26592 ||| IN
IVM  ||| S:26592 E:26596 ||| NNP
and  ||| S:26596 E:26600 ||| CC
confluent  ||| S:26600 E:26610 ||| NNS
or  ||| S:26610 E:26613 ||| CC
nocodazole-treated  ||| S:26613 E:26644 ||| JJ
cells  ||| S:26644 E:26650 ||| NNS
were  ||| S:26650 E:26655 ||| VBD
transferred ||| S:26655 E:26666 ||| VBN
.  ||| S:26666 E:26668 ||| .
Fused  ||| S:26668 E:26674 ||| JJ
embryos  ||| S:26674 E:26682 ||| NN
were  ||| S:26682 E:26687 ||| VBD
cultured  ||| S:26687 E:26696 ||| VBN
in  ||| S:26696 E:26711 ||| IN
the  ||| S:26711 E:26715 ||| DT
maturation  ||| S:26715 E:26726 ||| JJ
medium  ||| S:26726 E:26733 ||| NN
for  ||| S:26733 E:26737 ||| IN
15  ||| S:26737 E:26740 ||| CD
h  ||| S:26740 E:26742 ||| NNS
and  ||| S:26742 E:26746 ||| CC
then  ||| S:26746 E:26751 ||| RB
examined  ||| S:26751 E:26760 ||| VBN
for  ||| S:26760 E:26776 ||| IN
nuclear  ||| S:26776 E:26784 ||| JJ
swelling  ||| S:26784 E:26793 ||| NN
and  ||| S:26793 E:26797 ||| CC
polar  ||| S:26797 E:26803 ||| JJ
body  ||| S:26803 E:26808 ||| NN
formation ||| S:26808 E:26817 ||| NN
.  ||| S:26817 E:26819 ||| .
When  ||| S:26819 E:26836 ||| WRB
confluent  ||| S:26836 E:26846 ||| JJ
cells  ||| S:26846 E:26852 ||| NNS
were  ||| S:26852 E:26857 ||| VBD
used  ||| S:26857 E:26862 ||| VBN
as  ||| S:26862 E:26865 ||| IN
donors ||| S:26865 E:26871 ||| NNS
,  ||| S:26871 E:26873 ||| ,
fused  ||| S:26873 E:26879 ||| JJ
embryos  ||| S:26879 E:26887 ||| NN
were  ||| S:26887 E:26904 ||| VBD
cultured  ||| S:26904 E:26913 ||| VBN
in  ||| S:26913 E:26916 ||| IN
the  ||| S:26916 E:26920 ||| DT
medium  ||| S:26920 E:26927 ||| NN
supplemented  ||| S:26927 E:26940 ||| NN
with  ||| S:26940 E:26945 ||| IN
7.5  ||| S:26945 E:26949 ||| CD
μg ||| S:26949 E:26951 ||| FW
/ ||| S:26951 E:26952 ||| FW
ml  ||| S:26952 E:26967 ||| FW
cytochalasin  ||| S:26967 E:26980 ||| FW
B  ||| S:26980 E:26982 ||| NNP
to  ||| S:26982 E:26985 ||| TO
prevent  ||| S:26985 E:26993 ||| VB
extrusion  ||| S:26993 E:27003 ||| NN
of  ||| S:27003 E:27006 ||| IN
polar  ||| S:27006 E:27024 ||| JJ
bodies ||| S:27024 E:27030 ||| NNS
.  ||| S:27030 E:27066 ||| .
Behavior  ||| S:27066 E:27075 ||| NN
after  ||| S:27075 E:27081 ||| IN
Activation  ||| S:27081 E:27092 ||| NNP
of  ||| S:27092 E:27095 ||| IN
Donor  ||| S:27095 E:27101 ||| NNP
Cell  ||| S:27101 E:27118 ||| NNP
Nuclei  ||| S:27118 E:27137 ||| NNP
In  ||| S:27137 E:27140 ||| IN
Experiment  ||| S:27140 E:27151 ||| NNP
3 ||| S:27151 E:27152 ||| CD
,  ||| S:27152 E:27154 ||| ,
the  ||| S:27154 E:27158 ||| DT
behavior  ||| S:27158 E:27167 ||| NN
of  ||| S:27167 E:27170 ||| IN
nuclei  ||| S:27170 E:27177 ||| NN
of  ||| S:27177 E:27180 ||| IN
confluent  ||| S:27180 E:27202 ||| NN
or  ||| S:27202 E:27205 ||| CC
nocodazole-treated  ||| S:27205 E:27224 ||| JJ
cells  ||| S:27224 E:27230 ||| NNS
transferred  ||| S:27230 E:27242 ||| VBN
into  ||| S:27242 E:27247 ||| IN
enucleated  ||| S:27247 E:27270 ||| JJ
M  ||| S:27270 E:27272 ||| NNP
I  ||| S:27272 E:27274 ||| NNP
or  ||| S:27274 E:27277 ||| CC
M  ||| S:27277 E:27279 ||| NNP
II  ||| S:27279 E:27282 ||| NNP
oocytes  ||| S:27282 E:27290 ||| NN
was  ||| S:27290 E:27294 ||| VBD
examined  ||| S:27294 E:27303 ||| VBN
after  ||| S:27303 E:27309 ||| IN
activation ||| S:27309 E:27319 ||| NN
.  ||| S:27319 E:27333 ||| .
Embryos  ||| S:27333 E:27341 ||| JJ
reconstituted  ||| S:27341 E:27355 ||| NN
with  ||| S:27355 E:27360 ||| IN
M  ||| S:27360 E:27362 ||| NNP
I  ||| S:27362 E:27364 ||| PRP
oocytes  ||| S:27364 E:27372 ||| RB
were  ||| S:27372 E:27377 ||| VBD
cultured  ||| S:27377 E:27386 ||| VBN
in  ||| S:27386 E:27401 ||| IN
the  ||| S:27401 E:27405 ||| DT
maturation  ||| S:27405 E:27416 ||| JJ
medium  ||| S:27416 E:27423 ||| NN
with  ||| S:27423 E:27428 ||| IN
or  ||| S:27428 E:27431 ||| CC
without  ||| S:27431 E:27439 ||| IN
cytochalasin  ||| S:27439 E:27452 ||| JJ
B  ||| S:27452 E:27466 ||| NN
for  ||| S:27466 E:27470 ||| IN
15  ||| S:27470 E:27473 ||| CD
h  ||| S:27473 E:27475 ||| NNS
and  ||| S:27475 E:27479 ||| CC
then  ||| S:27479 E:27484 ||| RB
activated ||| S:27484 E:27493 ||| VBN
.  ||| S:27493 E:27495 ||| .
M  ||| S:27495 E:27497 ||| NNP
II  ||| S:27497 E:27500 ||| NNP
oocytes  ||| S:27500 E:27508 ||| NN
were  ||| S:27508 E:27525 ||| VBD
enucleated  ||| S:27525 E:27536 ||| VBN
at  ||| S:27536 E:27539 ||| IN
42  ||| S:27539 E:27542 ||| CD
h  ||| S:27542 E:27544 ||| NN
after  ||| S:27544 E:27550 ||| IN
IVM  ||| S:27550 E:27554 ||| NNP
and  ||| S:27554 E:27558 ||| CC
embryos  ||| S:27558 E:27566 ||| JJ
reconstituted  ||| S:27566 E:27592 ||| NN
with  ||| S:27592 E:27597 ||| IN
them  ||| S:27597 E:27602 ||| PRP
were  ||| S:27602 E:27607 ||| VBD
activated  ||| S:27607 E:27617 ||| VBN
at  ||| S:27617 E:27620 ||| IN
3  ||| S:27620 E:27622 ||| CD
h  ||| S:27622 E:27624 ||| NN
after  ||| S:27624 E:27630 ||| IN
fusion ||| S:27630 E:27636 ||| NN
.  ||| S:27636 E:27638 ||| .
Activated  ||| S:27638 E:27660 ||| JJ
embryos  ||| S:27660 E:27668 ||| NN
were  ||| S:27668 E:27673 ||| VBD
cultured  ||| S:27673 E:27682 ||| VBN
in  ||| S:27682 E:27685 ||| IN
100  ||| S:27685 E:27689 ||| CD
μl  ||| S:27689 E:27692 ||| NN
of  ||| S:27692 E:27695 ||| IN
G  ||| S:27695 E:27697 ||| NNP
1.2  ||| S:27697 E:27701 ||| CD
medium  ||| S:27701 E:27708 ||| NN
for  ||| S:27708 E:27712 ||| IN
6  ||| S:27712 E:27714 ||| CD
h  ||| S:27714 E:27728 ||| NNS
and  ||| S:27728 E:27732 ||| CC
then  ||| S:27732 E:27737 ||| RB
examined  ||| S:27737 E:27746 ||| VBN
for  ||| S:27746 E:27750 ||| IN
nuclear  ||| S:27750 E:27758 ||| JJ
swelling  ||| S:27758 E:27767 ||| NN
and  ||| S:27767 E:27771 ||| CC
polar  ||| S:27771 E:27777 ||| JJ
body  ||| S:27777 E:27794 ||| NN
formation ||| S:27794 E:27803 ||| NN
.  ||| S:27803 E:27805 ||| .
When  ||| S:27805 E:27810 ||| WRB
confluent  ||| S:27810 E:27820 ||| JJ
cells  ||| S:27820 E:27826 ||| NNS
were  ||| S:27826 E:27831 ||| VBD
used  ||| S:27831 E:27836 ||| VBN
as  ||| S:27836 E:27839 ||| IN
donors ||| S:27839 E:27845 ||| NNS
,  ||| S:27845 E:27859 ||| ,
embryos  ||| S:27859 E:27867 ||| NN
were  ||| S:27867 E:27872 ||| VBD
cultured  ||| S:27872 E:27881 ||| VBN
in  ||| S:27881 E:27884 ||| IN
G1.2  ||| S:27884 E:27889 ||| CD
medium  ||| S:27889 E:27896 ||| NN
supplemented  ||| S:27896 E:27909 ||| NN
with  ||| S:27909 E:27926 ||| IN
7.5  ||| S:27926 E:27930 ||| CD
μg ||| S:27930 E:27932 ||| FW
/ ||| S:27932 E:27933 ||| FW
ml  ||| S:27933 E:27936 ||| FW
cytochalasin  ||| S:27936 E:27949 ||| FW
B  ||| S:27949 E:27951 ||| NNP
for  ||| S:27951 E:27955 ||| IN
2  ||| S:27955 E:27957 ||| CD
h  ||| S:27957 E:27959 ||| NN
after  ||| S:27959 E:27965 ||| IN
activation  ||| S:27965 E:27976 ||| VBG
to  ||| S:27976 E:27991 ||| TO
prevent  ||| S:27991 E:27999 ||| VB
extrusion  ||| S:27999 E:28009 ||| NN
of  ||| S:28009 E:28012 ||| IN
polar  ||| S:28012 E:28018 ||| JJ
bodies  ||| S:28018 E:28025 ||| NNS
[  ||| S:28025 E:28027 ||| -LRB-
44 ||| S:28027 E:28029 ||| CD
] ||| S:28029 E:28030 ||| -RRB-
.  ||| S:28030 E:28066 ||| .
Development  ||| S:28066 E:28078 ||| NN
of  ||| S:28078 E:28081 ||| IN
Reconstructed  ||| S:28081 E:28095 ||| NNP
Embryos  ||| S:28095 E:28115 ||| NNP
Experiment  ||| S:28115 E:28126 ||| NNP
4  ||| S:28126 E:28128 ||| CD
was  ||| S:28128 E:28132 ||| VBD
undertaken  ||| S:28132 E:28143 ||| VBN
to  ||| S:28143 E:28146 ||| TO
compare  ||| S:28146 E:28154 ||| VB
in  ||| S:28154 E:28157 ||| IN
vitro  ||| S:28157 E:28175 ||| JJ
developmental  ||| S:28175 E:28189 ||| JJ
abilities  ||| S:28189 E:28199 ||| NNS
of  ||| S:28199 E:28202 ||| IN
reconstructed  ||| S:28202 E:28216 ||| JJ
embryos  ||| S:28216 E:28236 ||| NNS
produced  ||| S:28236 E:28245 ||| VBN
by  ||| S:28245 E:28248 ||| IN
transferring  ||| S:28248 E:28261 ||| VBG
confluent  ||| S:28261 E:28271 ||| NNS
or  ||| S:28271 E:28286 ||| CC
nocodazole-treated  ||| S:28286 E:28305 ||| JJ
cells  ||| S:28305 E:28311 ||| NNS
into  ||| S:28311 E:28316 ||| IN
enucleated  ||| S:28316 E:28327 ||| JJ
M  ||| S:28327 E:28329 ||| NNP
I  ||| S:28329 E:28331 ||| NNP
or  ||| S:28331 E:28334 ||| CC
M  ||| S:28334 E:28336 ||| NNP
II  ||| S:28336 E:28351 ||| NNP
oocytes  ||| S:28351 E:28359 ||| VBD
as  ||| S:28359 E:28362 ||| RB
described  ||| S:28362 E:28372 ||| VBN
above ||| S:28372 E:28377 ||| IN
.  ||| S:28377 E:28379 ||| .
After  ||| S:28379 E:28385 ||| IN
culture  ||| S:28385 E:28393 ||| NN
in  ||| S:28393 E:28396 ||| IN
G1.2  ||| S:28396 E:28413 ||| CD
medium  ||| S:28413 E:28420 ||| NN
for  ||| S:28420 E:28424 ||| IN
3  ||| S:28424 E:28426 ||| CD
days ||| S:28426 E:28430 ||| NNS
,  ||| S:28430 E:28432 ||| ,
the  ||| S:28432 E:28436 ||| DT
embryos  ||| S:28436 E:28444 ||| NN
were  ||| S:28444 E:28449 ||| VBD
transferred  ||| S:28449 E:28461 ||| VBN
into  ||| S:28461 E:28478 ||| IN
100  ||| S:28478 E:28482 ||| CD
μl  ||| S:28482 E:28485 ||| NN
of  ||| S:28485 E:28488 ||| IN
G2.2  ||| S:28488 E:28493 ||| CD
medium  ||| S:28493 E:28500 ||| NN
[  ||| S:28500 E:28502 ||| -LRB-
60 ||| S:28502 E:28504 ||| CD
]  ||| S:28504 E:28506 ||| -RRB-
and  ||| S:28506 E:28510 ||| CC
continued  ||| S:28510 E:28520 ||| VBD
to  ||| S:28520 E:28523 ||| TO
be  ||| S:28523 E:28538 ||| VB
cultured ||| S:28538 E:28546 ||| NNS
.  ||| S:28546 E:28548 ||| .
The  ||| S:28548 E:28552 ||| DT
embryos  ||| S:28552 E:28560 ||| NN
were  ||| S:28560 E:28565 ||| VBD
examined  ||| S:28565 E:28574 ||| VBN
for  ||| S:28574 E:28578 ||| IN
cleavage  ||| S:28578 E:28587 ||| NN
and  ||| S:28587 E:28603 ||| CC
blastocyst  ||| S:28603 E:28614 ||| JJ
formation  ||| S:28614 E:28624 ||| NN
at  ||| S:28624 E:28627 ||| IN
2  ||| S:28627 E:28629 ||| CD
and  ||| S:28629 E:28633 ||| CC
7  ||| S:28633 E:28635 ||| CD
days  ||| S:28635 E:28640 ||| NNS
after  ||| S:28640 E:28646 ||| IN
culture ||| S:28646 E:28653 ||| NN
,  ||| S:28653 E:28667 ||| ,
respectively ||| S:28667 E:28679 ||| RB
.  ||| S:28679 E:28681 ||| .
At  ||| S:28681 E:28684 ||| IN
the  ||| S:28684 E:28688 ||| DT
end  ||| S:28688 E:28692 ||| NN
of  ||| S:28692 E:28695 ||| IN
the  ||| S:28695 E:28699 ||| DT
culture  ||| S:28699 E:28707 ||| NN
period ||| S:28707 E:28713 ||| NN
,  ||| S:28713 E:28715 ||| ,
the  ||| S:28715 E:28731 ||| DT
number  ||| S:28731 E:28738 ||| NN
of  ||| S:28738 E:28741 ||| IN
cells  ||| S:28741 E:28747 ||| NNS
in  ||| S:28747 E:28750 ||| IN
blastocysts  ||| S:28750 E:28762 ||| NN
was  ||| S:28762 E:28766 ||| VBD
examined ||| S:28766 E:28774 ||| VBN
.  ||| S:28774 E:28776 ||| .
The  ||| S:28776 E:28792 ||| DT
blastocysts  ||| S:28792 E:28804 ||| NN
were  ||| S:28804 E:28809 ||| VBD
placed  ||| S:28809 E:28816 ||| VBN
on  ||| S:28816 E:28819 ||| IN
slides  ||| S:28819 E:28826 ||| NNS
with  ||| S:28826 E:28831 ||| IN
a  ||| S:28831 E:28833 ||| DT
drop  ||| S:28833 E:28838 ||| NN
of  ||| S:28838 E:28853 ||| IN
mounting  ||| S:28853 E:28862 ||| VBG
medium  ||| S:28862 E:28869 ||| NN
consisting  ||| S:28869 E:28880 ||| VBG
of  ||| S:28880 E:28883 ||| IN
glycerol  ||| S:28883 E:28892 ||| NN
and  ||| S:28892 E:28896 ||| CC
PBS  ||| S:28896 E:28900 ||| NNP
( ||| S:28900 E:28901 ||| -LRB-
9 ||| S:28901 E:28902 ||| CD
: ||| S:28902 E:28903 ||| :
1 ||| S:28903 E:28904 ||| LS
)  ||| S:28904 E:28918 ||| -RRB-
containing  ||| S:28918 E:28929 ||| FW
0.1  ||| S:28929 E:28933 ||| FW
mg ||| S:28933 E:28935 ||| FW
/ ||| S:28935 E:28936 ||| FW
ml  ||| S:28936 E:28939 ||| FW
Hoechst  ||| S:28939 E:28947 ||| NNP
33342 ||| S:28947 E:28952 ||| CD
.  ||| S:28952 E:28954 ||| .
A  ||| S:28954 E:28956 ||| DT
cover  ||| S:28956 E:28962 ||| NN
slip  ||| S:28962 E:28967 ||| NN
was  ||| S:28967 E:28983 ||| VBD
placed  ||| S:28983 E:28990 ||| VBN
on  ||| S:28990 E:28993 ||| IN
the  ||| S:28993 E:28997 ||| DT
top  ||| S:28997 E:29001 ||| NN
of  ||| S:29001 E:29004 ||| IN
the  ||| S:29004 E:29008 ||| DT
blastocysts  ||| S:29008 E:29020 ||| NN
and  ||| S:29020 E:29024 ||| CC
the  ||| S:29024 E:29028 ||| DT
edge  ||| S:29028 E:29033 ||| NN
was  ||| S:29033 E:29049 ||| VBD
sealed  ||| S:29049 E:29056 ||| VBN
with  ||| S:29056 E:29061 ||| IN
fingernail  ||| S:29061 E:29072 ||| JJ
polish ||| S:29072 E:29078 ||| NN
.  ||| S:29078 E:29080 ||| .
The  ||| S:29080 E:29084 ||| DT
numbers  ||| S:29084 E:29092 ||| NNS
of  ||| S:29092 E:29095 ||| IN
nuclei  ||| S:29095 E:29114 ||| NN
were  ||| S:29114 E:29119 ||| VBD
counted  ||| S:29119 E:29127 ||| VBN
under  ||| S:29127 E:29133 ||| IN
ultraviolet  ||| S:29133 E:29145 ||| JJ
light ||| S:29145 E:29150 ||| NN
.  ||| S:29150 E:29191 ||| .
Statistical  ||| S:29191 E:29203 ||| NNP
Analysis  ||| S:29203 E:29222 ||| NNP
All  ||| S:29222 E:29226 ||| DT
percentage  ||| S:29226 E:29237 ||| NN
data  ||| S:29237 E:29242 ||| NNS
were  ||| S:29242 E:29247 ||| VBD
subjected  ||| S:29247 E:29257 ||| VBN
to  ||| S:29257 E:29260 ||| TO
an  ||| S:29260 E:29263 ||| DT
arcsin  ||| S:29263 E:29270 ||| JJ
square  ||| S:29270 E:29287 ||| JJ
root  ||| S:29287 E:29292 ||| NN
transformation  ||| S:29292 E:29307 ||| NN
in  ||| S:29307 E:29310 ||| IN
each  ||| S:29310 E:29315 ||| DT
replicate  ||| S:29315 E:29325 ||| NN
and  ||| S:29325 E:29329 ||| CC
the  ||| S:29329 E:29333 ||| DT
transformed  ||| S:29333 E:29355 ||| JJ
values  ||| S:29355 E:29362 ||| NNS
were  ||| S:29362 E:29367 ||| VBD
analyzed  ||| S:29367 E:29376 ||| VBN
using  ||| S:29376 E:29382 ||| VBG
one-way  ||| S:29382 E:29390 ||| JJ
( ||| S:29390 E:29391 ||| -LRB-
Experiment  ||| S:29391 E:29402 ||| NNP
2 ||| S:29402 E:29403 ||| CD
)  ||| S:29403 E:29405 ||| -RRB-
or  ||| S:29405 E:29418 ||| CC
two-way  ||| S:29418 E:29426 ||| NNP
( ||| S:29426 E:29427 ||| -LRB-
Experiments  ||| S:29427 E:29439 ||| NNP
3  ||| S:29439 E:29441 ||| CD
and  ||| S:29441 E:29445 ||| CC
4 ||| S:29445 E:29446 ||| LS
)  ||| S:29446 E:29448 ||| -RRB-
ANOVA  ||| S:29448 E:29454 ||| NNP
followed  ||| S:29454 E:29463 ||| VBD
by  ||| S:29463 E:29476 ||| IN
Student-Newman-Keuls  ||| S:29476 E:29497 ||| JJ
test ||| S:29497 E:29501 ||| NN
.  ||| S:29501 E:29503 ||| .
The  ||| S:29503 E:29507 ||| DT
numbers  ||| S:29507 E:29515 ||| NNS
of  ||| S:29515 E:29518 ||| IN
cells  ||| S:29518 E:29524 ||| NNS
in  ||| S:29524 E:29537 ||| IN
blastocysts  ||| S:29537 E:29549 ||| NN
were  ||| S:29549 E:29554 ||| VBD
analyzed  ||| S:29554 E:29563 ||| VBN
using  ||| S:29563 E:29569 ||| VBG
Student  ||| S:29569 E:29577 ||| NNP
t-test ||| S:29577 E:29583 ||| NNP
.  ||| S:29583 E:29585 ||| .
A  ||| S:29585 E:29597 ||| DT
probability  ||| S:29597 E:29609 ||| NN
of  ||| S:29609 E:29612 ||| IN
P  ||| S:29612 E:29614 ||| NN
< ||| S:29614 E:29616 ||| SYM
0.05  ||| S:29616 E:29621 ||| CD
was  ||| S:29621 E:29625 ||| VBD
considered  ||| S:29625 E:29636 ||| VBN
statistically  ||| S:29636 E:29660 ||| RB
significant ||| S:29660 E:29671 ||| JJ
.  ||| S:29671 E:29697 ||| .
